










The handle http://hdl.handle.net/1887/32932 holds various files of this Leiden University 
dissertation 
 
Author: Mast, Mirjam 
Title: Avoiding the heart : about optimising whole breast irradiation 
Issue Date: 2015-06-23 
About optimising whole 






About optimising whole breast irradiation
AVOIDING THE HEART
About optimising whole breast irradiation
Mirjam Mast
Cover idee   Floris Mast
Grafisch ontwerp  Suze Swarte grafisch ontwerp i.s.m. Laura Bolczek
Printed by   Cito Repro Groep, Amsterdam
ISBN    978-90-822415-1-8
© Mirjam Mast, The Netherlands, 2015
Avoiding the heart. About optimising whole breast irradiation.
Thesis, Leiden University, The Netherlands, 2015
All rights reserved. 
No part of this publication may be reproduced, stored in a retrieval system, or transmit-
ted in any form or by anymeans, electronic or mechanical, including photocopying, and 
recording, or otherwise, without the written permission of the author.
AVOIDING THE HEART
About optimising whole breast irradiation
Proefschrift
ter verkrijging van 
de graad van Doctor aan de Universiteit Leiden,
op gezag van Rector Magnificus prof. mr. C.J.J.M. Stolker, 
volgens besluit van het College voor Promoties
te verdedigen op dinsdag 23 juni 2015 klokke 15.00 uur
door
 Mirjam Esther Mast 
geboren te Haarlem 
in 1970
AVOIDING THE HEART
About optimising whole breast irradiation
Promotiecommissie 
Promotor  Prof. dr. H. Struikmans 
Co-promotores   Dr. A.L. Petoukhova, MCHaaglanden, Den Haag 
   Dr. A.N. Scholten, NKI-AvL, Amsterdam 
Overige leden   Prof. dr. J.W.R. Nortier 
   Prof. dr. J.P. Pignol, Erasmus Universiteit, Rotterdam 
   Prof. dr. E.J.Th. Rutgers, Universiteit van Amsterdam 
Te weten wat men weet, 
en te weten wat men niet weet, 
dat is kennis. 
Confucius (China 551-479 v.Chr.)
CONTENTS
General introduction          11 
       
Chapter 1        23
MRI and target volume delineation of the glandular 
breast tissue and the lumpectomy cavity
    Optimal registration method of MRI and CT for delineation in   25
   radiotherapy planning of breast cancer patients treated with 
   breast conserving therapy 
   Target volume delineation in breast conserving radiotherapy:   43
   are co-registered  CT and MR images of added value?
Chapter 2
Treatment planning studies in whole breast irradiation    57 
to reduce heart and LAD dose
   A heart sparing technique in women with left-sided breast cancer.   59 
   Results of 4 years of experience in Radiotherapy Centre West
   Left-sided breast cancer radiotherapy with and without breath-hold: 69      
   Does IMRT reduce the cardiac dose even further?
   Whole breast proton irradiation for maximal reduction of heart dose  81
   in breast cancer patients Reduction of heart dose in left-sided whole 
   breast irradiation: IMRT versus TomoTherapy in breath-hold
   Tangential IMRT versus TomoTherapy with and without breath-hold  95
   in left-sided whole breast irradiation 
Chapter 3        105
Vascular heart damage before and after whole breast irradiation
   Preradiotherapy calcium scores of the coronary arteries in a             107
   cohort of women with early-stage breast cancer: A comparison with  
   acohort of healthy women
   Less increase of CT based calcium scores of the coronary arteries   119 
   three years after breast-conserving radiotherapy using breath-hold 
General discussion        133
 
   Concluding remarks                                          144
Summary         153
Samenvatting         159
Appendices         165
   Abbreviations
   List of publications  
   Curriculum Vitae






Over the past decades, an increasing incidence in breast cancer has been observed in Eu-
rope [1]. Arnold et al. showed an estimated annual percentage change (APC): of 1.1% 
for women in the age group 35-49 years and of 0.7% in the age group 50-74 years 
during 1998-2007. An APC of 1.1% and 0.7% stands for an increasing trend in breast 
cancer incidence [2]. Female breast cancer represents around 30% of all new cancer cas-
es in Europe [3]. In comparison to other countries, The Netherlands shows one of the 
highest breast cancer rates. In 2012, over 14,000 women were diagnosed with invasive 
breast cancer and around 2,200 women with breast carcinoma in situ [4].
Mastectomy was the standard local treatment modality in the early years of breast 
cancer treatment. However, several large prospectively randomised controlled trials 
showed that the overall survival after breast conserving surgery followed by radiation 
therapy was comparable to that of mastectomy [5-8]. Based on these findings, breast 
conserving therapy (including whole breast irradiation) was introduced around 1980. 
As it was unclear at that time whether a boost dose was meaningful, the EORTC boost-
no boost trial was launched. This phase-III trial showed that a boost dose improved 
the local control in all age categories (with hazard ratios varying from 0.49-0.76). The 
absolute risk reduction was most pronounced in patients under 40 years that received 
a boost dose [9]. 
Furthermore, in 2011 the meta-analysis of the Early Breast Cancer Trialists’ Collabora-
tive Group (EBCTCG) showed that breast cancer recurrences were decreased by 50% 
when using radiotherapy after breast conserving surgery in breast cancer patients with 
different absolute risks. Apart from this, a decrease of breast cancer death (after 15 
years) and any death was noted when applying radiotherapy [10]. Finally, it appeared 
that the use of adjuvant systemic therapy significantly contributed to obtaining a lower 
risk of ipsilateral recurrent disease [11].   
These results show that radiotherapy is of importance, and is, therefore, an integral 
part of the breast conserving therapy. However, several improvements in the radiation 
therapy treatment can be realised. A relatively new development is the introduction of 
hypofractionation schemes. Several randomized studies reported comparable local con-
trol rates and breast cosmesis for the hypofractionation schedule compared to those of 
the standard treatment (25x2Gy per fraction) [12,13]. According to Whelan et al. the 
hypofractionation schedule is more convenient for patients and less costly, which may 
result in an increase in the number of women receiving whole breast irradiation after 
breast conserving surgery [13]. The implementation of Accelerated Partial Breast Irra-
diation (APBI) techniques is the latest step in adapting the radiation treatment, applied 
following the ASTRO and ESTRO guidelines for the “low risk” group [14,15].
Over the past few years, radiation therapy techniques in breast cancer treatment have 
changed. Since 2000, planning computed tomography (CT) scans have been applied 
and radiation oncologists have started delineating target volumes (i.e. the glandular 
breast tissue and the lumpectomy cavity) as well as the critical structures surrounding 
the target volumes, in order to obtain information about the dose in these volumes. 
The used treatment planning techniques changed from 2D planning techniques to 3D 
conformal radiotherapy planning techniques (3D-CRT). And in just one decade other 
techniques such as Intensity Modulated Radiotherapy (IMRT), rotational therapy (Vol-
umetric Modulated Arc Therapy (VMAT), TomoTherapy) have made their appearance. 
Furthermore, within a few years, the Magnetic Resonance Imaging (MRI) accelerator 
will make its clinical entrance in The Netherlands, which accordingly will result in new 
insights [16].
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However, as it is the case for every medical treatment, side effects occur when applying 
radiotherapy [17]. Preclinical and clinical studies suggest that breast cancer radiother-
apy is associated with an increased rate of major coronary events [6,18,19]. This is 
especially applicable for patients with left-sided breast cancer [20-25]. Consequently, 
irradiation of left-sided breast cancer patients implies that special attention should be 
paid to avoid late radiation induced coronary artery toxicity by applying optimised 
treatment techniques.
MRI and target volume delineation of the glandular breast 
tissue and the lumpectomy cavity 
Before starting with the treatment planning process the target volume needs to be de-
fined. Several authors studied the differences in delineating the glandular breast volume 
and the lumpectomy cavity volume [26-28]. Li et al. showed that differences in target 
volume delineation for whole breast irradiation were of significance both clinically and 
dosimetrically. For example, in one of the case studies, the heart volume receiving 20 Gy 
varies from 0% to 7% according to the various delineations performed by nine radia-
tion oncologists [29]. This indicates that guidelines for defining the target volume and 
the heart are needed. 
Besides using delineation protocols, the used imaging modalities are of importance in 
delineating the target volumes. In radiation therapy, the standard imaging modality is 
the CT scan. MRI is a diagnostic imaging modality that has proven to increase the vis-
ualisation of soft tissues [30], and has shown to improve the agreement between observ-
ers in delineating the breast cancer lumpectomy cavity volume in an APBI study using 
brachytherapy [31]. Therefore, an increased visibility of the glandular breast tissue and 
the lumpectomy cavity may be obtained by using MRI based delineation instead of CT 
based delineation. The latter may enable a further decrease of the interobserver varia-
tion in delineating the glandular breast tissue as well as that of the lumpectomy cavity. 
Therefore, we hypothesised that an MRI technique could improve the delineation of 
the glandular breast cancer target volume and the lumpectomy cavity in external beam 
radiation treatment. We performed two studies to examine the differences in glandular 
breast tissue (GBT) and lumpectomy cavity (LC) volume delineation on the MRI and 
the CT. And we assessed the inter-observer variability for both volumes on both imag-
ing modalities as well. For a total of 15 patients, who underwent a MRI and CT scan 
in supine position, it appeared that no differences were found delineating the volumes 
on MRI compared to CT. Also the inter-observer variability was comparable for both 
imaging modalities [32,33]. However, still the question remained if the observers agree-
ment could be improved after co-registration of the MRI and the CT. 
Treatment planning studies in whole breast irradiation to reduce 
heart and left anterior descending (LAD) coronary artery dose 
The literature shows that reducing the heart and LAD coronary artery dose is a major 
issue when applying radiotherapy [24], even in today’s improved treatment planning 
techniques [23]. A breath-hold technique can be used to reduce the dose in the heart 
and the heart vessels. Over the past few years, several authors carried out studies to 
evaluate the pros and cons of various breath-hold techniques and these have proven to 
be easy performable and reproducible [34-38]. In 2008 the Active Breathing Control 
(ABC) method, a breath-hold technique, was introduced in our institution (Radiothera-
py Centre West, RCWEST). Because of the ALARA (As Low As Reasonably Achievable) 
principle, and in the absence of a threshold dose for the radiation-induced damage to 
General introduction
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the heart and the main coronary artery, the LAD dose should be minimised in all pa-
tients. Therefore, all left-sided breast cancer patients were treated with this breath-hold 
technique, without setting an age limit, since 2010. After two years, the feasibility of our 
ABC method was evaluated. It appeared that 98% of our breast cancer patients were 
able to undergo the breath-hold technique [39]. 
As RCWEST aims to continuously improve radiation treatment we tried to identify which 
treatment technique would be best in the reduction of the dose to the critical structures, 
i.e. the heart and the LAD. Therefore, several treatment planning studies were carried out. 
Yartsev et al. confirmed that treatment planning studies are valuable to explore if (new) 
treatment planning techniques meet the constraints according to the department re-
quirements [40]. Our hypothesis was, that Intensity Modulated Radiotherapy (IMRT), 
proton therapy and TomoTherapy would be superior in sparing the heart and LAD 
than a standard 3D-Conformal Radiotherapy (3D-CRT) technique. 
Vascular heart damage before and after whole breast irradiation
Several risk factors play a role in developing breast cancer [2,39]. In the Dutch national 
guideline of diagnosis and treatment of breast cancer the various risk factors are sum-
marised, see Figure 1 [41]. 
The relative risk of physical inactivity and a high Body Mass Index were indicated 
as risk factors in the overview (Figure 1). Acccording to the World Heart Federation 
(WHF), both were also indicated as risk factors of heart disease as well.
The WHF reported that 6% and 5% of global deaths were attributed to physical inac-
tivity and a high Body Mass Index, respectively; the leading risk factor of heart disease 
is hypertension, to which 13% of global deaths are attributed. Furthermore, women 
experience an increased risk of heart disease with increasing age [42]. 
Taking into account the above described risks the question arose whether breast cancer 
patients have an a priori higher risk for developing heart disease. 
The Framing Risk Score (FRS) is the most commonly used Coronary Artery Disease (CAD) 
risk prediction score [43]. However, Oudkerk et al. state that the FRS does not take lifestyle 
factors and the extent of atherosclerotic disease burden into account [44]. The calcium 
score (number of calcium deposits) in the coronary arteries (CAC scores), as a surrogate 
of total atheroma burden, appears to predict the risk of subsequent cardiovascular events 
in cases without symptomatic CAD [44,45]. The calcium score measurement is based on 
a non-invasive CT scan and appears to improve the FRS predictions [46]. Therefore, we 
investigated the calciumscores in three cohorts of breast cancer patients. 
As was stated above, radiation therapy has side effects on critical organs surrounding 
the glandular breast tissue, such as the lungs, the contralateral breast and the heart and 
the coronary arteries. Several studies pointed out that radiation treatment for left-sided 
breast cancer increased the risk of heart disease [20-25]. 
We hypothesised that patients with left-sided breast cancer were more at risk for an 
increase in CAC scores than patients with right-sided breast cancer or left-sided breast 
cancer treated with a heart sparing radiation technique. Therefore, a longitudinal study 
was conducted to follow a cohort of breast cancer patients before and 3 years after the 
radiation treatment in order to evaluate the possible effects on the CAC scores. 
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Figure 1: Risk factors for developing breast cancer [41].
Factor Relative risk Reference 
Older age (over age 45 versus under age 25) < 10 Dumitrescu 2005 
McPherson 2000 
Mutations in BRCA1/2 6 – 8 Dumitrescu 2005 
McPherson 2000 
Geographic region (North American and Northern Europe versus the 
Far East, Africa and South America) 
5 - 10 Dumitrescu 2005 
High density mammogram 4 - 6 Boyd 2010 
Atypical benign breast laesions: 
Atypical (ductal or lobular) hyperplasia, flat epithelial atypia, lobular 
carcinoma in situ, papillary laesions and complex sclerosing laesions 
(radial scars) 




Prior history of radiation; chest and/or axillary radiation, e.g. due to 
Hodgkin’s lymphoma before age 40 
3 - 20 De Bruin 2009 
Van Leeuwen 2003 
Aleman 2003 
Breast carcinoma or DCIS in medical history 2 - 4 Morrow 1999 
Late age at the time of first child, over age 35 vs. before age 20 2 Dumitrescu 2005 
McPherson 2000 
High postmenopausal bone density 2 - 3.5 Dumitrescu 2005 
Diethylstillbestrol (DES) use during pregnancy 2 McPherson 2000 
Late menopause, after age 54 ≤ 2 Dumitrescu 2005 
McPherson 2000 
Morrow 1999 
Nulliparity < 2 Dumitrescu 2005 
McPherson 2000 
Morrow 1999 
Hormone replacement therapy (HRT) use for over 10 years 1.4 - 3 Dumitrescu 2005 
Alcohol intake, risk is dose-dependent, 2-5 units per day vs. no 
alcohol intake 










Mutations in other highly penetrant genes; p53, PTEN 1 - 6 Dumitrescu 2005 
Early menarche, before age 11 1 - 3 Dumitrescu 2005 
McPherson 2000 
Morrow 1999 
Physical exercise 5x per week vs. inactivity 0.85 Patterson 2010 
Bernstein 2009 






Premenopausal, body mass index > 35 






Outline of this thesis 
The first and second parts of this thesis focus on optimizing the radiation treatment 
technique. In chapter 1 we analyse the optimization of the breast target volume deline-
ation and the additional value of coregistered CT/MR images. 
As confirmed in the literature, sparing the heart when applying a radiation therapy 
technique is of great importance. We evaluated the use of the Active Breathing Con-
trol method, as used in RCWEST. Furthermore, three planning studies are described in 
chapter 2, evaluating the best treatment planning technique. 
In chapter 3, the cardiac side-effects of radiation therapy are described. Firstly, the 
baseline characteristics of a cohort of breast cancer patients in RCWEST are analysed 
and compared to a cohort of healthy Caucasian women. Secondly, we prospectively an-
alysed if there were differences in calcium scores before and three years after radiation 
treatment found in three groups of patients treated with radiation treatment for breast 
cancer.
Finally, the main findings of this thesis are summarised and discussed and recommenda-
tions for clinical practice are given. 
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Registration of MRI and CT for target volume delineation in 
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To assess the optimal method of MRI to CT registration of the glandular breast tissue 
(GBT) and the lumpectomy cavity (LC).
Materials and methods
After breast conserving surgery 10 breast cancer patients underwent a planning-CT and 
a MRI (1.5 T, T1 weighted) in supine radiotherapy treatment position. Co-registration 
of the CT and MR images was performed with five different methods (breast-markers, 
thoracic-markers, surgical (titanium) clips, normalized mutual information and local 
correlation). Parameters of the rigid-body transformation (3D translation and 3D rota-
tion) to match the CT and MRI were recorded. Accuracy was evaluated by comparing 
the misalignment between CT and MR for breast-markers, thoracic-markers, surgical 
clips and all fiducials. Additionally, an evaluation was performed by delineating the 
GBT based on CT and MRI by four observers (two radiation oncologists and two 
radiologists). We determined which registration procedure yields the smallest non-over-
lapping (rest) volume.
Results
The thoracic-marker-based registration resulted in smallest MRI-CT distances between 
breast markers. For the surgical clip evaluation, the mean MRI-CT distance for the 
breast-marker-based registration is the lowest. But the use of surgical clips for MRI-CT 
registration resulted in large rotations (> 3˚) for 7 out of 8 patients. Moreover, clips 
were not always well visible on the MR images. The thoracic-marker-based and breast-
marker-based registrations resulted in the smallest MRI-CT displacements between all 
fiducials.
Co-registration of CT and MR data sets based on breast-markers gave the best result 
for the GBT delineation in terms of the rest volume.
Conclusions
The use of breast markers for MRI-CT co-registration gives the best results and is rec-
ommended not only for delineation of the GBT, but also for delineation of the lumpec-
tomy cavity. For lumpectomy cavity delineation the clip-based registration is an alter-




In radiotherapy, target volume delineation is based on computed tomography (CT), 
while magnetic resonance imaging (MRI) is able to complement the CT data for its 
superior soft tissue visualisation. The added value of co-registration of CT together 
with MR images was clearly assessed for various tumour sites such as brain, head-and-
neck and prostate [1-3]. However, this added value was not studied in detail for breast 
cancer radiotherapy [4]. There are some published data available about registration 
of MR images with mammography and ultrasound [5]. Kirby et al. [6] and Jolicoeur 
et al. [7] described co-registration of CT to MR images (in prone position and supine 
position, respectively) for breast cancer radiotherapy. These two studies focussed on 
co-registration of CT/MRI for surgical bed volumes. For patients in supine position, 
comparison of CT and MRI remains difficult due to the limited bore size of conven-
tional closed MRI scanners (for example, 60 cm in diameter for a Siemens Magnetom 
Symphony MRI scanner), respiratory motion artifacts, and distortion of breast tissue 
by overlying MR receiver coils. In our previous studies [8,9], a first attempt to find an 
added value of MRI was described for delineation of the glandular breast tissue (GBT) 
and lumpectomy cavity, respectively. In these studies non-registered CT and MR scans 
were used. To investigate whether MRI indeed improves GBT and lumpectomy cavity 
delineation, a method has to be developed for accurate rigid registration of MR and CT 
in breast cancer.
The majority of registration algorithms in medical imaging can be classified as being 
either frame based [10], point based [11] or voxel based [12]. Stereotactic frame-based 
registration is very accurate, but not suitable for breast imaging. The anatomical point-
based registration methods are labour-intensive and their accuracy depends on the ac-
curate identification of corresponding landmarks in all modalities. Voxel-based regis-
tration methods [12] optimize the similarity of all geometrically corresponding voxel 
pairs for some features. The overall registration accuracy should be within an accept-
able tolerance for 3D treatment planning (2–5 mm) [13]. According to Fraass et al. 3D 
registration results in about 2 mm accuracy, including distortions and transfer of MRI 
contours to CT dataset [13].
Nowadays rigid image registration has become more accurate [4,14]. According to De-
vic et al. [4] the MRI to CT image co-registration error is of the order of 1–2 mm, 
except for deformable methods. However, the magnitude of the co-registration error 
depends on the co-registration technique and also on the anatomical site. Skerl et al. 
[14] compared 12 similarity measures for the rigid registration of multi-modal head 
images. They concluded that the results for the registration of CT to MR images and 
MR to CT images indicate that such methods as normalized mutual information are 
the most accurate similarity measures and have the smallest risk of being trapped in a 
local optimum.
In addition to the clinically used large region of interest (ROI), a registration of multiple 
ROIs can be used (mROI). Van Kranen et al. [15] proposed to use this method (based 
on mROI registration of cone beam computed tomography scans and the planning CT) 
and van Beek et al. [16] reported the first clinical experience with this method for head-
and-neck cancer patients.
In our study, CT and MR images of ten breast cancer patients who were candidates 
for breast conserving therapy were made in supine position after surgery and before 
starting the radiotherapy treatment. On the breast of these patients breast markers 
were placed. For these patients co-registration of the CT and MR images was per-
formed with five different methods (breast-markers, thoracic-markers, surgical clips, 
anatomical markers, normalized mutual information (NMI) [12] and local correlation 
Target volume delineation 
28
[17]. The rigid-body transformation consists of a 3D translation and 3D rotation, and 
these parameters were recorded for each registration method. Registration accuracy 
was evaluated by performing a comparison of the misalignment between CT and MR 
by breast-markers, thoracic-markers, surgical clips and all fiducials (breast-markers, 
thoracic-markers and surgical clips). Additionally, an evaluation was performed by de-
lineating the GBT on CT and MRI by four observers (two radiation oncologists and 
two radiologists). Thereafter, we investigated which registration procedure yields the 
smallest non-overlapping volume (rest volume).
The aim of this manuscript is to describe advantages and disadvantages of each regis-




Ten patients with early stage breast cancer (clinicallyT1-2; N0-1) were treated with 
breast conserving therapy (patients did not undergo en bloc axillary dissection). After 
referral to the radiotherapy department a planning-CT scan and directly afterwards an 
MRI scan were performed. Patient and tumour characteristics are presented in Table 
1. All patients confirmed participation in our study by signing an informed consent. 
The study was approved by the regional institutional review board METC Zuidwest 
Holland [18].
Table 1.  Patient and tumour characteristics.  
Abbreviations: *pre = premenopausal; †post = postmenopausal.
CT and MR images of patients
Patients underwent planning CT followed by MRI in the same supine radiotherapy treat-
ment position. No intravenous contrast was used. Patients were imaged in supine po-
sition with back, shoulders and arms supported by a CT and MRI compatible wedge 
(Thorawedge, CIVCO Medical Solutions, The Netherlands) at 5˚ slope angle and with a 
knee support for comfort. Both arms were in abduction with both hands jointed above the 
head. CT and MR images were obtained using 3 mm slice thickness from lung apices up 
to diaphragm. The field of view covered the whole of the patient’s chest and both breasts. 
CT scans (using a 512 x 512 matrix and a 1.07 mm pixel size) were performed using an 
AcQSim single slice CT scanner (Philips Medical Systems, Cleveland, OH, USA) with a 
bore size of 85 cm. MR images were taken using a Magnetom Symphony 1.5 T scanner 
(Syngo MR 2004A MRI, Siemens, The Netherlands) with a bore size of 60 cm. Only MR 
images in one direction: T1 weighted TSE (Turbo Spin Echo) transverse MRI scans (256 x 

















or lobular (L) 
carcinoma
57 (44 - 86) †post: 4x L:3x upper outer: 3x pT1:  6x 27 (12 - 41) D: 10x
*pre:   6x R:7x upper inner: 1x pT2:  4x




upper 12 o’ clock: 1x
lower 6 o’ clock: 1x
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No fat suppression was used as the entire GBT including the lumpectomy cavity was in-
tended to be visualized. The MRI body coil was set at a bandwidth of 150.0 Hz/pixel 
with a signal-to-noise ratio of 1. An additional phased-array coil was positioned over the 
affected breast supported by foam blocks aside to the breast to prevent changes of the 
original breast shape and to keep the breast in radiotherapy treatment position. The border 
of palpable GBT was marked with a thin plastic tube by the radiation oncologist (HS) just 
prior to CT scanning. The position of the tube remained the same during both CT and MR 
scanning. For CT and MR imaging the tube was filled with either a copper wire or lipiodol, 
respectively. During CT and MR scans multimodality hydrogel filled markers (MedCaT 
B.V., Erica, The Netherlands) were used to evaluate MR-CT matching possibilities. The do-
nut shaped markers were 15 mm in diameter and had a thickness of 3.5 mm with a hole in 
the middle with a diameter of 5 mm. Four markers were placed along the laser lines on the 
thorax and four markers were placed on the breast (see Figure 1) of each patient. Surgical 
(titanium) clips (Teleflex Medical, Morrisville, NC, USA) within the breast, applied by sur-
geons to mark the borders of the lumpectomy cavity, were no contra-indication for MRI. 
In two of the remaining ten patients no surgical clips were placed in the lumpectomy cavity. 
CT and MR image registration
CT and MR images were registered using Syntegra software of the Pinnacle3 treatment 
planning system (version 8.0, Philips Medical Systems, The Netherlands). Syntegra pro-
vides manual and point-based image registration, and three automated methods of gray 
value voxel-based image registration.
NMI registration is nowadays the state of the art for many clinical sites. For ten breast 
patients, the registration of the MR with CT images was performed with five different 
methods: four point-based (breast-markers, thoracic-markers, and surgical clips) and 
two automated voxel-based (NMI and local correlation) methods. 
Multimodality markers (thoracic-markers or breast-markers) matching was achieved 
by using the midpoint of each marker by one observer (ALP). The midpoints were man-
ually identified on each of the CT and MR scans. Misalignment between CT and MR 
markers was calculated in terms of the distance, defined as the mean of the distances 
between all point pairs. Syntegra software allows for automatic minimization of this 
distance between two sets. 
The centre of gravity of the hole of each donut was manually determined on the axial 
slices of the CT and MR scans, sagittally and coronally reconstructed images were used 
for verification. For each clip, an identical procedure of identification of the centre of 
gravity was manually performed. Impaired visibility of the surgical clips on the MR 
images of some patients [9] made registration on the surgical clips difficult. Moreover, 
the surgical clips were often located close to each other (see e.g. Figure 2).
NMI and local correlation are two automated image registration algorithms in Pinnacle3. 
They are based on maximizing of similarity measures: NMI is based on probability dis-
tributions of the gray values in each image set [12], whereas local correlation assumes a 
local linear relationship between gray values. Local correlation is the default option in 
Syntegra for registration of CT and MR images because it works best for different image 
sets in which equivalent features can easily be seen. After a preliminary study for NMI 
and local correlation the complete set of CT and MR scans were used. Alternatively, a 
bounding box was used to limit the image set to a rectangular box defined by the user. An 
attempt to define the bounding box around the breast of each patient has failed probably 
because of the absence of high-contrast structures such as bones in the breast. Likewise, 
the use of a ROI to limit the existing image set was not preferred because this method is 
time consuming and subjective since the results strongly depend on the ROI delineation.
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Figure 1.  Patient 1 lying in the supine radiotherapy position on a Thorawedge with 5˚ slope angle. Four  
multimodality markers were placed along the laser lines on the thorax (red circles) and four markers 
were placed on the breast (aqua circles). The border of palpable GBT was marked with a thin copper 
wire. Thin blue and green lines indicate the CT and MR scan volumes, respectively.
Figure 2.  Patient 8 (54 years, premenopausal status) with four surgical clips in the breast: sagittal CT (left) and 
MR (right) images registered using breast markers. Note that the four clips, which can be seen on these 
images, are located very close to each other.
Evaluation of the registration accuracy
For each patient and each registration method the rigid-body transformation was record-
ed, defined as a 3D translation along the x-, y- and z-axis and 3D rotation around the 
x-, y- and z-axes. Note that according to the patient’s CT scans, in all cases the x-axis is 
directed from patient’s right to left, the y-axis is directed from posterior to anterior and 
the z-axis is directed from cranial to caudal. Although each patient underwent the CT and 
MR scans in the same treatment position, limited rotations between two scans can occur.
Chapter 1
31
Each registration method started with the movement of the centre of the MR data 
set to the centre of the CT data set. Consecutively the translations and rotations were 
adjusted according to the applied registration method. For each evaluation method the 
fiducials (breast-markers or thoracic-markers or the clips) remained on the same place 
during the CT and MR. For each patient the registration accuracy of each method was 
evaluated (post-registration) by comparison of the average MR-CT displacement of the 
breast-markers or the surgical clips, the thoracic-markers or all fiducials.
In addition to the other registration method evaluations, target delineations (Clinical 
Target Volume) of the GBT by four observers (two radiation oncologists and two ra-
diologists) [8] were used. The GBTs were delineated blind to the viewing contours of 
others and using written delineation instructions according to Giezen et al. [8]. For each 
individual patient, the mean, range and standard deviation values of the GBT delinea-
tion were calculated to evaluate the inter-observer variability in GBT delineation. For 
each registration method an averaged rest volume over the four observers on CT and 
MR images was determined according to Rasch et al. [19]. The rest volume (CT, MRI) 
was determined for each observer and consisted of specific parts of the GBT volumes, 
which were delineated on CT but not on MRI.
MR image distortion and validation of the methods used
Sources of MRI distortion can be divided into two groups: machine related distor-
tions and object induced (i.e. patient dependant) effects [4]. Machine related distortions 
could be quantified and subsequently corrected for. Modern MRI scanners compensate 
for the majority of machine-derived distortions [4]. Object induced distortions arise 
from magnetic susceptibility effects, which modify the local magnetic field and tend to 
be most pronounced at air/tissue boundaries. The other major source of object induced 
distortions is chemical shift. Protons in fatty tissues resonate at slightly lower frequen-
cies than those in water. The difference in frequency is called chemical shift [20] and 
water-fat shift (WFS) for the specific case of body fat. Susceptibility-induced distortions 
of the markers were minor. The markers are used for evaluation of registration accuracy 
without any correction for shift. Motion is an additional problem in MR imaging which 
can result in blurring, misregistration and artifacts within the scanned images. Both 
cardiac as well as respiratory movements affect the thorax.
Statistics
For the statistical analysis SPSS version 17 (SPSS Inc. Chicago, IL, USA) was used. To 
analyze the differences between the different registration methods a Wilcoxon signed-
rank test was used to compare the differences of the average values between both im-
aging modalities. The level of statistical significance was considered p<0.05 (two-sided) 
for all calculations. 
Results
CT and MR images registration
The translations of MRI relative to CT images along the x-, y-, and z-axes, as deter-
mined with five registration algorithms, are presented in Table 2. 
Differences between various registration methods for the translation along the same 
axis are limited within a few millimetres. The angles of rotations of the MR image 
data sets along the x-, y-, and z-axes after completing MRI/CT fusion with the five 
registration algorithms are shown in Table 3. Figure 3 shows an example of the breast-
marker-based and clip-based registrations for patient 4. For the clip-based registration a 
rotation of the MR image along the z-axis relative to the CT image can be seen clearly. 
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Table 2.  CT and MR image registration parameters found for breast-marker, thoracic-marker, surgical-clip-based 
registration, local correlation and normalized mutual information (NMI). The Table shows the translation 
of MR images along the x-, y-, and z-axes and the distance (d) between the two imaging modalities.
Table 3.  The same as Table 2, but for rotation of MR images around the x-, y-, and z-axes.  
Rotations larger than 3˚ are highlighted by shadowing.  
*In patients 6 and 7 no surgical clips were placed in the lumpectomy cavity.
Registration accuracy
The registration accuracy for the five registration methods evaluated using breast-mark-
ers; surgical clips, thoracic-markers and all fiducials are presented in Figures 4a, 4b, 4c and 
4d, respectively. The various registration methods are given in the Figures in an increasing 
level of misalignment between the CT and MR scans according to the breast-marker 
evaluation, shown in Figure 4a. For the other three evaluation methods the same order 
was used. Note that the smallest MRI-CT distances for the breast markers are achieved 
for breast-multimodality-marker registration (breast-mmm). This is not surprising, since 
here the same breast markers are used for matching and evaluation. This result can be 
considered as an indicator of the best achievable accuracy of the markers themselves. 
Pa-
tient
Translations and distance d (cm)
Breast-markers Thoracic-markers Surgical clips Local Correlation
Normalized Mutual 
Information
# x y z d x y z d x y z d x y z d x y z d
1 -0.4 -48.0 2.1 48.0 0.2 -47.8 2.1 47.9 -0.3 -47.7 2.2 47.7 -0.4 -47.7 2.1 47.7 -0.4 -47.7 2.3 47.7
2 0.7 -48.2 0.3 48.2 0.1 -47.5 0.7 47.5 0.7 -49.1 1.4 49.1 0.1 -47.4 0.7 47.4 0.0 -47.3 0.6 47.3
3 0.2 -46.3 3.0 46.4 0.0 -46.4 3.1 46.5 -0.2 -47.3 4.2 47.5 -0.2 -46.4 3.5 46.6 -0.2 -46.4 3.6 46.6
4 -0.3 -50.5 1.7 50.5 -0.1 -50.4 1.7 50.4 -1.6 -51.1 2.1 51.2 -0.5 -50.4 2.1 50.5 -0.5 -50.4 2.2 50.4
5 -1.8 -46.7 -2.3 46.8 -2.2 -46.8 -2.0 46.9 -2.2 -46.9 -3.2 47.1 -2.3 -46.8 -2.2 46.9 -2.3 -46.8 -2.1 46.9
6 0.5 -47.2 -8.4 47.9 0.6 -47.0 -8.2 47.7 n.a.* n.a.* n.a.* n.a.* 0.4 -47.2 -8.3 48.0 0.4 -47.2 -8.4 47.9
7 1.3 -47.5 -7.4 48.1 1.4 -47.0 -7.5 47.6 n.a.* n.a.* n.a.* n.a.* 1.0 -47.2 -7.2 47.7 1.0 -47.1 -7.1 47.7
8 -0.1 -50.9 -8.1 51.5 0.0 -50.9 -7.9 51.5 -0.4 -50.9 -7.4 51.5 -0.2 -50.8 -7.8 51.4 -0.2 -50.8 -7.8 51.4
9 -2.3 -47.1 -1.9 47.2 -2.0 -47.1 -1.4 47.2 -2.2 -47.0 -0.9 47.0 -1.9 -47.1 -1.2 47.1 -1.9 -47.1 -1.1 47.1











# x y z x y z x y z x y z x y z
1 -2.1 1.2 -3.1 -2.0 0.6 -1.3 1.0 -1.0 -1.1 -0.9 0.3 -1.1 -0.9 0.5 -0.9
2 -3.6 -2.1 7.5 -3.8 -1.3 2.8 -3.0 2.7 10.5 -1.8 -0.6 2.2 -1.4 -0.5 2.0
3 -3.8 -0.7 -0.1 -2.2 -0.4 -1.1 -10.2 -4.1 -2.8 -2.0 -0.3 -0.2 -1.2 -0.3 -0.4
4 -2.8 1.6 0.0 -1.8 2.2 2.2 -1.4 -1.6 -6.1 -1.2 2.3 0.3 -1.0 2.0 1.0
5 -0.1 -1.5 0.0 -2.3 0.3 -0.2 3.1 -4.1 1.1 -1.1 0.7 0.0 -0.8 0.8 -0.3
6 -0.8 -2.3 0.6 -2.0 -2.2 1.4 n.a.* n.a.* n.a.* -1.4 -2.3 0.4 -1.4 -2.3 0.4
7 -1.8 -1.2 -2.2 -2.3 -0.3 -0.1 n.a.* n.a.* n.a.* -2.2 0.5 0.4 -1.8 0.2 0.6
8 -2.8 1.3 -0.3 -3.0 0.6 0.3 -4.3 -1.3 -1.8 -2.3 0.3 -0.4 -2.5 0.4 -0.1
9 -1.2 0.5 0.9 -1.7 -0.4 1.7 -4.7 -3.2 2.1 -2.0 -1.2 0.2 -1.6 -1.3 0.6
10 -1.3 0.4 -0.3 -0.5 0.3 0.1 -1.9 3.1 0.6 -0.2 1.4 0.4 -0.2 1.6 0.4
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Figure 3.  Axial scans of the fused CT and MR images of patient 4 (44 years, premenopausal status) with a  
breast-marker: the left panel shows the result of breast-marker based registration the right panel  
shows that for surgical clips based registration. The red and blue circles show the position of the  
marker on the CT and MR images, respectively.
Figure 4.  Analysis of CT/MRI fusion accuracy for five registration methods: breast-multimodality-markers (breast-mmm), 
thoracic-multimodality-markers (thoracic-mmm), surgical clips (clips), local correlation (LC) and normalized mu-
tual information (NMI). Evaluation of each registration is performed using the breast-markers (a), surgical clips 
(b) or thoracic-markers (c) or all fiducials (d). Each registration result is presented as the mean value with the 
arrows for ± 1SD. Note that the y-scale is twice as large for evaluation based on thoracic-markers compared 
to breast-markers, surgical clips and all fiducials. The (biased) method used for the evaluation is marked with a 
star (*) and an open symbol. In Figure 4d registration method based on fusion of all fiducials is added.
The thoracic-marker-based registration resulted in smallest MRI-CT distances between 
breast markers (see Figure 4a). If measured using the breast marker MRI-CT distance, 
the difference between the thoracic-marker-based and the clip-based (p=0.05) or local 
correlation based (p≤0.01) registration was significant, whereas the local correlation 
based and NMI based registration methods showed worse results than the thorac-
ic-marker-based and the clip-based methods.
For the surgical clip evaluation, the mean MRI-CT distance for the breast-marker-based 
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registration is the lowest (see Figure 4b). The mean value of the clip MRI-CT distance 
for breast-marker-based registration is not significantly lower (p=0.09) than that for the 
thoracic-marker-based registration.
Evaluation by delineating the GBT on MRI and CT
Figure 5 shows the glandular breast tissue delineations by 4 observers on CT and MRI 
for patient 7. For each patient in this study, a mean rest volume as percentage of the 
mean GBT volume is presented in Table 4 for each of the five registration methods. The 
mean rest volume is the smallest on CT and on MRI for the breast marker registration 
(followed by the local correlation registration). 
Figure 5.  Axial scans (top panels) and sagittally reconstructed scans (bottom panels) of the fused CT and MR 
images of patient 2 (49 years, premenopausal status) for breast-marker-based registration: the glandular 
breast tissue delineations by 4 observers on fused CT and MRI (left, CT in red and MRI in green),  
CT (middle) and MRI (right). The GBT delineations on CT and MRI are shown in black and white,  
respectively. The arrow in the top panels points to a breast marker. On the axial and sagittally  
reconstructed scans respectively two and three markers around the seroma, are visible.  Note that  
the GBT volume is well fused with breast marker registration, although a rotation up to 7.5 degrees 
between CT and MRI took place. 
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*defined as the average volume delineated by the same observer on MRI, but not on CT. 
# In patients 6 and 7 no surgical clips were placed in the lumpectomy cavity.
Table 4.  GBT volume delineation on CT (a) and MR (b) images and rest volumes for CT (a) and MRI (b) found  
for breast-marker, thoracic-marker, surgical-clip-based registration, local correlation (LC) and normalized 
mutual information (NMI). For each patient the rest volume is given as the percentage of the 
corresponding mean GBT volume.
(a)







markers Surgical clips LC NMI
1 643 (592-675, 37) 12.5 15.5 12.8 12.9 12.4
2 919 (865-977, 46) 10.7 10.6 13.7 10.5 10.4
3 863 (826-902, 40) 7.7 7.0 14.5 6.8 7.9
4 326 (309-360, 23) 16.9 19.4 35.0 17.9 18.6
5 364 (343-413, 33) 15.0 17.6 24.3 14.7 18.5
6 672 (595-767, 81) 15.8 16.3   n.a.#  15.7 15.8
7 408 (366-487, 54) 16.1 17.7   n.a.#  16.4 16.7
8 495 (430-594,76) 13.3 15.8 12.9 12.6 13.1
9 808 (727-1008, 142) 11.7 12.8 11.6 14.3 14.2
10 410 (366-524, 77) 22.8 21.7 22.6 22.6 22.1
Mean 591 14.2 15.4 18.4 14.4 15.0
SD 220 4.1 4.3 8.2 4.3 4.3
(b)







markers Surgical clips LC NMI
1 614 (549-667, 59) 8.3 11.5 8.6 8.7 8.2
2 893 (752-974, 100) 8.0 8.0 11.2 7.9 7.7
3 951 (804-1038, 115) 16.1 15.5 22.3 15.3 16.3
4 347 (290-388, 41) 21.9 24.2 38.9 22.9 23.5
5 361 (271-410, 63) 14.2 16.8 23.7 13.9 17.8
6 621 (495-733, 99) 8.8 9.4 n.a. # 8.7 8.9
7 392 (296-441, 66) 12.9 14.6  n.a. # 13.2 13.5
8 497 (361-558, 92) 13.6 16.1 13.2 12.9 13.4
9 808 (653-971, 130) 11.7 12.8 11.6 14.3 14.2
10 354 (307-421, 49) 10.5 9.3 10.4 10.3 9.8
Mean 584 12.6 13.8 17.5 12.8 13.3
SD 232 4.2 4.8 10.3 4.4 5.0
Target volume delineation 
36
Discussion
Comparison of five different registration methods (breast-markers, thoracic-markers, 
surgical clips, normalized mutual information and local correlation) was performed for 
the GBT and the lumpectomy cavity. The use of breast markers for MRI-CT co-registra-
tion gives the best results and is recommended not only for delineation of the GBT, but 
also for delineation of the lumpectomy cavity. For lumpectomy cavity delineation the 
clip-based registration is an alternative to the breast-marker-based registration.
CT and MR images registration 
We have chosen, because of the absence of the established gold standard in assessment 
of the registration accuracy of retrospective intermodality image registration [21], for 
the comparison of five different registration methods for the GBT and the lumpecto-
my cavity. The performance of the methods was evaluated by the agreement between 
delineations [8.9] and by the size of the standard deviation of registration parameters.
A rigid transformation was chosen based on our previous results [8]. In this article, 
Giezen et al. showed that the GBT volumes were comparable on CT and MR scans 
(mean [SD] ratio MRI to CT GBT volumes, 1.04 [0.06]). In the present study, the mean 
[SD] ratio MRI to CT GBT volumes was 0.98 [0.07]. In literature breast deformation 
was observed for MRI in prone position and for CT in supine position [22]. Further 
investigation of non-rigid transformation is beyond the scope of this study.
MRI-CT translation parameters were comparable for different registration methods 
(see Table 2), while the rotations were for some registration methods larger than 3˚. For 
the registration using surgical clips, rotations larger than 3˚ were found for 7 out of 8 
patients. We believe that these rotations occur due to small distances between the clips 
rather than a rotation of the clips relative to patient anatomy. 
Results for GBT
Delineation of the CTV of GBT based on CT scans remains a challenge in spite of rel-
atively low interobserver variability [23.24], because of the difficulty of differentiating 
between fatty (involuted) breast tissue and fatty non-breast tissue. Struikmans et al. [23] 
found a mean conformity index (CI), calculated as an average of the ratios between the 
common volume and encompassing volume for all possible pairs of delineations, on CT 
scans of 0.87 (range, 0.75–0.92) for five observers (two radiation oncologists, two ra-
diation oncologist trainees, and one radiologist) averaged over 18 patients. Hurkmans 
et al. [24] reported the interobserver variability of GBT delineations by four radiation 
oncologists in seven breast cancer patients (Ccommon = 0.43, where Ccommon was calculated 
as a ratio of the volume commonly delineated by all observers to the encompassing 
volume). According to Giezen et al. [8] interobserver variability of the delineation of the 
CTV of GBT on CT and MRI is comparable. 
As can been seen in Table 4, the mean rest volume was the smallest for the breast 
marker registration and the largest for the clip registration but the differences between 
various registration methods were small and not statistically significant because of the 
interobserver variability. 
For the breast-marker evaluation, the misalignment between CT and MRI was the 
smallest for the thoracic-marker registration (except for the breast-marker registration). 
The breast- and thoracic-marker-based registration resulted in the smallest MRI-CT 
distances between all fiducials.
In our study the mean MRI-CT distance between the breast marker pairs averaged over 
10 patients was 1.8 mm [SD = 0.7 mm] for the breast-marker-based registration. The 
last results are comparable with the mean clip misalignment described below. Note, that 
the matching region is larger for the breast-markers (GBT) than for the clips (lumpecto-
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my cavity). The local correlation and NMI methods use a larger region than the breast 
to match. This probably results in additional misalignment, for instance due to distor-
tion of the contra lateral breast by overlying MR receiver coils.
The thoracic-marker evaluation requires a significantly larger region to match. A larg-
er matching region can make registration more difficult due to machine-related and 
patient-induced image distortions and cardiac and respiratory movements. The mean 
misalignment between CT and MR across 10 patients was found to be 2.4 mm [SD = 
0.9 mm] for the registration based on the same fiducials, which is only slightly larger 
than the result for breast markers. For thoracic-marker-based evaluation the local cor-
relation showed lowest misalignment between CT and MR scans, followed by the NMI.
To our knowledge, CT and MR images co-registration for the GBT was not discussed in 
literature so far. We therefore cannot compare our results with other studies. 
Results for lumpectomy cavity
Delineation of the lumpectomy cavity is based on surgical titanium clips attached to 
the cavity wall by the surgeon [6]. The interobserver variability in the delineation of the 
lumpectomy cavity on CT scans is high even in the presence of delineation guidelines: 
Struikmans et al. [23] reported the mean CI of 0.56 (range 0.39 – 0.74), according 
to van Mourik et al. [25] considerable delineation variation was present (mean CI = 
0.42, range 0.19 - 0.59); partially because of the relatively small volume of the cavity. 
Addition of MR images to CT/clip data can probably improve interobserver variabil-
ity [6,9]. Further investigation based on delineation of lumpectomy cavity on MR-CT 
co-registered images is needed.
For the surgical clip evaluation, which is a reasonable approach for the lumpectomy 
cavity, the mean CT-MR distance for the breast-marker-based registration was the low-
est (except for the clips themselves) 3.6 mm [SD=1.4 mm].
If the thoracic markers were used for registration, the mean misalignment between CT 
and MR for the clips was 4.5 mm [SD=1.3 mm]. However, if the clips were used for 
registration the mean misalignment of thoracic markers was larger by more than a fac-
tor of two, 12 mm [SD=6 mm]. This large difference can be related to the fact that the 
clips were close to each other while the thoracic markers were much further away. As a 
result, small uncertainties in the registration using clips will be greatly enhanced when 
the thoracic markers were used for the evaluation. The situation is distinctly different 
when the thoracic markers were used in the registration while clips are exploited for 
the evaluation.
Kirby et al. [6] used surgical clips to register MRI with CT images of 30 patients in 
prone position. As a matching structure, clips have the advantage over the chest wall 
to overcome the problem of accurately identifying bony boundaries on MR images. 
Moreover, according to Kirby et al. the use of the clips for registration led to a smaller 
field of view and, therefore, reduced machine-related image distortion. They registered 
a mean clip misalignment between CT and MRI across all 30 cases of 0.8 mm (medi-
al-lateral), 0.6 mm (superior-inferior), and 1.0 mm (anterior-posterior), yielding a mean 
misalignment distance of 1.4 mm.
This result is in good agreement with the MRI-CT distance of 1.7 mm [SD = 0.6 mm] 
averaged over 8 patients for the registration based on the surgical clips in our study. 
Surgical-clip-based registration resulted in large rotations (see Table 3 and Figure 3) for 
7 out of 8 patients in the present study. This effect is not described by Kirby et al. [6], 
probably because of smaller rotations in their study due to larger number of the surgical 
clips (6 to 12 versus 4 to 6 in our case). Moreover, not all the patients have surgical 
clips for various reasons. In our case 2 out of 10 patients did not have any surgical clips. 
Jolicoeur et al. [7] used the predefined fusion points (the nipple, the tip of scapula, the 
sternal notch and the carina) for MRI-CT registration. A qualitative evaluation was 
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then performed using the skin surface markers on the surgical scar and the nipple. They 
reported a mean MRI-CT distance of 5.6 mm (range: 1.9–11.6 mm). For the breast-
marker-based evaluation and clip registration, the mean MRI-CT distance was 5.3 mm 
[SD=1.8 mm] (range: 2.8-7.7 mm). These results are difficult to compare because of 
absence of clips in the study by Jolicoeur et al. [7].
Conclusions
For the breast-marker evaluation, the misalignment between CT and MRI was the 
smallest for the thoracic-marker registration. For the surgical clips evaluation, the mis-
alignment between CT and MRI was the smallest for the breast-marker registration. 
The use of surgical clips for MRI-CT registration resulted in large rotations (> 3˚) for 7 
out of 8 patients. Moreover, the clips were not always clearly visible on MR images. The 
thoracic-marker-based and breast-marker-based registrations resulted in the smallest 
MRI-CT displacements between all fiducials. Co-registration of CT and MR data sets 
based on breast-markers gave the best result for the glandular breast tissue delineation 
in terms of the rest volume. 
Considering all observed results, we recommend breast markers for MRI-CT co-reg-
istration for both glandular breast tissue and lumpectomy cavity delineation in radio-
therapy. For lumpectomy cavity delineation the clip-based registration is an alternative 
to the breast marker registration. Further work is required to optimize registration 
methods using deformable registration.
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In breast conserving radiotherapy differences of target volume delineations between 
observers do occur. We evaluated whether delineations based on co-registered comput-
ed tomography (CT) and magnetic resonance (MR) imaging may result in an improved 
consistency between observers. We used the delineation conformity index (CI) to com-
pare clinical target volumes of glandular breast tissue (CTV breast) and lumpectomy 
cavity (LC) on both imaging modalities.
Materials and methods
Four observers delineated CTV breast and LC on co-registered CTMR images in ten 
breast cancer patients. CIs were determined for CT and CTMR. Furthermore, the Cav-
ity Visualization Score (CVS) of LC was taken into account.
Results
The mean CI for CTV breast (CICT;CTV: 0.82 and CICT-CTMR;CTV: 0.80) and LC (CICT;LC: 
0.52 and CICT-CTMR;LC: 0.48) did not differ significantly (p = 0.07 and p = 0.33, respec-
tively). Taking CVS into account for the LC, with a CVS ≥ 4 the mean CI was 0.62 for 
both CICT;LC and CICT-CTMR;LC.
Conclusion
The mean volume of the delineated glandular breast tissue based on CT was significant-
ly larger compared to the volume based on CTMR. For patients with a CVS ≥ 4, the 
mean CIs of the LC were higher compared to CVS < 4 for volumes delineated on both 
CT as well as CTMR images. In our study cohort no significant differences between 
the CIs of the CTV breast and the LC delineated on CTMR co-registered images were 
found compared to the CIs on CT images only. Adding MR images does not seem to 
improve consistency of the delineation of the CTV breast and the LC, even though the 
volumes were copied from CT images. Since we included only ten patients, caution 




There can be substantial differences in identification of the target volumes among radia-
tion oncologists specialized in breast cancer radiotherapy [1]; even when written deline-
ation guidelines are used [2-4]. Compared to computed tomography (CT) magnetic res-
onance imaging (MRI) may reveal more relevant details [5]. And, according to Jolicoeur 
et al., the use of MRI improved the level of agreement between observers delineating 
the lumpectomy cavity compared to CT [6]. In our former study, published in 2011, we 
noted that the concordance for delineation of the volumes on CT differed only slightly 
from the concordance based on magnetic resonance (MR) images [7]. Whether the use 
of a co-registration of the two imaging modalities could lead to an improvement of the 
agreement between observers remained unclear.
Therefore, we analyzed the delineation conformity, when based on CT as well as on 
CTMR co-registered images. In our study, we have evaluated the delineated clinical 
target volumes of the glandular breast tissue (CTV breast) and the lumpectomy cavity 
(LC) in ten patients referred for radiation therapy after breast conserving surgery.
Materials and methods
Between July 2007 and August 2008, fifteen patients with early stage breast cancer 
(clinically T1-2; N0-1) and treated with breast conserving surgery were included in 
our study. The mean age was 57 years; 8 patients had right-sided and 7 patients had 
left-sided breast cancer; the tumor was mostly situated in the upper outer quadrant of 
the breast. Patient and tumor characteristics were described in detail earlier [7]. Since 
the rigid co-registration was performed on breast markers which were used only in 
patients 6–15, we included only these ten patients in the present study [8]. After referral 
for whole breast radiotherapy, a planning-CT scan and directly afterwards a MRI scan 
were performed, both in supine treatment position. The procedure was described in 
detail by Giezen et al. [7]. 
The study was approved by the regional institutional review board METC Zuidwest 
Holland. All patients agreed to participate in our study by signing an informed consent.
Four observers, i.e. two radiation oncologists and two radiologists, participated in the 
study and delineated the glandular breast tissue (CTV breast) [7] as well as the lumpec-
tomy cavity (LC) [9]. The four observers delineated CTV breast and LC according to 
the determined delineation instructions, Table 1 [9].
For all ten patients this resulted in the, for each observer, delineated CTV breast and LC, 
based on CT images only. After ten weeks, the observers re-evaluated these CTV breast 
and LC delineations copied on the co-registered CTMR images, and made adaptations 
when judged necessary. By choosing an interval time of ten weeks it was likely that the 
observers had forgotten specific details of their CT-based delineations of each specific 
case. By doing so a more reliable comparison (and eventually an adaptation) between 
the CT based images and the CTMR images may be achieved. The alternative method 
of delineating the co-registered CTMR images was not used because this would imply 
an intra-observer variability. 
After defining all CTV breast volumes, a scripting tool was applied to trim all CTV 
breast volumes up to 5 mm below the skin surface. 
To quantify the variability of one delineation compared to another we used the Con-
formity Index (CI). A CI of 0 indicates no overlap is present between delineations; a CI 
of 1 indicates completely identical delineations. A method for calculating the CI was 
used, that is unbiased by the number of observers delineating a target volume [10]. We 
determined two types of CI of the CTV breast and LC enabling us to assess the influ-
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ence of imaging modality on delineation variability, and the inter-observer variation, 
respectively. Firstly, for each observer, the delineated volumes on CT were compared to 
CTMR, indicated with the symbols CICT-CTMR;CTV and CICT-CTMR;LC. The resulting CIs were 
thereafter averaged over the patient population. Secondly, for every delineated target 
volume we determined the CIs for CT based and CTMR based delineations separately, 
by comparing the delineations of the different observers to each other.
Table 1.  Delineation instructions for CTV Breast and the lumpectomy cavity.  Abbreviations: LC Lumpectomy  
Cavity, WL window level, WW window width, HU Hounsfield Units, MRI Magnetic Resonance Imaging,  
CT computed tomography.
The resulting values are indicated with the symbols CICT;CTV, CICTMR;CTV, CICT;LC and CICT-
MR;LC. Again, an average over the patient population was calculated. Furthermore, the 
earlier assessed “Cavity Visualization Score” (CVS) [9] of the lumpectomy cavity was 
taken into account in the analysis as well. With the CVS according to Smitt et al. [11] 
depiction of the lumpectomy cavity is categorized from 1, cavity not visualized, to 5, all 
cavity margins clearly defined. Finally, a median 3D surface of the CTV breast and LC 
of all four observers was calculated [12] (local surface variation) in order to analyze and 
visualize the local inter-observer variation for each patient.





-  Fixed: WL 0 Hounsfield Unit (HU) and WW of  
500 HU for CT and variable WL and WW for MRI;
-  Change of WL and WW during delineation  
permitted for CT and MRI.
-  Fixed: WL 0 Hounsfield Unit (HU) and 
WW of 500 HU for CT and variable 
WL and WW for MRI;
-  Change of WL and WW during 
delineation permitted for CT and MRI.
Appearance -  The location of the marking wire, positioned  
around the palpable Glandular Breast Tissue (GBT), 
will be used as an aid for CTV Breast delineation; 
-  The clinical target volume (CTV) breast was defined  
to comprise all GBT including fatty (involuted) lobes
-  Margin of the GBT is (ventrally) assumed to be situated 
5 mm below the skin surface; in case of MRI the visible 
GBT fat is (ventrally) delineated as GBT margin;
-  Delineation is performed on all CT or MRI slices  
that are judged to contain GBT;
-  Appearance of the contralateral breast (by comparing 
with the ipsilateral breast) on CT or MR images;
-  The preoperative mammographies and location of 
the palpable GBT marking wire, visible on CT or  
MRI, all will serve as an aid for GBT delineation.
Appearance of contralateral breast 
(comparing with ipsilateral
breast) serves as aid for LC delineation.
Clips Surgical clips (if applicable)
should all be included within the delineated GBT.
All surgical clips (if applicable) should 
be included within
delineated LC.
Seroma Postoperative seroma/hematoma present in LC should 
be included within delineated GBT.
Postoperative seroma/hematoma pre-





Wilcoxon Signed Rank Test was performed to compare all data, CT versus CTMR, 
since the number of eligible data was less than 30. For analysis we used SPSS Statistics 
version 17.0. The level of statistical significance was considered p < 0.05 (two sided) 
for all tests.
Results
Glandular breast tissue (CTV breast)
Delineated volumes
The mean volume of the delineated glandular breast tissue based on CT (mean 576 cc; 
range 303–900) was significantly larger compared to the volume based on CTMR 
(mean 557 cc; range 287–892) (p < 0.01). 
CT versus CTMR: conformity indices and local surface variation
On the CTMR images few adaptations to the delineated volume were carried out. The 
range in CIs (CICT-CTMR;CTV) for each observer was 0.89 – 1.00 (mean SD 0.03), Table 2. 
The mean CI for all observers between CICT;CTV and CICTMR;CTV did not differ significant-
ly, Table 3.
The local surface variation in Figure 1 shows again that few adaptations were carried 
out on the co-registered CTMR images. We found a mean local standard variation be-
tween observers of 2.2 mm and 2.6 mm for CT and CTMR, respectively (p = 0.05). In 
seven out of ten patients the local standard variation increased on CTMR. For patient 
8, 11, 12, 13 and 15 the differences were mostly present in the medial part of the CTV 
breast.
Table 2.  Conformity indices of the CTV Breast and lumpectomy cavity (LC) delineations for each observer, 
CT compared to CTMR.
Table 3.  Conformity indices (CICT; CICTMR) of the CTV breast and lumpectomy cavity (LC) delineations based  
on CT and CTMR for all observers.
CICT-CTMR, CTV (SD) CICT-CTMR, LC (SD)
Observer_1 0.99 (0.01) 0.84 (0.09)
Observer_2 0.89 (0.05) 0.70 (0.23)
Observer_3 1.00 (0.00) 0.91 (0.17)
Observer_4 0.97 (0.05) 0.85 (0.30)
CTV breast; Mean CI_All (SD) LC;  Mean CI_All (SD)
CICT 0.82 (0.04) 0.52 (0.20)
CICTMR 0.80 (0.06) 0.48 (0.21)
p-value CICT-CTMR 0.07 0.33
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Inter-observer variability
In considering the variation in the local surface distance, it became apparent that the 
delineations of the observers varied, on CT as well as CTMR, predominantly in the 
medial and lateral part of the CTV breast, Figure 1.
Figure 1.  Left: Coronal posterior view of the ten delineated Clinical Target Volume (CTV) breast Computed 
Tomography (CT) volumes. Right: Coronal view of the ten delineated CTV breast CTMR volumes. The 
local surface distance variation of the four observers is projected on the median surface of each CTV 
breast. Colour map: Blue: high agreement between observers; Red: low agreement between observers 
according to the scale given.
Lumpectomy cavity (LC)
Delineated volumes
The mean volumes of the delineated LC based on CT (mean 24 cc; range 4–73) did not 
differ (p = 0.2) compared to those based on CTMR (mean 26 cc; range 7–71), Table 4.
Table 4.  Mean volumes for all observers of the lumpectomy cavity (LC) delineations based  
on CT and CTMR.
Mean Lumpectomy Cavity Volume  
CT














CT versus CTMR: conformity indices and local surface variation
For LC more adaptations were carried out than for CTV breast, since the range in CIs 
(CICT-CTMR;LC) for each observer decreased: 0.70 – 0.91 (mean SD 0.20), Table 2. The 
mean CI for all observers between CICT;LC and CICTMR;LC, however, did not differ signif-
icantly, Table 3.
When taking the CVS into account, we found that, if the CVS was ≥ 4, the mean CI 
appeared to increase. An increase of the CI to 0.62 was found for CICT;LC as well as for 
CICTMR;LC delineations in all 5 cases with a CVS of ≥ 4. In Figure 2 we display the mean 
CI of both CT and CTMR on the CVS scale from 0 to 5; see Figure 3 as well.
Figure 2.  For each patient for the lumpectomy cavity the Conformity Index (CI) on CT, The CI on CTMR  
and the Cavity Visualization Score (CVS) were determined. 
The local surface distance variation showed more variation in the delineation of the LC 
compared to CTV breast. We found a mean local standard variation between observers 
of 2.4 mm and 2.8 mm for CT and CTMR, respectively (p = 0.13). In five out of ten 
patients (patient 11, 12, 13, 14 and 15) the degree of variability increased on the co-reg-
istered CTMR images and in two patients (patient 6 and 7) the degree of variability was 
larger on the CT images. For the other two patients, no major variability was noted. 
As an example, in patient 12, a premenopausal patient, no seroma was found, no clips 
were placed and the CVS was 2, Figure 4.
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Figure 3.  Differences between the 4 observers on co-registered CTMR images; Left: volumes delineated on CT. 
Right: volumes delineated on CTMR; a. Example of a patient with seroma, a CVS of 5; b. Example of a 
patient with a CVS of 2.
Discussion
CT versus CTMR
In this study we investigated the potential merits of CTMR co-registration on the de-
lineation of the CTV breast and the Lumpectomy Cavity (LC). Concerning the study 
outline, we only focused on the advantages of CTMR co-registration. Therefore, to 
avoid intra-observer variability, we copied the CTV breast and LC delineated on the CT 
to the co-registered CTMR images. Thereafter each observer considered to adapt (yes 
or no) the CTV breast or LC, respectively when based on the CTMR images. Finally, 
the differences between the CT based and CTMR based delineations were analyzed. 
This method could have introduced a bias, since the observers did not delineate the 
CTMR co-registered images. Comparisons and eventually adaptations were, after an 
interval time of 10 weeks, done directly on the CTMR co-registered images. In doing 
so the observers could have been distracted by the copied volume. But the alternative 
method of delineating the co-registered CTMR images had the disadvantage that this 
would result in an intra-observer variability between the CT based and the CTMR 
based delineations. 
We found that the CT based CTV breast volumes, when compared with CTMR based 
volumes, were significantly larger. In our study cohort, it became apparent that the CIs 
for CTMR co-registered images, when compared to those based on CT images only, 
did not differ significantly from those based on CT images only, neither for CTV breast 
nor for LC. With respect to LC, in the 5 cases with a CVS ≥ than 4, the mean CI values 
increased to 0.62, whereas for the cases with a CVS < 4 a mean CI of 0.50 was found. 
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Compared to the results of our first investigation [9] the CI for the LC increases from 
0.32 for MR to 0.48 for the co-registered CTMR.
Figure 4.  Left: Coronal posterior view of the ten delineated Lumpectomy Cavity (LC) Computed Tomography 
(CT) volumes in both anterior as well as posterior view. Right: Coronal view of the ten delineated LC 
CTMR volumes in both anterior as well as posterior view. The local surface distance variation of the four 
observers is projected on the median surface of each LC. Colour map: Blue: high agreement between 
observers; Red: low agreement between observers according to the scale given.
Remarkably, we found higher CIs (Lumpectomy Cavity) for both CT and CTMR com-
pared to the results of Boersma et al. although our volumes were smaller and in our 
study the lumpectomy cavity was defined instead of the CTV boost [4]. The CTV boost 
in the study of Boersma et al. was defined as the 1.5 cm rim of tissue that had surround-
ed the primary tumor. Also, manual adaptation of the co-registration by each observer 
could be a reason for the lower CI in the study of Boersma et al., since this could be a 
bias in the analysis of the delineated structures. In our study, the co-registration was 
locked after performing the co-registration. Furthermore, in our study clips were placed 
directly in several segments in the lumpectomy cavity wall representing the extensions 
of the primary tumor, whereas in the Boersma study clips only had been placed at the 
deepest (dorsal) border of the lumpectomy cavity [4].
CTV breast 
The major differences in delineation of the target volume between observers were locat-
ed in the medial and lateral part of the CTV breast. This was confirmed in the study of 
Li et al. In their study, the effect of these variations on the dose in the organs at risk was 
studied as well. They concluded, that variations in normal structure dose were found 
Target volume delineation 
52
and that large variations in the medial-lateral borders contributed mostly to the varia-
tion in the normal structure dose [13]. Therefore, consistency in delineation of the CTV 
breast is of great importance. In our study cohort specific guidelines (Table 1) were used 
and consensus meetings had taken place. The latter could explain the non-significant 
differences in the CTV breast when MR imaging was added. 
Lumpectomy cavity
Delineations of the lumpectomy cavity were done by experienced radiation oncologists 
and trained radiologists. They used written delineation guidelines (Table 1). All this was 
in line with the findings of various recent studies. As Wong et al. showed in their study 
cohort, “trained” oncologists consistently produced smaller target volumes in seroma 
contouring compared to an “untrained” cohort. The implementation of guidelines re-
duced the inter-observer variability in volume delineation in their study. These data 
indicated that improved consistency among radiation oncologists may be achieved by 
consensus guidelines.[14].
Furthermore, our results reveal that, when the CVS was ≥ 4, the CI was increased for 
both CT as well as CTMR defined volumes. This finding was reported before by Landis 
et al. [1]. This could indicate that, for lumpectomy cavities with a CVS of < 4, specific 
landmarks such as surgical clips or gold markers may enable a more precise defined 
CTV boost [3,15]. According to Topolnjak et al. and Park et al., the position of these 
clips and markers remain stable throughout the treatment course [16,17]. Nevertheless, 
it seems important to be aware of interfractional target deformations as reported by 
Ahunbay et al. [18]. Concerning the use of surgical clips, Jolicoeur et al. did not use 
clips and found a concordance ratio of 0.66 on CT and 0.96 on MR [6].
Finally, as Van Mourik et al. also suggested [3], we confirm that a multi-disciplinary 
approach is what should be aimed at in target delineation; especially in the delineation 
of the LC and when the CVS is lower than 4, since every specialist can contribute to a 
better understanding. If an inconsistency of the surgical clips and at the edge of the ser-
oma was found, as described by Yang et al., this should be part of the multidisciplinary 
discussion [19].
Conclusion
The mean volume of the delineated glandular breast tissue based on CT was significant-
ly larger compared to the volume based on CTMR. For patients with a CVS ≥ 4, the 
mean CIs of the LC were higher compared to CVS < 4 for volumes delineated on both 
CT as well as CTMR images. In our study cohort no significant differences between 
the CIs of the CTV breast and the LC delineated on CTMR co-registered images were 
found compared to the CIs on CT images only. Adding MR images does not seem to 
improve consistency of the delineation of the CTV breast and the LC, even though the 
volumes were copied from CT images. Since we included only ten patients, caution 
should be taken with regard to the results of our study. 
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Summary
The literature shows that, with the increasing survival of breast cancer patients after 
breast conserving therapy, the various therapies are associated with an increased risk of 
fatal cardiovascular events. Furthermore, the data also indicate that even today, recent 
techniques in left-sided breast cancer radiotherapy administer high doses radiation to 
the heart, and more specifically to the left anterior descending coronary artery. 
A breathing adapted technique in left-sided breast cancer can be used to reduce the dose 
in the heart and in the coronary arteries. This technique is easy to use in daily practice. 
In Radiotherapy Centre West (RCWEST) the Active Breathing Control (ABC) method 
was used. We found that the preparation time increased once only by one hour; the time 
spent by the patient at the linear accelerator was not increased compared to the time 
without using the breathing adapted technique. The ABC method is well-suited to daily 
practice; 99% of the patients with clinical T1-2, N0-2, M0 left-sided breast cancer who 
were treated with the ABC technique, could complete the treatment. Until a thresh-
old has been found to reduce heart damage after breast conserving radiation therapy, 
RCWEST administers the ABC method to all patients with left sided-breast cancer, as 
every reduction in heart dose is of importance.
Introduction
Breast cancer is the most common type of all cancers in The Netherlands. Breast-con-
serving therapy (BCT) is offered only if a good cosmetic result and optimal loco-region-
al tumour control can be achieved. In all other cases breast ablative surgery is opted for. 
Fractionated whole breast irradiation is seen as an integral part of breast conserving 
therapy [1]. Due to the improved survival probability of breast cancer patients, Darby 
et al. reported in 2005 that the probability of the occurrence heart diseases as caused by 
the various treatment modalities, is increased. The latter specifically applies to left-sided 
radiation, chemotherapy (including anthracyclines) and biologicals (trastuzumab). Due 
to improved irradiation techniques the increased risk of heart disease after irradiation 
clearly decreased over the years and is, after more than 10 years of follow-up, no longer 
present [2]. However, Taylor et al. stated that parts of the heart (the myocardium, but 
especially the Left Anterior Descending coronary artery (LAD) still receive high radi-
ation doses with current radiation techniques [3]. The systematic review of Sardaro et 
al. shows that still much is unclear with respect to the resulting radiation-induced heart 
damage in breast cancer patients [4]. Various (preclinical and clinical) studies show 
the occurrence of atherosclerosis and arterial wall thickening after irradiation [5-7]. 
Decreasing the heart dose in breast cancer patients is, therefore, of (great) importance.
In recent years, several authors reported that a breathing-adapted irradiation technique 
could be used. This method, in which irradiation is applied only during a period of 
breath-hold, leads to a marked decrease of the heart dose. Breathing-adapted irradia-
tion can be carried out by various methods. Active Breathing Control (ABC) is one of 
these methods (see Figure 1). In a recent article Swanson et al. described that the ABC 
method leads to a significantly lowered heart dose. They also showed that this method 
is well able to be sustained in patients with breast cancer. In the mean time, they have 
applied the ABC method for 6 years [8]. Breathing-adapted method appears to be fea-
sible for loco-regional irradiation as well [9-11].
 
After an extensive literature study conducted by Van der Klein et al., we started an ABC 
pilot study in mid 2008 [12]. The aim of this study was to evaluate the feasibility of 
the routine implementation of the ABC method. In addition to providing support to the 
patient in the linear accelerator, the training of the patient on the computed tomography 
Chapter 2
61
(CT) -simulator and performing the CT scan differs from the routine procedure. The 
technique proved feasible for various patients [13]. From January 2010 onwards, the 
ABC method was implemented for all left-sided irradiation of breast cancer in our clin-
ic. In The Netherlands (and outside of The Netherlands as well), little is known about 
the feasibility of the ABC method in a radiotherapy department. For this reason, we 
present our experiences.
Figure 1.  Example of a specific case planned to be irradiated in “Radiotherapiecentrum West” for left sided 
breast cancer with free-breathing (FB) (left) and with breath hold (BH) (right). These axial slides show  
that the cardiac dose is lower for the BH-case. In yellow the CTV breast; green: lumpectomy cavity;  
red: dorsal radiotherapy field border. The anatomy differs slightly between the left and right side of  
the Figure because of the performed breath-hold.
Materials and methods
First of all, a dedicated radiation therapist (RTT) informs the patient on the radiother-
apy as well as on the necessary preparations. The latter is illustrated by a PowerPoint 
presentation. Then a training session takes place. In this training session, the patient 
practices with the Active Breathing Coordinator (ELEKTA, Crawley, United Kingdom) 
equipment. During this training session the lung volume of each patient and the thresh-
old, above which she should inhale, is determined. For each patient, the number of 
seconds during which she is able to hold her breath, is registered. Once the patient un-
derstands the method well and can carry out the instructions of the radiation therapist 
(RTT), a CT scan in free-breathing (FB) and a CT scan breath-hold (BH) are performed.
If the patient, at a later time, is unexpectedly unable to follow the instructions of the 
ABC method correctly, the FB CT scan can be used. The glandular breast tissue is, using 
the ABC method, irradiated with two tangential opposing fields. A dose of 16 x 2.66 Gy 
is administered. Only on indication a boost dose was given. This boost dose was di-
rected to the lumpectomy cavity. In this review on patients irradiated with BH at Ra-
diotherapy Centre West (RCWEST) we limit ourselves to the period of January 1th in 
2010 to December 31th in 2011. During this time, a total of 284 patients with left-sid-
ed breast cancer were irradiated. Forty of these patients were irradiated with another 
technique, e.g. irradiation of only the supraclavicular nodes or single dose radiother-
apy during breast conserving surgery, the so-called intraoperative radiation therapy 
(IORT). A total of 52 patients (18%) was not irradiated with the ABC method due to 
a prior estimate of the radiation oncologist or because the method was not feasible. 
In Table 1 we summarised the reasons why the ABC method could not be carried out. 
Ultimately, 192 patients were irradiated with ABC. Of this group, only the patients with 
cT1-2;N0-2;M0 left-sided breast cancer, that were irradiated locally or loco-regionally, 
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were included in this study. The following characteristics of each patient were regis-
tered: whether only a local or a locoregional radiation technique was applied; whether 
the ABC method could be completed by the patient or not; above which threshold (after 
the training) the patient ought to inhale; how long (in seconds) the patient could hold 
her breath; how many breath-holds had to be carried out during each session of irradi-
ation; and whether the patient was familiar with pre-existing lung disease.
Table 1.  Summary of limitations of patients with cT1-2; N0-2; M0 left-sided breast cancer prone  
to be irradiated with the ABC breath-hold technique.
Finally, in 20 consecutive patients of our study population we examined whether the 
dose in the heart and the left coronary artery (LAD) could be reduced when using the 
ABC method. For these analyses the following values were determined and compared 
to each other: (i) V50 %, the volume that receives 50% of the dose; (ii) D10, the dose 
that encompasses 10% of the volume; (iii) D50, the dose that encompasses 50% of the 
volume.
When performing the statistical analysis we used a ‘Wilcoxon Signed Rank Test’ and a 
p-value of <0.05 was considered as significant.
Results
Three (1.6 %) out of 192 patients were not able to complete the ABC procedure during 
their irradiation course. Retrospectively, we concluded that these patients had not com-
pletely understood the procedure. 
A total of 175 patients, 174 women and 1 male, bearing a cT1-2;N0-2;M0 left sided 
breast cancer, had been included in the study. A total of 18 patients were affected by 
a restriction, but still were treated with the ABC-method (see Table 2). For example, 
a patient was irradiated who could only speak a foreign language. After defining a 
number of clear agreements the ABC-method could be completed. The mean age of the 
cohort was 56 years, ranging from 28 to 85 years. Twenty-five percent of the patients 
was irradiated loco-regionally.
The mean number of seconds that the patients could hold their breath was 26, ranging 
from 18 to 33. The mean of all lung volumes was 1.7 litres; with a range of 0.7 litres- 
2.5 litres. The limited lung volume of 0.7 litres for one particular patient appeared to 
place no restriction on completing her treatment sessions without any problem. We 
noted that a difference in lung volume of at least 0.2 litres must be achieved, because a 
smaller difference leads to a very limited chest wall extension and, hence, will result in 
a too small increase in the distance between the heart and the radiation fields. The total 
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Not irradiated with the  
breath-hold technique
Age (>95 years) 1
Physical limitations: 5
- pulmonary diseases: e.g. COPD 4
- other
Communicative limitations (language, deafness, etc.) 8
Psychological limitations 5
Other; estimation of the radiation oncologist, e.g. latex allergy 29
     
Prematurely stopped with the  
ABC- reath-hold tec nique
Irradiated with the ABC- 
breat -hold technique
Prematurely stopped with the 
ABC-breath-hold techniqu
Age (>95 years) 0 0
Physical limitations:
- pulmonary diseases: e.g COPD 13 0
- other 0 0
Communicative limitations  
(language, deafness, etc.) 
4 0
Psychological limitations 1 1
     
Mean; n=20
BH FB p-value
Heart V50 (%) 1,4 4,9 <0,01 
Heart D10 (Gy) 3,0 7,3 <0,01 
Heart D50 (Gy) 0,8 1,0 <0,01 
LAD V50 (%) 16,9 41,6 <0,01 
LAD D10 (Gy) 20,9 33,0 <0,01 
LAD D50 (Gy) 7,3 19,7 <0,01 
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ABC-breath-hold techniqu
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pulmonary diseases: e.g COPD 13
- ther 0
Communicative limitations  
(language, deafness, etc.) 
4 0
Psychological limitations 1 1
     
Mean; n=20
BH FB p-value
V5  (%) 1 4 4 9
1 3 0 7 3
Heart D50 (Gy) 0,8 1,0 
V5  (%) 16 41 6
1 20,9 33 0
LAD D50 (Gy) 7,3 19,7 <0,01 
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irradiation time takes about 2-3 minutes. For this reason the patient is asked to hold her 
breath over and over again. During each session of radiotherapy, on average 5 periods 
of breath-hold, with a range of 2-10 breath-holds, were necessary. The highest number 
of breath-holds was needed when irradiating loco-regionally. The same threshold values 
were used in patients receiving a boost dose (directed at the lumpectomy cavity). Again, 
on average 5 breathing-holds, with a range of 3-9 breath-holds, were needed.
Table 2.  Summary of limitations of patients with cT1-2; N0-2; M0 left-sided breast cancer  
irradiated with and without the ABC breath-hold technique.
With the introduction of the ABC method the preparation time, when compared to the 
situation without using the ABC method, lasted about one hour longer; in one and a 
half hours, the patient has undergone the training and the two CT scans were made (FB 
and BH). After going through the learning curve of the radiation therapist, for which 
temporary extra time was given to accompany the patient on the radiation device to 
control the breathing, the time that is scheduled per patient lasts no longer than was 
previously the case (without the use of the ABC method), and is the same for a right-sid-
ed breast cancer irradiation. For local irradiation 10 minutes and for loco-regional 
irradiation 15 minutes is scheduled. Apart from the patients whose ABC method was 
not feasible in the long run, we noted no further challenges or emergency stops during 
the full course of the radiation therapy.
The analyses of the radiation treatment plans show that the ABC-method results in a 
significantly lower dose in the heart and the heart vessels and at the same time appear 
to have a comparable coverage of the irradiated target volume (see Table 3).
Table 3.  Dose volume values for the heart and the ‘Left Anterior Descending coronary artery’  
(LAD): For the ‘breath-hold’(BH) technique and in ‘Free-breathing’(FB). 
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Discussion
The breathing-adapted irradiation is well enforceable in daily practice; of patients with 
cT1-2;N0-2;M0 left-sided breast cancer, and being irradiated with the ABC-method, 
99% can completely sustain the treatment. Little is known about the feasibility of the 
ABC method. Massaccesi et al. indicated that 90% of the patients the method can insist, 
however, they have examined a group of only 20 patients [14].
But data are available on another method of heart sparing: the ‘Gating’ technique. Irra-
diation with this technique is administered only when the breathing cycle of the patient 
is within a certain predefined phase. In their institute, Berson et al. noted beforehand 
that 20% of their patients (n=136) were not suitable to undergo the ‘Gating’-technique 
[15]. The latter was partly due to reasons other than not being able to perform the 
technique. They reported that 97% of the patients who started the treatment with the 
“Gating” method could sustain it till the end [15]. 
 
Our study showed that 29 patients (15%) were irradiated without the ABC method. 
The radiation oncologist had judged beforehand that these patients were not suitable to 
undergo the ABC method. This assessment did not only take place in the start-up phase, 
but was kept up regularly in the past 2 years. For example, patients have been irradiated 
without ABC. One of the considerations was a latex allergy. But the ABC-respiratory 
equipment contains no latex, so in that respect, this patients could have undergone the 
irradiation with the ABC method. Thus, eventually more patients could have been irra-
diated with the ABC method. We recommend that radiation therapists perform an as-
sessment to judge whether (yes/no) the patient is able to complete irradiation combined 
with the ABC method. The radiation oncologist decides on medical grounds whether 
(yes/no) the patient is eligible for the ABC method. 
Since RCWEST is located in the centre of The Hague, relatively a large number of 
patients of foreign origin is referred for treatment to RCWEST (patients living in the 
‘Schilderswijk’, patients working at the embassies). Many of them do not speak the 
Dutch language properly. We did not explicitly investigate this item. Despite the ob-
served language barrier, we observed that the ABC method could successfully be carried 
out regularly in this group. Massaccesi et al. noted in their feasibility study that the 
workload increased [14]. However, we noticed that when the ABC method is adminis-
tered to all patients with left-sided breast cancer, this technique is no longer an excep-
tion and, hence, the radiation therapists feel familiar with this method. For this reason, 
there is no need anymore to schedule extra time on the linear accelerator. The prepara-
tion time, though, remained increased by about one hour. This extra time is required to 
prepare the patient in a proper manner for the breathing adapted irradiation. Based on 
these findings, we plan to pass the FB scan, thus reducing the preparation time.
To handle a maximum age to propose (or not to propose) the option with ABC is a matter 
of opinion and grounds for debate. However, a paper by Van Schoor et al. makes clear that 
the expected mean median survival duration of women aged 75 years is 10 years [16]. Also, 
Louwman et al. indicate that the relative survival (taking into account the risk of mortality 
due to causes other than breast cancer) of a 70-year old patient with breast cancer lasts 
3-10 years after breast cancer diagnosis. This is similar to the relative survival duration of 
breast cancer patients aged 40-70 years. The relative survival 3-5 years after diagnosis of 
breast cancer of 80-year old female breast cancer patients is 5% lower than breast cancer 
patients of 40-70 years; it should be kept in mind that the stage distribution in this 80-year 
old group was often worse and that this group of patients was regularly undertreated [17].
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Since the effects of irradiation for cardiovascular damage may become mani-
fest after 10 years, using the ABC method of patients over 70 years of age can be 
justified [2]. In RCWEST, no age limit is used when proposing the ABC method. 
Wang et al. indicate that, by means of an automatic planning process, insight is obtained 
into which patients may benefit from a breathing adapted irradiation technique [18]. 
They opt for a dose reduction at the heart of a small group of patients (the threshold 
V50> 10 cm3), which implies that only in 15-20% of all left-sided breast cancer patients 
the ABC method would useful [18]. Taylor et al., however, do not expect that the dose 
of the current irradiation techniques, when compared to those of the older techniques, 
is reduced. And a threshold dose is not yet determined [19]. For this reason, the aim of 
RCWEST is to reduce the dose to the heart and the heart vessels to zero.
Qi et al. indicated that because of the intrinsic motion the position of the heart and the 
heart vessels on the CT scan varies and appears to be only a snapshot in time. On a 
4D-CT, this is a CT scan in which the patients were scanned in several phases of respi-
ration; the location of both varies over a short period of time. They reconfirm that the 
lowest dose in the heart and the LAD was found at the end of the normal inspiration. 
In RCWEST, when using the ABC method, the patient is irradiated at a level of 75% of 
the patient’s deep inspiration [20]. Wang et al. have also investigated the displacement 
of the heart and the coronary arteries, which shows that during the deep inspiration, the 
LAD was displaced around 2.3 mm. For this reason, they suggest to implement an extra 
safety margin of ≥5 mm between the LAD and the radiation field edge [21]. Follow-up 
studies to examine further reduction of the dose in the heart and the cardiac vessels (to 
compensate for the displacement of the heart) will take place in RCWEST.
Conclusion
The Active Breathing Control method appeared to be feasible in daily practice; in 99% 
of the left-sided breast cancer patients (cT1-2;N0-2;M0), treated with the ABC method, 
it can be sustained. Until it becomes clear which threshold dose should be used for eval-
uating the risk of reducing heart damage, in RCWEST the breathing adapted irradiation 
technique is offered to all patients with left-sided breast cancer. Furthermore, any reduc-
tion in heart dose is judged to be of importance, especially in patients who are prone to 
receive cardio toxic chemotherapy (e.g., adriamycin and trastuzumab).
Recommendations
1.     We advice to combine the breath-hold technique with irradiation for all women 
bearing left-sided breast cancer, because this technique is easy to implement into 
daily practice.
2.     More research is needed to assess the threshold dose.
Acknowledgements
We would like to thank the following people for the various efforts they have made R. 
Gangabisoensingh and L. Kwakkel-Huizenga for the datamanagement. J. van Egmond 
for his assistance with Excel. I. Korteland for retrieving patient data. L. van Kempen, 
M. Heijenbrok, H. Rozema and Y. Kalidien for their contribution in the planning study. 
And finally, M. van Dalum, A. van Hek, J. Kuipers and L. Versluis for implementing the 
ABC method and training their colleagues.
Treatment planning studies in whole breast irradiation
66
References
1.       Richtlijn mammacarcinoom. Versie: 2.0, 
Consensus based 2012-02-13. NABON, 
Landelijke richtlijn. Te raadplegen via 
www.oncoline.nl/mammacarcinoom 
(Accessed 17 augustus 2012).
2.       Darby SC, McGale P, Taylor CW, et al. 
Long-term mortality from heart disease 
and lung cancer after radiotherapy for 
early breast cancer: prospective cohort 
study of about 300.000 women in US 
SEER cancer registries. Lancet Oncol 
2005;6:557-65.
3.       Taylor CW, Povall JM, McGale P, et al. 
Cardiac dose from tangential breast cancer 
radiotherapy in the year 2006. Int J Radiat 
Oncol Biol Phys 2008;72:501-7.
4.       Sardaro A, Petruzzelli MF, D’Errico MP, 
et al. Radiation-induced cardiac damage 
in early left breast cancer patients: 
risk factors, biological mechanisms, 
radiobiology, and dosimetric constraints. 
Radiother Oncol 2012; 103:133-42.
5.       Stewart FA, Heeneman S, Te Poele J, 
et al. Ionizing radiation accelerates the 
development of atherosclerotic lesions 
in ApoE-/- mice and predisposes to an 
inflammatory plaque phenotype prone to 
hemorrhage. Am J Pathol 2006;168:649-58.
6.       Schultz-Hector S, Trott KR. Radiation-
induced cardiovascular diseases: is the 
epidemiologic evidence compatible with 
the radiobiologic data? Int J Radiat Oncol 
Biol Phys 2007;67:10-8.
7.       Dorresteijn LD, Kappelle AC, Scholz NM, 
et al. Increased carotid wall thickening 
after radiotherapy on the neck. Eur J 
Cancer 2005;41:1026-30.
8.       Swanson T, Grills IS, Hong Y, et al. Six-
year experience routinely using moderate 
deep inspiration breath-hold for the 
reduction of cardiac dose in left-sided 
breast irradiation for patients with early-
stage or locally advanced breast cancer. 
Am J Clin Oncol 2013;36(1):24-30.
9.       Stranzl H, Zurl B, Langsenlehner T, et 
al. Wide tangential fields including the 
internal mammary lymph nodes in patients 
with left-sided breast cancer influence of 
respiratory-controlled radiotherapy (4D-




10.     Jagsi R, Phil D, Moran J, et al. Evaluation 
of four techniques using intensity-
modulated radiation therapy for 
comprehensive locoregional irradiation of 
breast cancer. Int J Radiat Oncol Biol Phys 
2010;78:1594-1603.
11.     Hjelstuen M, Mjaaland I, Vikström J, 
et al. Radiation during deep inspiration 
allows loco-regional treatment of left 
breast and axillary-, supraclavicular- and 
internal mammary lymph nodes without 
compromising target coverage or dose 
restrictions to organs at risk. Acta Oncol 
2011; Early online:1-12.
12.     Van der Klein JN. Een literatuurstudie 
naar ABC bij het mammacarcinoom en 
het longcarcinoom. Gamma Professional 
2007;57:36-9.
13.     Benschop E, Limpens KM, Reurink NM, 
et al. Introductie en implementatie van de 
Active Breathing Control methode in de 
praktijk. Gamma Professional 2008;58:31-3.
14.     Massaccesi M, Caravatta L, Cilla S, et al. 
Active Breathing Coordinator in adjuvant 
three-dimensional conformal radiotherapy 
of early stage breast cancer: a feasibility 
study. Tumori 2010;96:417-23.
15.     Berson AM, Emery R, Rodriguez L, et al. 
Clinical experience using respiratory gated 
radiation therapy: comparison of free-
breathing and breath-hold techniques Int J 
Radiat Oncol Biol Phys 2004;60:419-26.
16.     Van Schoor G, Otten JD, Den Heeten GJ, 
et al. Breast cancer among women over 75 
years: an important public health problem? 
Eur J Public Health 2012;22:422-4.
17.     Louwman WJ, Vulto JC, Verhoeven RH, et 
al. Clinical epidemiology of breast cancer in 
the elderly. Eur J Cancer 2007;43:2242-52.
18.     Wang W, Purdie TG, Rahman M, et al. 
Rapid automated treatment planning 
process to select breast cancer patients for 
active breathing control to achieve cardiac 
dose reduction. Int J Radiat Oncol Biol 
Phys 2012;82:386-93.
19.     Taylor CW, Bronnum D, Darby SC, et al. 
Cardiac dose estimates from Danish and 
Swedish breast cancer radiotherapy during 






20.     Qi XS, Hu A, Wang K, et al. Respiration 
induced heart motion and indications 
of gated delivery for left-sided breast 
irradiation. Int J Radiat Oncol Biol Phys 
2012;82:1605-11.
21.     Wang X, Pan T, Pinnix C, et al. Cardiac 
motion during deep-inspiration breath-
hold: implications for breast cancer 
radiotherapy. Int J Radiat Oncol Biol Phys 
2012;82:708-14.
Treatment planning studies in whole breast irradiation
68 Chapter 2
69
Left-sided breast cancer radiotherapy with and without breath-hold: 
Does IMRT reduce the cardiac dose even further? 
Mirjam Masta, Loes van Kempen-Hartevelda, Mark Heijenbrokb, Yamoena Kalidiena, 
Hans Rozemaa, Wim Jansenc, Anna Petoukhovaa and Henk Struikmansa,c
a     Radiotherapy Centre West, The Hague, The Netherlands;
b      Department of Radiology, Medical Center Haaglanden, The Hague,  
The Netherlands; 
c      Department of Clinical Oncology, Leiden University Medical Center,  
The Netherlands
Radiother Oncol 2013;108(2):248-253




In radiotherapy for left-sided breast cancer, Active Breathing Control enables a decrease 
of cardiac and Left Anterior Descending (LAD) coronary artery dose. We compared 
3D-Conformal (3D-CRT) to Intensity Modulated Radiotherapy (IMRT) treatment 
plans based on free-breathing (FB) and breath-hold (BH). We investigated whether 
IMRT enables an additional decrease of cardiac dose in radiotherapy plans with and 
without BH.
Materials and methods
Twenty patients referred for whole breast irradiation were included. The whole breast, 
heart and LAD-region were contoured. Four treatment plans were generated: FB_3D-
CRT; FB_IMRT; BH_3D-CRT; BH_IMRT. Several doses were obtained from Dose Vol-
ume Histograms and compared. Results were compared statistically using the Wilcoxin 
Signed Rank Test.
Results
For heart and LAD-region, a significant dose reduction was found in BH (p < 0.01). 
For both BH and FB, a significant dose reduction was found using IMRT (p < 0.01). By 
using IMRT an average reduction of 5% was noted in the LAD-region for the volume 
receiving 20 Gy.
In 5 cases, the LAD-region remained situated in the vicinity of the radiation portals 
even in BH. Nevertheless, with IMRT the LAD dose was reduced in these cases.
Conclusion 
IMRT results in a significant additional decrease of dose in the heart and LAD-region 




Left-sided breast cancer radiotherapy has been associated with an increased risk of fatal 
cardiovascular events [1]. These findings were confirmed in population-based studies 
carried out in Denmark, Sweden and The Netherlands. In these series, the risk of de-
veloping ischemic heart disease, pericarditis and valvular disease was increased [2,3]. 
Several (pre)clinical studies established that a higher risk on atherosclerotic lesions was 
found after radiation treatment [4,5]. Nilsson et al. and Correa et al. described the effect 
of radiotherapy on the development of stenosis after several years [6,7]. Recently, Darby 
et al. found that the incidence of ischemic heart disease was proportional to the mean 
dose to the heart and started to increase within a few years to at least 20 years after ex-
posure [8]. Patients with pre-existing cardiac risk factors had higher absolute risks after 
radiotherapy than those without [8]. Correa et al. described that, in modern radiothera-
py, a reduction in risk of coronary damage was noticed [7]. However, Taylor et al. found 
that, even in modern radiotherapy techniques, the anterior part of the heart, including 
the LAD, still receives doses of over 20 Gy [9]. These findings confirm the importance of 
taking the coronary arteries (i.e. the Left Anterior Descending coronary artery (LAD)) 
into account as an ‘‘Organ At Risk’’ when defining a radiation treatment plan.
Therefore, sparing the heart and the coronary arteries, specifically, the LAD, seems high-
ly relevant to reduce cardiac morbidity risk in contemporary radiotherapy.
Various techniques are available to decrease the cardiac dose; the Active Breathing Con-
trol (ABC) method is one of these techniques. When using the ABC method the patient 
holds her breath during the administration of radiotherapy for left-sided breast cancer 
patients. In doing so, the distance between the heart and the radiation fields is enlarged. 
The use of ABC results in a significant decrease of the dose applied to the heart as well 
as of the dose applied to the LAD [10,11]. Intensity Modulated Radiotherapy (IMRT) 
is successfully used as a class solution for various tumor sites. Subsequently, several au-
thors described the use of IMRT for the dose reduction in the heart during breast cancer 
irradiation. Coon et al. showed that the dose to the heart can be lowered in patients 
with unfavorable cardiac anatomy, when using an IMRT technique. And Schubert et al. 
found that inversely planned IMRT, when compared to a 3D-CRT technique, resulted in 
a lower dose to the heart without compromising the dose in the target volume [12,13].
In the present study, we examined whether the use of IMRT enabled an additional 
decrease of the cardiac dose as well as a further decrease of the dose to the LAD, 
in cases with and without the use of the ABC breath-hold technique. Therefore, we 
compared 3D-Conformal Radiotherapy (3D-CRT) treatment plans to IMRT treatment 
plans based on either a free-breathing or a breath-hold CT scan. In this way we were 
able to distinguish between the contributions of the breath-hold technique and those of 
the IMRT technique in lowering the cardiac dose and the dose to the LAD.
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Materials and methods
Twenty consecutive patients, diagnosed with left-sided ductal carcinoma in situ or in-
filtrative breast cancer, were included in this planning study. All patients underwent 
breast-conserving surgery (and axillary staging). Thereafter, they were treated with 
whole breast radiotherapy using the breath-hold technique. No regional radiotherapy 
was given. All patients underwent a free-breathing CT scan and a breath-hold CT scan 
in the same treatment position, i.e. they were placed on a carbon fiber breast board 
(Sinmed B.V., Reeuwijk, The Netherlands) with both arms abducted above the head. A 
copper wire was placed around the palpable breast tissue as an aid for Clinical Target 
Volume (CTV) delineation. 
Single-slice CT images (AcQSim Inc., Philips Medical Systems, Cleveland, OH, United 
States) were obtained using 3-mm inter-slice thickness from lung apices to the dia-
phragm. The breath-hold CT scan was executed using the ELEKTA Active Breathing 
Coordinator™ device (ELEKTA, Crawley, United Kingdom), the threshold was deter-
mined at 75% of the moderate deep inspiration as described by Remouchamps et al. 
[10]. Patients were trained on the CT-simulator to hold their breath for a maximum 
duration of 30 s, using a mouth piece, nose clip and prism glasses. The duration of the 
breath-hold was defined for each patient individually. The method described above has 
been the standard procedure in our department since October 1st, 2010 for all left-sided 
breast cancer radiotherapy patients [14].
Target delineation and organs at risk 
To avoid inter-observer-based differences, the glandular breast tissue, heart and the 
LAD-region were delineated for each breath-hold- and free-breathing-scan by one ob-
server only (by MLKH). All delineations were performed in the Pinnacle3 planning sys-
tem (version 8.0m, Philips Medical Systems, United States). The glandular breast tissue 
was contoured according to RTOG delineation guidelines [15] and was defined as the 
CTV. PTV was created by expanding the CTV 5 mm in the transversely, 6 mm cranially, 
and 9 mm caudally. The PTV was retracted 5 mm from the patient surface to minimize 
high-dose levels in the build-up regions for IMRT plans (PTVtrim). 
The heart was delineated according to the University of Michigan cardiac atlas of Feng 
et al., from the cranial border of the left atrium to the apex of the heart [16]. As no 
contrast was used during the planning-CT scan, the LAD was in some slices difficult 
to visualize and, therefore, the LAD-region was contoured instead [9,16]. To contour 
this region we followed the anatomic borders of the pericardium, which served as the 
anterior border. The superior border was defined as the origin of the LAD from the 
left main coronary artery and followed the anterior-interventricular groove; the caudal 
border was situated at the apex cordis. When, in some slices the LAD was difficult to 
visualize, its location was inferred from the course of the interventricular groove and 
interpolated between slices. Delineations of the heart and LAD-region were reviewed 
by the radiologist (MH). 
Our 3D-CRT technique consisted of two opposing wedged tangential fields. If optimal 
dose homogeneity was not achieved an additional field was added. With our IMRT 
technique, 60% of the dose was given with two open tangential fields and 40% with 
four inversely planned IMRT fields, with a ‘Step-and-Shoot’ technique. For the optimi-
zation a Direct Machine Parameter Optimization (DMPO) was used with the follow-
ing criteria: the maximum number of segments was constricted to 12; the minimum 
segment area was set to 9 cm2; and the threshold for the minimum number of monitor 
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units (MUs) per segment was 4 MUs. For the heart we started to define a maximum 
equivalent dose of 20 Gy after weights for the heart and the LAD-region were set indi-
vidually for each individual patient to enable a maximum sparing of these structures. 
For the PTVtrim several constraints were used: uniform dose (42.56 Gy), maximum dose 
(45.5 Gy) and minimum dose (40.6 Gy). 
All plans were calculated with a Collapsed Cone algorithm using heterogeneity correc-
tion (Philips Medical Systems 2006 Pinnacle3. Physics REFERENCE GUIDE Release 
8.0). For 3D-CRT as well as for IMRT plans identical gantry angles and beam energies 
were used. In this way a more reliable comparison of the two techniques could be ob-
tained. Moreover, the dose to the contralateral breast was not biased due to the use of 
identical gantry angles. All treatment plans had to meet the criterion that 97% of the 
PTVtrim was covered by at least of the 95% isodose (and <108% isodose). The plans 
were judged and approved by one radiation oncologist (HS). 
The prescribed dose was 42.56 Gy in 16 fractions in all cases. For both techniques 
(3D-CRT and IMRT), the treatment plans based on the breath-hold and free-breathing 
scans were compared for all patients. For PTVtrim, the percentages of volumes receiving 
95% and 107% of the prescribed dose (V95%; V107%) were determined and com-
pared. Furthermore, for the heart and the LAD-region, various dose volume parameters 
were generated and evaluated; the choice was based on those published in the literature. 
As far as the lung tissue was concerned, the mean lung dose and the volume receiving 
20 Gy (V20 Gy) (averaged over both lungs) were analyzed for both techniques. And 
finally, the total body dose, the volume receiving 5% of the prescribed dose (V5%), and 
the number of monitor units were compared.
Statistics
A Wilcoxon Signed Rank Test was performed to compare doses and volume differences 
since the number of eligible cases was less than 30. For analysis, we used SPSS Statistics 
version 17.0 (IBM Corporation, Armonk, NY, United States). The level of statistical 
significance was considered at a p-value of <0.05 for all tests.
Results
Heart and LAD-region
For both the heart and the LAD-region a significant dose reduction (p < 0.01) was 
found when comparing the treatment plans based on breath-hold to those based on 
the free-breathing scans. In the LAD-region an average volume reduction for the 20 Gy 
(V20 Gy) of 20% was achieved by using the breath-hold technique.
Another 5% reduction in irradiated volume for the 20 Gy (V20 Gy) could be achieved 
by using an IMRT technique. Furthermore, for the IMRT technique when compared 
to the 3D-CRT technique, a significant dose reduction (p < 0.01) was found (Table 1).
However, in 6 out of 20 patients over 30% of the LAD-region still received 20 Gy in 
3D-CRT, even when using the breath-hold technique. In these cases, IMRT resulted in 
a reduction of the V20 Gy with an average of 15%.
Figure 2 shows that the caudal part of the heart in particular, and thus the LAD-region, is 
situated in the vicinity of the radiation portals, even in the breath-hold treatment plans. 
With IMRT, a lower dose was attained in the LAD-region, and in doing so, in all patients 
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a decrease of the dose in the caudal part of the LAD-region was found. This was attained 
by the fact that the multileaves enclosed the PTVtrim better by rotating the collimator 
angle (Figure 3). Nevertheless, in five patients the caudal part of the LAD-region, i.e. 
around 45 mm from the apex cordis, still received doses between 21 and 34 Gy.
Table 1.  Overview of mean doses and volumes, including the p-value. Abbreviations: BH: Breath-hold. FB: 
Free-breathing. V5 Gy, 10 Gy, 20 Gy, 30 Gy: volume receiving 5 Gy, 10 Gy, 20 Gy, 30 Gy respectively. 
Dmax: dose encompassing 2% of the volume. V95%, V107%: volume receiving ≥95% and 107% of the 
prescribed dose respectively. V5%: volume receiving ≥5% of the prescribed dose.
Figure 1.  Mean Dose Volume Histograms of the 20 patients of the study; Left: the Left Anterior Descending 
coronary artery region; Right: the heart. In black the breath-hold technique; in grey the free-breathing 
technique. The dotted lines represent the Intensity Modulated Radiotherapy technique. Note that the 
y-scale is different for he left and right graphs. 
 Mean (SD) (n=20) p-value
Breath-hold (BH) Free-breathing (FB) BH compared to 
FB, for both 
3D-CRT and IMRT
3D-CRT compa-
red to IMRT, for 
both BH and FBTable 1.  3D-CRT IMRT 3D-CRT   IMRT
Heart Mean (Gy) 1.8 (0.8) 1.5 (0.5) 3.3 (1.6) 2.7 (1.3) p < 0.01 p < 0.01
 Dmax (Gy) 15.8 (13.0) 8.6 (6.2) 29.2 (14.6) 24.7 (14.7) p < 0.01 p < 0.01
 V5Gy (%) 3.8 (3.0) 2.5 (2.1) 8.9 (5.0) 7.4 (4.7) p < 0.01 p < 0.01
 V20Gy (%) 1.5 (1.5) 0.6 (0.8) 5.0 (3.5) 3.5 (3.0) p < 0.01 p < 0.01
 V30Gy (%) 1.0 (1.1) 0.3 (0.4) 4.0 (3.1) 2.4 (2.3) p < 0.01 p < 0.01
LAD- 
region Mean (Gy) 9.6 (6.9) 6.7 (5.1) 18.6 (9.3) 14.9 (9.3) p < 0.01 p < 0.01
 Dmax (Gy) 25.2 (15.3) 18.8 (13.6) 35.5 (11.6) 31.4 (13.0) p < 0.01 p < 0.01
V5Gy (%) 39.4 (26.4) 30.3 (25.9) 62.6 (23.0) 54.9 (25.1) p < 0.01 p < 0.01
 V10Gy (%) 25.0 (23.8) 18.2 (21.5) 49.9 (25.2) 42.9 (26.6) p < 0.01 p < 0.01
V20Gy (%)    17.8 (20.1) 9.7 (15.1) 42.5 (25.6) 32.8 (27.1) p < 0.01 p < 0.01
Lung Mean (Gy) 3.0 (1.0) 2.6 (0.9) 3.3 (1.1) 2.9(1.1) p < 0.02 p < 0.01
Dmax (Gy) 36.1 (8.0) 33.4 (5.7) 18.0 (6.9) 35.5 (5.0) p < 0.01 p < 0.01
 V5Gy (%) 11.4 (3.3) 10.1 (3.1) 11.3 (3.3) 10.1 (3.3)
3D-CRT: p = 0.94 / 
IMRT: p = 0.90 p < 0.01
 V20Gy (%) 6.2 (2.4) 5.1 (2.2) 6.8 (2.8) 5.7 (2.6)
3D-CRT: p < 0.01 / 
IMRT: p = 0.06 p < 0.01
Total body  V5% (%) 18.3 (5.0) 16.2 (4.8) 20.0 (5.2) 17.4 (5.2) P < 0.02 p < 0.01
Monitor Units 462 340 467 342 p > 0.7 p < 0.01
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The mean doses and volumes, averaged over 20 patients, are presented in Table 1. In 
Figure 1, mean Dose Volume Histograms (DVHs) of the LAD-region and the heart were 
reproduced for both breath-hold and free-breathing, as well as for the 3D-CRT and 
IMRT technique.
Figure 2.  Comparison of the 95% isodose (white line) in the caudal part of the radiation fields for the 3D-Confor-
mal Radiotherapy (left) and the Intensity Modulated Radiotherapy (right) technique on the breath-hold 
scan. Black line = PTVtrim.  
Figure 3.  Beams Eye View of the left anterior oblique treatment field; Left: the 3D-Conformal Radiotherapy tech-
nique; Right: the Intensity Modulated Radiotherapy technique. The collimator was turned to adapt the 
treatment field as much as possible to the PTVtrim. This collimator adaption is not possible for 3D-Con-
formal radiotherapy because of the wedge. In grey PTVtrim was visualized. 
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Lung
For the 3D-CRT plans, the lung volume receiving 20 Gy was significantly reduced in 
breath-hold (p < 0.01). In the IMRT plans, a borderline significant reduction was found 
for the lung volume that received 20 Gy in breath-hold (p = 0.06). For the mean lung 
dose a significant reduction was found in breath-hold (p < 0.02).
Total body
The volume of the total body receiving 5% of the prescribed dose was significantly 
reduced when using the breath-hold technique (p < 0.02). Also, a significant reduction 
of irradiated volume (p < 0.01) was found when 3D-CRT and IMRT techniques were 
compared (Table 1).
Delineated volumes
For the delineated volume of the LAD-region no significant differences (p = 0.15) were 
found in treatment plans in breath-hold (mean 10.5 cm3, range 6.3–19.2) when com-
pared to those in free-breathing (mean 10.9 cm3, range 6.8–14.2). The delineated heart 
volumes in breath-hold treatment plans appeared to be significantly smaller compared 
to free-breathing; mean of 682 cm3 (range 516–884) and 741 cm3 (range 561–883) re-
spectively (p < 0.01). Significantly larger lung volumes were found in breath-hold than 
in free-breathing (p < 0.01); mean lung volume in breath-hold was 5506 cm3 (range 
4681–6476) and in free-breathing 3049 cm3 (range 1341-4718).
Monitor units
Significantly less monitor units (p < 0.01) were needed using the IMRT technique when 
compared to the amount of monitor units used in the 3D-CRT technique. We found an 
average of 465 monitor units versus 341 respectively (Table 1).
Discussion
In general, we found that the breath-hold technique resulted in a significant dose re-
duction in the heart and of the dose in the LAD-region. Furthermore, with IMRT a 
significant further dose reduction could be attained. IMRT enables a decrease in the 
dose in the LAD-region in the caudal part of the radiation fields as well. Even when 
using the breath-hold technique, the LAD-region is situated close to the radiation fields, 
because of the position of the heart, and more specifically of the LAD, in the thorax. 
Sparing the caudal part of the LAD seems to be of great (clinical) relevance, since Nils-
son et al. found a four- to sevenfold increase of high-grade coronary artery stenosis after 
radiation therapy in the mid- and distal LAD when comparing women with left- and 
right-sided breast cancer [6]. In our study we defined the caudal part of the LAD-region, 
comparable to the distal branch of the LAD Nilsson et al. described [6]. However, the 
cranial border of the distal branch was difficult to define, therefore we chose the crani-
al border of the distal branch arbitrarily at a distance of 15 slices (3 mm/slice) on the 
planning CT scan, starting from the apex cordis in cranial direction.
Kirby et al. delineated the LAD itself without using contrast, they made use of the 
course of the anterior-interventricular groove, when the LAD was difficult to find and 
added an isotropic 10 mm margin around the defined LAD to take delineation uncer-
tainties and heart/respiratory motion into account [17]. In our cases, the pericardium 
was defined as the border of the LAD-region [16], and in this way the LAD-region 
could remain at a somewhat larger distance from the high-dose areas of the radiation 
fields. Because of these delineation differences between the two investigations the LAD 
doses were difficult to compare. As for the significantly smaller volumes of the heart in 
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the breath-hold scan, the breath-hold probably influences the heart volume as well. No 
studies were identified to confirm this finding.
Neither for the dose in the heart nor for the dose in the LAD any specific thresholds 
could be defined according to several authors, summarized in the systematic review per-
formed by Sardaro et al. [18]. Since no threshold doses for the heart and LAD are avail-
able and the clinical effect of low doses is not completely clear, we think it would be best 
clinical practice to keep the dose in the heart and LAD as low as achievable. Therefore, 
we decided to use the breath-hold technique for all left-sided breast cancer patients. It is 
a simple method, which has been completely implemented in our clinic. Other breathing 
adapted radiation techniques could be useful as well, such as the fluoroscopy-guided 
Deep Inspiration Breath-hold (DIBH) irradiation technique [19], the gated technique 
[20] and the voluntary inspiration breath-hold [21].
No significant differences were found according to the PTVtrim coverage for both the 
breath-hold and free-breathing scans; however, a significantly lower dose outside the 
PTVtrim was observed for IMRT in comparison to 3D-CRT. Since Remouchamps et 
al. and Schubert et al. reported that, with IMRT, generally a more homogeneous dose 
distribution will be achieved in comparison to a 3D-CRT technique, dose homogeneity 
was not involved in our study [10,13]. According to Cao et al. the influence of breathing 
motion should be considered and thus the choice for an optimal treatment technique 
should be made. Using IMRT and a breathing adapted radiation treatment technique, 
the dosimetric coverage may be more optimal [22]. Furthermore, significantly less mon-
itor units were determined for the IMRT technique compared to 3DCRT; this was also 
found in the study of Remouchamps et al. [10]. The significant reduction in mean lung 
dose, found for both lungs, was confirmed in the study by Borst et al. [19].
Finally, the ABC method in our experience is a simple and well-tolerated technique. 
Also, Swanson et al. report 6 years of experience in their clinic with this method [10]. In 
the evaluation study of Mast et al. it was stated that 99% of the patients with clinical 
T1–2, N0–2, M0 left-sided breast cancer who were treated with the ABC technique, 
completed the treatment without any problem [14].
Conclusion
We confirmed that the breath-hold technique in left-sided breast cancer radiotherapy 
leads to a significant dose reduction in the heart and the LAD-region. IMRT enables 
an additional dose reduction in these critical organs in both free-breathing and breath-
hold. Applying an IMRT technique can reduce the dose in the caudal part of the radia-
tion fields in both free-breathing and breath-hold as well.
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In left-sided breast cancer radiotherapy, tangential intensity modulated radiotherapy 
combined with breath-hold enables a dose reduction to the heart and left anterior de-
scending (LAD) coronary artery. Aim of this study was to investigate the added value 
of intensity modulated proton therapy (IMPT) with regard to decreasing the radiation 
dose to these structures. 
Materials and methods 
In this comparative planning study, four treatment plans were generated in 20 patients: 
an IMPT plan and a tangential IMRT plan, both with breath-hold and free-breathing. 
At least 97 % of the target volume had to be covered by at least 95 % of the prescribed 
dose in all cases. Specifically with respect to the heart, the LAD, and the target volumes, 
we analyzed the maximum doses, the mean doses, and the volumes receiving 5–30 Gy. 
Results
As compared to IMRT, IMPT resulted in significant dose reductions to the heart and 
LAD-region even without breath-hold. In the majority of the IMPT cases, a reduction to 
almost zero to the heart and LAD-region was obtained. IMPT treatment plans yielded 
the lowest dose to the lungs. 
Conclusions
With IMPT the dose to the heart and LAD-region could be significantly decreased com-
pared to tangential IMRT with breath-hold. The clinical relevance should be assessed 
individually based on the baseline risk of cardiac complications in combination with 
the dose to organs at risk. However, as IMPT for breast cancer is currently not widely 





Postoperative radiotherapy is considered standard of care after breast-conserving sur-
gery for breast cancer [1]. After mastectomy, radiotherapy is required in case of inter-
mediate or high risk of locoregional failure [2,3]. Previous studies [4,5] have shown that 
radiotherapy is associated with an increased rate ofmajor coronary events, especially 
in patients treated for left-sided breast cancer. However, it should be noted that the 
follow-up period in these studies is relatively short [4, 5].With improved survival, more 
patients will be at risk for long-term radiation-induced toxicity, thus making it even 
more important to reduce the dose to all organs at risk (OARs). 
Recently, Darby et al. found that the rate of major coronary events was proportional 
to the mean dose to the heart starting within a few years after exposure. Patients with 
pre-existing cardiac risk factors had higher absolute risks after radiotherapy than those 
without [6]. Given its anatomical location, the left anterior descending (LAD) coronary 
artery is most at risk for developing atherosclerosis after left-sided breast-conserving ra-
diotherapy [7]. Taylor et al. showed that even with contemporarily delivered tangential 
fields, the mean dose to the LAD was considerable: 7.6 Gy. Furthermore, half of the 
patients appeared to receive more than 20 Gy in the ventral part of the heart [8]. As the 
rate of ischemic heart disease is proportional to the mean heart dose, Darby et al. ad-
vised to reduce the dose to the heart as much as possible. In order to reduce the dose to 
the heart and the LAD using photons, intensity modulated radiotherapy (IMRT), either 
combined or not combined with breath-hold techniques, has been investigated [9–11] and 
compared to 3D-conformal radiotherapy (3D-CRT) with and without breath-hold [11]. 
A commonly used IMRT technique for breast cancer treatment is an IMRT technique 
based on the standard tangential fields with additional smaller subfields in order to im-
prove dose homogeneity [12]. The advantage of this technique, compared to the full 
inversed planned multiple beam IMRT, is, that the dose redistribution is confined to the 
same area as the tangential fields, thus avoiding an excessive low dose to surrounding 
OARs. In addition, breath-hold techniques can be used to decrease the heart dose. With 
a breath-hold technique, a patient holds her breath during 25–30 s intervals in which 
radiation is administered. In doing so, the distance between the heart and the radiation 
fields increases and, consequently, the dose to the heart decreases [10]. 
However, due to anatomical variations in some patients, the radiation dose to the heart 
remains relatively high, even with the use of advanced photon-based techniques. Due 
to its physical characteristics, proton therapy may eventually enable a further decrease 
of dose to the heart. In contrast to a photon beam, a proton beam is characterized by a 
very narrow width of a relatively high peak of maximum dose administration: the Bragg 
peak. In other words, a proton beam is characterized by a dose distribution that is finite 
and adjustable in depth depending on the energy of the proton beam. Theoretically, these 
characteristics of protons enable a very precise irradiation of the target volume, while 
at the same time better sparing of the surrounding normal tissue can be obtained [13]. 
Therefore, we assumed that proton therapy may enable an improved sparing of the heart 
and LAD in left-sided breast cancer patients, especially in cases where the heart dose 
remains (relatively) high with advanced photon techniques [14–16]. In a previous paper, 
we found that tangential IMRT in combination with a breath-hold procedure resulted in 
a significant decrease of the dose to the heart and LAD-region compared to 3D-CRT in 
breathhold, while retaining optimal target volume coverage [11]. Furthermore, compared 
to standard photon 3D-CRT, tangential IMRT improves overall cosmesis and reduces the 
risk of skin telangiectasia [17]. However, to the best of our knowledge, planning compar-
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ative studies are lacking, which focus on the additional value of protons for whole breast 
irradiation compared to that of tangential IMRT (both with and without breath-hold). 
Therefore, the aim of this planning comparative study was to determine whether a fur-
ther dose reduction to the heart and LAD could be obtained with proton therapy (either 
with or without breath-hold). 
Materials and methods
We used the same methods as described in our previous planning comparative study 
comparing conformal photon radiotherapy (3D-CRT) and tangential IMRT (with and 
without breath-hold) [11]. The current study population consisted of 20 consecutive 
female breast cancer patients (pT1-2; pN0-1; M0). All patients underwent breast-con-
serving surgery and axillary staging with a sentinel node procedure.
To avoid interobserver-based delineation differences, the glandular breast tissue was con-
toured by one experienced radiation oncologist (LKH), according to RTOG delineation 
guidelines [18], and defined as the CTV. The PTV was created by expanding the CTV 
with 5 mm in transverse directions, 6 mm cranially, and 9 mm caudally according to the 
guidelines of our department for 3D-CRT and IMRT. The PTV was retracted 5 mm from 
the patient surface (PTVtrim) to minimize high-dose levels in the buildup regions for IMRT 
plans. No adaptations for PTVtrim were performed in the direction of the lungs, in doing 
so the thoracic wall may be included in PTVtrim. In order to be able to compare the same 
volumes, we applied the same margins to the proton plans. Furthermore, the heart and 
the LAD-region were delineated by one experienced radiation oncologist (LKH) and were 
subsequently reviewed by an experienced cardiac radiologist (MH). All volumes were de-
lineated on each breath-hold scan and free-breathing scan. For the breath-hold scan, the 
Active Breathing Control (ABC) method was used (ELEKTA Active Breathing Coordina-
torTM device, Crawley, United Kingdom) [19]. A high feasibility rate was reported when 
using the ABC method [10,20]. Details concerning the ABC method were described by 
Mast et al. [11].
Treatment planning techniques
Tangential IMRT-planning
All IMRT plans were produced by one experienced dosimetrist (HR), who was blinded 
for the IMPT plans. The applied IMRT technique was a tangential IMRT technique. 
According to this technique, approximately 60 % of the dose was given with two tan-
gential open fields, and 40 % with four inversely planned tangential IMRT fields using 
the same gantry angles, with a ‘step-and-shoot’ technique [11,12]. The nominal energy 
used was 6 MV in most of the cases, and occasionally 10 MV. 
Proton planning
Spot scanning intensity modulated proton therapy (IMPT) plans were planned by two ex-
perienced IMPT dosimetrists (HC, PK) using a research version of the Pinnacle3 planning 
system (version 9.1, Philips Medical Systems, Cleveland, OH, United States). Both were 
blinded for the IMRT plans. With spot scanning, a pencil beam of protons is regulated in 
a highdose spot. This spot can be positioned for a specified period of time; by superim-
posing several spots, the desired radiation dose can be composed. Generally, for protons a 
RBE of 1.1 is used over the full depth of the proton beam, and the dose is represented as 
CGE (Cobalt Gray Equivalent, which is Relative Biological Effectiveness (RBE) 9 physi-
cal dose in Gy) [15]. In the doses we report here, this RBE has been taken into account. 
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IMPT dose calculations and field configurations were planned according to Ares et al. 
[21]. In all plans, the gantry angles were 345º (-15º), 27º, and 75º. The different beams 
were set to distribute the spots in such a way that no spot was more than 0.2 cm out-
side the PTVtrim. Spots were placed over the PTVtrim with 8 mm separation in the plane 
perpendicular to the beam direction; while in depth, spot layers were positioned and 
interspaced with 5 mm between each spot.
Energy layers ranged from 7.7 to 23.0 g/cm2 (representing the depth of the Bragg peak 
location) or 100–185 MeV. Corresponding lateral spot sizes ranged approximately 
from 15 to 8 mm full-width-at-half-maximum at the isocenter in air and without range 
shifter. A range shifter of 75 mm water equivalent thickness was used so that the spot 
positions ranged from 2 to 155 mm water equivalent depth. Note that the range shifter 
and air gap between range shifter and patient skin increase the spot size.
All plans were adapted to the individual target volumes and critical organs, using the 
‘‘trial-and-error’’ method.
IMRT and IMPT treatment plan optimization
The prescribed dose was 42.56 Gy in 16 fractions in all cases. For all IMRT and IMPT 
plans, 97 % of the PTVtrim had to be covered by at least 95 % of the prescribed dose 
with a maximum of 2 % receiving more than 107 % of the prescribed dose [22]. No 
compromises on the PTV coverage with either of the techniques were made to ensure 
a fair comparison. For the PTVtrim, the following constraints were used: uniform dose 
(42.56 Gy), maximum dose (45.5 Gy, point dose), and minimum dose (40.6 Gy). The 
maximum dose (Dmax) was defined as the maximal dose to a volume of at least 2 % 
of that specific volume; according to the ICRU 83. All further planning objectives used 
were similar again to obtain fair dosimetric comparisons between the two techniques. 
For the purposes of our study, IMRT and IMPT treatment plans based on the breath-
hold and free-breathing scans were compared in all patients. 
Furthermore, various dose volume parameters of PTVtrim, heart, LAD-region, and lung 
(both lungs as well as the left lung separately) were generated and evaluated. The choice 
of these dose volume parameters (Dmax; mean; V5–V30 Gy) was based on those pub-
lished in the literature [10,22,23]. Finally, all plans were evaluated and approved by two 
experienced breast cancer radiation oncologists (HS and JM).
Statistics
A Wilcoxon signed-rank test was performed to compare dose and volume differences 
since the number of eligible cases was less than 30. For this analysis, we used SPSS Sta-
tistics version 20.0. The level of statistical significance was defined by a p value of 0.05 
(two-sided) for all tests. (IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp.)
Results
Heart and LAD-region
The mean doses for the heart and LAD-region, for IMRT and IMPT, in breath-hold and 
free-breathing, in all cases are presented in Figure 1. 
Despite the use of tangential IMRT with breath-hold in some patients, the dose to the 
LAD-region remained relatively high (Table 1; Figure 1). With breath-hold IMRT, still 
9 out of 20 patients received a mean dose to the LAD-region exceeding 5 Gy, while in 4 
out of 20 patients the dose remained beyond 10 Gy. In 3 patients, the mean heart dose 
was more than 2 Gy (Figure 1). 
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Figure 1  Isodose lines in the caudal part of the patient on the breathhold scan. Delineated organs at risk: white 
line heart; black line region of the left anterior descending coronary artery. Planning target volume: black 
line PTVtrim; thick white line 95 % isodose line. At the bottom right, the used gantry angles were pointed 
out, represented by the small arrows.
Figure 2  Left: Mean dose administered to the heart. Right: Mean dose administered to the LAD-region; both with intensity 
modulated radiotherapy (IMRT) and intensity modulated proton therapy (IMPT) in breath-hold (BH) and free- 
breathing (FB). The cases were rearranged using the increasing (from left to right) IMRT FB technique values.
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An additional reduction of the various dose parameters could be obtained with IMPT as 
well as with breath-hold IMPT. The volume of the heart and LAD-region receiving 20 
Gy (V20 Gy) could be reduced to almost zero in all patients (Figure 1 and 2; Table 1).
Lung
As compared to IMRT, the mean lung dose, the V5 Gy, and the V20 Gy in both lungs 
and in the left lung could be reduced significantly. In particular, the mean V20 Gy value 
for both lungs could be reduced from 5.1 % (SD 2.2) with breath-hold IMRT to 1.3 % 
(SD 0.8) with breath-hold IMPT (Table 1).
Table 1.  Non-significant data is presented in bold. BH breath-hold, FB free-breathing, IMPT intensity modulated 
proton therapy, IMRT intensity modulated radiotherapy, V5, V10, V15, V20, V30, and V40 Gy volume 
receiving 5, 10, 15, 20, 30, and 40 Gy, respectively, Dmax dose encompassing 2 % of the volume. V95 % 
and V107 % volume receiving 95 and 107 % of the prescribed dose, respectively.
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 Mean (SD) (n=20) p-value
BH FB
BH compared 
to FB, for both 
IMPT and IMRT
IMPT compared 
to IMRT, for 




parameters  IMPT IMRT IMPT IMRT
Heart Mean (Gy) 0.1 (0) 1.5 (0.5) 0.2 (0.1) 2.7 (1.3) p < 0.01 p < 0.01
 Dmax (Gy) 0.3 (0.3) 8.6 (6.2) 1.2 (1.7) 24.7 (14.7) p < 0.01 p < 0.01
 V5Gy (%) 0.1 (0.2) 2.5 (2.1) 0.5 (0.8) 7.4 (4.7) p < 0.01 p < 0.01
 V20Gy (%) 0 0.6 (0.8) 0.1 (0.2) 3.5 (3.0) IMPT: p = 0.02 / 
IMRT: p < 0.01
p < 0.01
 V30Gy (%) 0 0.3 (0.4) 0 2.4 (2.3) IMPT: p = 1.80 / 
IMRT: p < 0.01
p < 0.01
LAD-region Mean (Gy) 0.3 (0.2) 6.7 (5.1) 0.7 (0.8) 14.9 (9.3) p < 0.01 p < 0.01
 Dmax (Gy) 1.8 (1.9) 18.8 (13.6) 4.5 (3.4) 31.4 (13.0) p < 0.01 p < 0.01
V5Gy (%) 0.4 (0.9) 30.3 (25.9) 2.8 (5.8) 54.9 (25.1) p < 0.01 p < 0.01
 V10Gy (%) 0.1 (0.3) 18.2 (21.5) 0.8 (2.7) 42.9 (26.6) IMPT: p = 0.04 / 
IMRT: p < 0.01
p < 0.01
V20Gy (%) 0 9.7 (15.1) 0.1 (0.6) 32.8 (27.1) IMPT: p = 0.06 / 
IMRT: p < 0.01
BH: p = 0.20 / 
FB: p < 0.01
Bilateral lung Mean (Gy) 0.8 (0.4) 2.6 (0.9) 0.9 (0.3) 2.9 (1.1) IMPT: p = 0.10 / 
IMRT: p < 0.02
p < 0.01
Dmax (Gy) 14.6 
(8.0)
33.4 (5.7) 18.0 
(6.9)
35.5 (5.0) p < 0.05 p < 0.01
 V5Gy (%) 3.6 (1.9) 10.1 (3.1) 4.0 (1.2) 10.1 (3.3) IMPT: p = 0.08 / 
IMRT: p = 0.90
p < 0.01
 V20Gy (%) 1.3 (0.8) 5.1 (2.2) 1.5 (0.7) 5.7 (2.6) IMPT: p = 0.06 / 
IMRT: p = 0.03
p < 0.01
Lung Left Mean (Gy) 1.5 (0.6) 5.4 (1.8) 1.6 (0.6) 6.1 (2.3) IMPT: p = 0.20 / 
IMRT: p < 0.01
p < 0.01
 Dmax (Gy) 23.6 
(8.2)
37.1 (2.8) 27.0 
(7.0)
38.7 (2.3) p < 0.04 p < 0.01
V5Gy (%) 7.1 (2.7) 21.4 (6.6) 7.7 (2.7) 21.9 (7.1) IMPT: p = 0.17 / 
IMRT: p = 0.59
p < 0.01
 V20Gy (%) 2.5 (1.4) 10.9 (4.7) 2.8 (1.4) 12.4 (5.7) IMPT: p = 0.04 / 






97.9 (0.15) 99.7 
(0.19)
97.9 (0.18) IMPT: p = 0.09 / 
IMRT: p = 0.70
p < 0.01
V107% (%) 0 0.4 (1.0) 0 0.2 (0.4) IMPT: p = 1.00 / 





The main objective of this study was to investigate if the dose to the heart and LAD-re-
gion could be reduced using spot scanning IMPT. The results showed that, with both 
IMPT techniques (with and without breath-hold), the doses to the heart as well as to the 
LAD-region could be reduced significantly compared to IMRT with breath-hold. This 
could be achieved without compromising the doses to the target volumes. It should be 
stressed that, with IMPT, a further reduction to almost zero to the heart and LADregion 
could be obtained in the majority of cases. The results show that a breath-hold tech-
nique had no added value when using IMPT. However, using breath-hold may improve 
the robustness of the IMPT technique, since the tissue shift will be less in breath-hold. 
Protons are more sensitive than photons to the effects of motion due to the range of 
the Bragg Peak. When using a proton field from a perpendicular direction, a tissue shift 
could cause thickness changes and thus range changes. 
Recently Darby et al. reported a dose–effect relationship between the dose to the heart 
and the rate of major coronary events [6]. The authors could not identify any threshold 
dose for the development of coronary events, emphasizing the need to reduce the dose 
to as low as possible. The average mean heart dose of the left-sided breast cancer pa-
tients in their cohort was 6.6 Gy [6]. However, we noted lower mean heart doses with 
our tangential IMRT (2.7 Gy with free-breathing and 1.5 Gy with breath-hold). With 
IMPT further reductions could be obtained (0.2 Gy with free-breathing and 0.1 Gy 
with breath-hold). 
Our study compares two techniques using the same fractionation scheme, with a frac-
tion dose of 2.66 Gy and a total dose of 42.65 Gy. However, if the effects on reduction 
in cardiac dose of this study are being compared to the results of other planning studies, 
this needs to be taken into account.
It has been shown that decreasing of the mean heart dose is relevant [6]. The lifetime 
risk of radiation-induced ischemic heart disease for breast cancer patients increases 
linearly with an increase of the mean dose to the heart of 7.4 % per Gy (95 % con-
fidence interval, 2.9–14.5) [6]. Consequently, the baseline risk should be taken into 
account. Recently, Duma et al. [24] approximated the increased rate of absolute radi-
ation-induced ischemic heart disease by using the tables of the Darby publication [6]. 
They reported that, irradiating a 50-year-old breast cancer patient without cardiac risk 
factors with a mean heart dose of 3 Gy, the risk of having at least one acute coronary 
event by the age of 80 years rises from 4.5 to 5.4 %. They subsequently noted that in 
the presence of pre-existent cardiac risk factors, the risk of having at least one acute 
coronary event by the age of 80 years would rise from 8 to 9.7 %. If the mean heart 
dose would be 10 Gy and in the presence of cardiac risk factors, this risk would increase 
from 8 to 13.5 % [24]. Although, with breath-hold IMPT, the mean heart dose could be 
reduced to almost zero, the question arises whether all left-sided breast cancer patients 
will have clinically relevant benefit from proton irradiation. Recently, Langendijk et al. 
described the so-called modelbased approach, to define which patients could be selected 
for proton therapy. In this model-based approach, the estimated benefit in terms of risk 
reduction can be obtained by integrating dose differences in prediction models [25]. 
The excess risk on ischemic heart disease depends on the dose, and the relative increase 
per Gy is independent of the baseline risk on cardiac events, meaning that the absolute 
excess risk can be easily estimated by calculating the baseline risk, e.g., the Reynolds 
score [26], in addition to the mean heart dose. 
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Apart from the mean heart dose, there are data suggesting that the dose to the LAD 
coronary artery is most at risk for developing atherosclerosis after left-sided breastcon-
serving radiotherapy due to its anatomical position in relation to the breast [7]. In the 
current study, the average mean dose to the LAD-region was 6.7 Gy with breath-hold 
IMRT which could be reduced to 0.3 Gy with breath-hold IMPT. These doses are lower 
when compared to the mean LAD doses of 20 and 9.4 Gy, without using breath-hold [6, 
8]. It should be noted that the methodologies of defining the LAD or LAD-region varied 
widely among these three studies [6,8,11].
As in most treatment planning comparative studies, some critical notes also apply to 
this study. First, set-up errors and geometric changes during radiation treatment are 
more likely to affect the dose distributions when using IMPT. It should be noted that the 
effect of range uncertainties and patient breathing motion using IMPT were relatively 
small, as shown by Ares et al. [21] which is in line with the results of Xu et al. [27]. 
However, Wang et al. compared a passive scattered proton beam with a spot scanning 
IMPT technique and stated that IMPT is more sensitive for set-up uncertainties and 
breathing motion [28]. With advanced position verification procedures and adaptive 
treatment strategies in combination with a breath-hold technique, these uncertainties 
are expected to be minimized. Furthermore, as pointed out by other authors, set-up 
errors and range uncertainties need to be accounted for by applying robust IMPT treat-
ment planning techniques rather than by using the traditional CTV-PTV margin con-
cept [29,30].
Second, some authors reported higher skin dose when using protons and, hence, worse 
cosmetic outcome can be expected. Girodet et al. reported worse cosmetic outcome in 
accelerated partial breast irradiation (APBI) when using protons. However, they used a 
single field per treatment and stated that multiple proton beam scanning and advances 
in patient set-up could result in decreased margins [31]. In our planning comparative 
study, we were not able to compare the dose to the skin since a treatment planning sys-
tem is not able to adequately calculate the dose to the skin. Therefore, the clinical expe-
rience when using protons in breast cancer treatment is of importance. Several phase-II 
studies report on the cosmetic results after proton beam therapy [31,32]. 
Third, for the current study, we decided to use tangential IMRT with 60 % of the dose 
given with two open tangential fields. Further dose reductions to the heart could be 
obtained by using IMRT with a larger degree of freedom. However, in most cases this 
can only be achieved at the expense of dose to other OARS and normal tissue [20, 33]. 
Ares et al. showed that, using proton irradiation, in leftsided breast cancer the dose to 
the OARs can significantly be reduced when compared to photons [21]. As yet, no plan-
ning study has compared proton and photon irradiation in combination with breath-
hold in left-sided breast cancer radiotherapy. In most dep artments, a 3D-CRT photon 
technique is considered  the current standard. However, recently it has been shown that 
tangential IMRT with breath-hold further reduces the dose to the heart and LAD-re-
gion without increasing the dose to other normal tissues [11].
Based on the radiation principles that dose should be ‘‘As Low As Reasonably Achiev-
able’’ (ALARA) there is no doubt that patients will benefit from protons at least to 
some extent. Due to limited accessibility of proton therapy and higher costs, it will not 
be feasible to offer protons to all breast cancer patients. A model-based approach will 
enable the identification of patients who will benefit most from this new technology and 
thus will ensure a more costeffective use. For all other left-sided breast cancer patients, a 
tangential IMRT technique with breath-hold can be used to reduce the dose to the heart 
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and LAD-region. In future, it may be possible to make choices based on individual 
planning comparisons in order to individualize the radiation treatment.
Conclusion
In left-sided breast cancer irradiation, IMPT is the most promising technique to maxi-
mally reduce the dose to heart and LAD-region, even without a breath-hold technique. 
However, as IMPT for breast cancer is currently not widely available, IMPT should be 
reserved for patients remaining at high risk for major coronary events.
Acknowledgments 
We thank T. F. H. Vissers for bibliographical assistance and J. F. D. Bouricius for criti-
cally editing this article. 
Conflict of interest 
The authors have nothing to disclose and indicate no potential conflict of interest.
Open Access 
This article is distributed under the terms of the Creative Commons Attribution Non-
commercial License which permits any noncommercial use, distribution, and reproduc-
tion in any medium, provided the original author(s) and the source are credited.
91Treatment planning studies in whole breast irradiation
References
1.       Early Breast Cancer Trialists’ 
Collaborative Group (EBCTCG), Darby 
S, McGale P (2011) Effect of radiotherapy 
after breast surgery on 10-year recurrence 
and 15-year breast cancer death: meta-
analysis of individual patient data for 
10,801 women in 17 randomised trials. 
Lancet 378(9804):1707–1716.
2.       Clarke M, Collins R, Darby S et al (2005) 
Effects of radiotherapy and of differences 
in the extent of surgery for early breast 
cancer on local recurrence and 15-year 
survival: an overview of the randomised 
trials. Lancet 366(9503):2087–2106.
3.       Kyndi M, Overgaard M, Nielsen HM, 
Sørensen FB, Knudsen H, Overgaard J 
(2009) High local recurrence risk is not 
associated with large survival reduction 
after postmastectomy radiotherapy in 
high-risk breast cancer: a subgroup 
analysis of DBCG 82 b&c. Radiother 
Oncol 90(1):74–79.
4.       Darby SC, McGale P, Taylor CW, Peto R 
(2005) Long-term mortality from heart 
disease and lung cancer after radiotherapy 
for early breast cancer: prospective cohort 
study of about 300,000 women in US 
SEER cancer registries. Lancet Oncol 
6(8):557–565.
5.       Hooning MJ, Botma A, Aleman BM et al 
(2007) Long-term risk of cardiovascular 
disease in 10-year survivors of breast 
cancer. J Natl Cancer Inst 99(5):365–375.
6.       Darby SC, Ewertz M, McGale P et al 
(2013) Risk of ischemic heart disease 
in women after radiotherapy for breast 
cancer. N Engl J Med 368(11):987–998.
7.       Nilsson G, Holmberg L, Garmo H et al 
(2012) Distribution of coronary artery 
stenosis after radiation for breast cancer.  
J Clin Oncol 30(4):380–386.
8.       Taylor CW, Povall JM, McGale P et al 
(2008) Cardiac dose from tangential breast 
cancer radiotherapy in the year 2006. Int J 
Radiat Oncol Biol Phys 72(2):501–507.
9.       Schubert LK, Gondi V, Sengbusch E et al 
(2011) Dosimetric comparison of left-sided 
whole breast irradiation with 3DCRT, 
forward-planned IMRT, inverse-planned 




10.     Swanson T, Grills IS, Ye H et al (2013) 
Six-year experience routinely using 
moderate deep inspiration breath-hold for 
the reduction of cardiac dose in left-sided 
breast irradiation for patients with early-
stage or locally advanced breast cancer. 
Am J Clin Oncol 36(1):24–30.
11.     Mast ME, van Kempen-Harteveld L, 
Heijenbrok MW et al (2013) Left-sided 
breast cancer radiotherapy with and 
without breathhold: does IMRT reduce 
the cardiac dose even further? Radiother 
Oncol 108(2):248–253.
12.     van Asselen B, Schwarz M, van Vliet-
Vroegindeweij C, Lebesque JV, Mijnheer 
BJ, Damen EM (2006) Intensity-modulated 
radiotherapy of breast cancer using direct 
aperture optimization. Radiother Oncol 
79(2):162–169.
13.     Levin WP, Kooy H, Loeffler JS, DeLaney 
TF (2005) Proton beam therapy. Br J 
Cancer 93:849–854.
14.     Weber DC, Ares C, Lomax AJ et al (2006) 
Radiation therapy planning with photons 
and protons for early and advanced breast 
cancer: an overview. Radiat Oncol 20(1):22.
15.     Moon SH, Shin KH, Kim TH et al (2009) 
Dosimetric comparison of four different 
external beam partial breast irradiation 
techniques: three dimensional conformal 
radiotherapy, intensitymodulated 
radiotherapy, helical tomotherapy, and 
proton beam therapy. Radiother Oncol 
90(1):66–73.
16.     Hoppe BS, Flampouri S, Su Z et al (2012) 
Effective dose reduction to cardiac 
structures using protons compared 
with 3DCRT and IMRT in mediastinal 
Hodgkin lymphoma. Int J Radiat Oncol 
Biol Phys 84(2):449–455.
17.     Mukesh MB, Barnett GC, Wilkinson JS 
et al (2013) Randomized controlled trial 
of intensity-modulated radiotherapy for 
early breast cancer: 5-year results confirm 
superior overall cosmesis. Am J Clin Oncol 
31(36):4488–4497
18.     http://www.rtog.org/LinkClick.
aspx?fileticket=vzJFhPaBipE%
         3d&tabid=236; visited 13 June 2014.
92 Chapter 2
19.     Remouchamps VM, Letts N, Vicini FA et 
al (2003) Initial clinical experience with 
moderate deep-inspiration breath-hold 
using an active breathing control device 
in the treatment of patients with left-
sided breast cancer using external beam 
radiation therapy. Int J Radiat Oncol Biol 
Phys 56(3):704–715.
20.     Mast ME, van der Klein JN, van 
Geen S et al (2012) Een hartsparende 
bestralingstechniek bij vrouwen met 
linkszijdige borstkanker. De resultaten van 
vier jaar ervaring in Radiotherapiecentrum 
West. Ned Tijdschr Oncol 9(6):270–276.
21.     Ares C, Khan S, Macartain AM et al 
(2010) Postoperative proton radiotherapy 
for localized and locoregional breast 
cancer: potential for clinically relevant 
improvements? Int J Radiat Oncol Biol 
Phys 76(3):685–697.
22.     Borst GR, Sonke JJ, den Hollander S et 
al (2010) Clinical results of image-guided 
deep inspiration breath-hold breast 
irradiation. Int J Radiat Oncol Biol Phys 
78(5):1345–1351.
23.     Tan W, Liu D, Xue C et al (2012) Anterior 
myocardial territory may replace the heart 
as organ at risk in intensity-modulated 
radiotherapy for left-sided breast cancer. Int 
J Radiat Oncol Biol Phys 82(5):1689–1697.
24.     Duma MN, Molls M, Trott KR (2014) 
From heart to heart for breast cancer 
patients: cardiovascular toxicities in breast 
cancer radiotherapy. Strahlenther Onkol 
190(1):5–7.
25.     Langendijk JA, Lambin P, De Ruysscher 
D, Widder J, Bos M, Verheij M (2013) 
Selection of patients for radiotherapy with 
protons aiming at reduction of side effects: 
the model-based approach. Radiother 
Oncol 107(3):267–273.
26.     Ridker PM, Buring JE, Rifai N, Cook NR 
(2007) Development and validation of 
improved algorithms for the assessment of 
global cardiovascular risk in women: the 
Reynolds Risk Score. JAMA 297(6):611–619.
27.     Xu N, Ho MW, Li Z, Morris CG, 
Medenhall NP (2013) Can proton therapy 
improve the therapeutic ratio in breast 
cancer patients at risk for nodal disease?  
 
 
Am J Clin Oncol. 2014;37(6):568-574.
28.     Wang X, Zhang X, Li X et al (2013) 
Accelerated partial-breast irradiation using 
intensity-modulated proton radiotherapy: 
do uncertainties outweigh potential 
benefits? Br J Radiol86:1029–1040.
29.     Unkelbach J, Bortfeld T, Martin BC et al 
(2009) Reducing the sensitivity of IMPT 
treatment plans to setup errors and range 
uncertainties via probabilistic treatment 
planning. Med Phys 36:149–163.
30.     Fredriksson A, Forsgren A, Hårdemark B 
(2011) Minimax optimization for handling 
range and setup uncertainties in proton 
therapy. Med Phys 38:1672–1684.
31.     Galland-Girodet S, Pashtan I, MacDonald 
SM et al (2014) Longterm cosmetic 
outcomes and toxicities of proton beam 
therapy compared with photon-based 
3-dimensional conformal accelerated 
partial-breast irradiation: a phase 1 trial. Int 
J Radiat Oncol Biol Phys. 90(3):493-500.
32.     Bush DA, Do S, Lum S et al (2014) 
Partial breast radiation therapy with 
proton beam: 5-year results with cosmetic 
outcomes. Int J Radiat Oncol Biol Phys. 
90(3):501-505.
33.     Borges C, Cunha G, Monteiro-Grillo I, 
Vaz P, Teixeira N (2014) comparison of 
different breast planning techniques and 
algorithms for radiation therapy treatment. 
Phys Med 30(2):160–170.
93Treatment planning studies in whole breast irradiation
94 Chapter 2
95
Tangential IMRT versus TomoTherapy with and without breath-hold 
in left-sided whole breast irradiation
Mirjam Masta, Truus Reyndersb, Mark Heijenbrokc, Loes van Kempen-Hartevelda, 
Hilde Van Parijsb, Hans Rozemaa, Anna Petoukhovaa, Dirk Verellenb, Mark De Ridderb 
and Henk Struikmansb,d 
a     Radiotherapy Centre West, The Hague, The Netherlands;
b     Radiotherapy Department, Oncology Center, UZ Brussel, Brussels, Belgium;
c      Department of Radiology, Medical Center Haaglanden, The Hague,  
The Netherlands;
d      Department of Clinical Oncology, Leiden University Medical Center,  
The Netherlands.
Acta Oncol Accepted 26-04-2015




Active Breathing Control enables a decrease of cardiac and Left Anterior Descending 
(LAD) coronary artery dose in left-sided breast cancer radiotherapy. Applying a tangen-
tial IMRT technique results in an additional  decrease in these organs of risk (OAR). 
Other studies showed that TomoTherapy decreases the dose in the OARs when com-
pared to tangential IMRT. We investigated whether TomoTherapy enables an addition-
al decrease of cardiac dose in radiotherapy plans with and without breath-hold (BH).
Materials and methods
We compared tangential Intensity Modulated Radiotherapy (IMRT) and TomoTherapy 
treatment plans based on free-breathing (FB) as well as on BH. Twenty patients re-
ferred for whole breast irradiation were included. The glandular breast tissue, heart and 
LAD-region were contoured. Four treatment plans were generated: FB_IMRT; FB_To-
moTherapy; BH_IMRT; BH_TomoTherapy. Several doses were obtained from Dose 
Volume Histograms and compared.
Results
For the mean dose in the heart and LAD-region a significant reduction of the dose was 
found when using TomoTherapy instead of tangential IMRT in both breath-hold and 
free-breathing.  For the LAD-region TomoTherapy in breath-hold resulted in a signifi-
cant lower mean dose of 4.9 Gy, with tangential IMRT in breath-hold a mean dose of 
6.7 Gy was found. The doses in the contralateral lung, both lungs and planning target 
volume (PTV) were comparable for both techniques in breath-hold. However, for the 
V107% in the PTV significant lower doses were found when using TomoTherapy in 
breath-hold.
Conclusion
In daily clinical practice tangential IMRT in breath-hold is the preferred technique to 





Whole breast irradiation (WBI), with or without a boost dose, is seen as the standard 
therapy after breast conserving surgery. But WBI may, amongst others, induce ischaemic 
heart disease. The incidence of ischaemic heart disease appears to be proportional to the 
mean dose to the heart and starts within a few years after exposure [1]. It is, therefore, 
of importance to define the most optimal radiation treatment technique for left-sided 
WBI. The aims are achieving the lowest dose in the critical structures as well as achiev-
ing optimal target coverage. 
Using a breath-hold technique during left-sided breast cancer radiotherapy reduces the 
dose in the heart [2]. Tangential beam intensity modulated radiotherapy (IMRT) in 
combination with a breath-hold technique, when compared to 3D-CRT with breath-
hold,  resulted in a significantly larger decrease of the dose in the heart and left anterior 
descending coronary (LAD) artery [3]. However, others reported that TomoTherapy 
resulted in less dose in the critical structures when compared to tangential IMRT [4, 
5]. The question is, does this finding still hold when tangential IMRT is used with a 
breath-hold technique?
The aim of this comparative planning study, therefore, was to determine whether a 
further dose reduction to the heart and the LAD-region could be obtained with Tomo-
Therapy compared to tangential IMRT, with (and without) breath-hold. 
Materials and methods
The study population consisted of 20 consecutive female breast cancer patients (pT1-2; 
N0-1; M0). All patients underwent breast-conserving surgery. Axillary staging was car-
ried out by performing a sentinel node biopsy. We used the same methods as described 
in our former treatment planning comparison studies 3D-CRT and tangential IMRT 
(with and without breath-hold), and comparing tangential IMRT to proton therapy 
(with and without breath-hold) in the Pinnacle3 planning system (Philips Medical Sys-
tems, Cleveland, OH, United States). The delineated volumes were described in these 
studies as well [3, 6]. 
The PTV was retracted 5 mm from the patient surface (PTVtrim) [3, 6], in order to be 
able to compare the same volumes; we applied the same margins to the TomoTherapy 
plans. For all tangential IMRT and TomoTherapy plans, 97% of the PTVtrim had to be 
covered by at least 95% of the prescribed dose with a maximum of 2% receiving more 
than 107% of the prescribed dose [7]. No compromises on the PTV coverage with ei-
ther of the techniques were made to ensure a fair comparison. The prescribed dose was 
42.56 Gy in 16 fractions in all cases.
Tangential IMRT-planning
With the applied tangential IMRT technique, approximately 60% of the dose was given 
with two tangential open fields, and 40% with four inversely planned tangential IMRT 
fields, using the same gantry angles, with a ‘step-and-shoot’ technique [8]. The nominal 
energy used was 6 MV in most of the cases, and occasionally 10 MV.
For the PTVtrim the following constraints were used: uniform dose (42.56 Gy), max-
imum dose (45.5 Gy, point dose) and minimum dose (40.6 Gy). The maximum dose 
(Dmax) was defined as the maximal dose to a volume of at least 2% of that specific vol-
ume; according to ICRU 83. 
For tangential IMRT and TomoTherapy treatment plans, based on the breath-hold as 
well as on the free-breathing scans, were compared in all patients. Furthermore, various 
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dose volume parameters of PTVtrim, heart, LAD-region and lung (both lungs as well 
as the left lung separately) were generated and evaluated, and were the same as in the 
earlier study [3]. 
For treatment optimisation, the Direct Machine Parameter Optimization (DMPO) [7] 
was used with the following criteria: the maximum number of segments was restricted 
to 12 (to achieve a better sparing of the critical structures; and to keep the same time 
slot as for conventional treatment, in order to make a breath-hold treatment feasible); 
the minimum segment area was set to 9 cm2. For the heart we started defining a maxi-
mum dose (point dose) of 20 Gy; after which the weights for the heart and LAD-region 
were set individually per patient to make a maximum sparing of these structures possi-
ble. All plans were calculated with a Collapsed Cone algorithm. 
TomoTherapy planning
The TomoTherapy Hi-ART treatment planning system used a different set of factors 
than Pinnacle to control the dose administration. For treatment, only ‘tight’ pitch fac-
tors were applied between 0.25 and 0.30. The primary collimation jaws were set to 
a field width of 2.45 cm at isocentre to determine the fan beam width. A modulation 
factor of 2.0 was used for all plans. Using TomoTherapy for breast cancer cases de-
mands the addition of a constraint to the contralateral breast. Since TomoTherapy is a 
rotational technique, the contralateral breast needs to be avoided. This technique was 
also used in another planning comparison study. We used these dose constraints which 
were described by Reynders et al. [9]. 
Statistics
A Wilcoxon Signed Rank Test was carried out to compare dose and volume differences, 
since the number of eligible cases was less than 30. For the convenience of compar-
ison the values in Table 1 were averaged over twenty patients. For this analysis, we 
used SPSS Statistics version 20.0 (IBM SPSS Statistics for Windows. Armonk, NY: IBM 
Corp.). The level of statistical significance was defined by a p-value of ≤0.05 (two-sided) 
for all tests.
Results 
For the mean dose in the heart a significant reduction of the dose was found when using 
TomoTherapy instead of IMRT in both breath-hold and free-breathing. The mean dose 
for TomoTherapy in breath-hold was reduced to 1.1 Gy compared to 1.5 Gy when us-
ing IMRT. For the LAD-region TomoTherapy in breath-hold, when compared to IMRT 
in breath-hold, resulted in a significant lower mean dose of 4.9 Gy versus 6.7 Gy, respec-
tively. See the Table 1 and Figure 1.
For the other dose-volume values (V5Gy, V10Gy, V20Gy, V30Gy) no significant differ-
ences were noted between the two techniques for the heart and LAD-region, when using 
breath-hold. With breath-hold in both IMRT and TomoTherapy, a significant lower 
dose could be achieved in all dose-volume values, see Table 1.
The doses in the contralateral lung and both lungs were comparable for both techniques 
in breath-hold; a mean dose of 5.2 Gy and 5.4 Gy was found for the left lung for To-
moTherapy and IMRT, respectively. For PTVtrim comparable dose values were found for 
both techniques as well; however, for the V107% significant lower doses were found 
when using TomoTherapy in breath-hold. See Table 1.
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Table 1.  Non-significant data is presented in bold. BH breath-hold; FB free-breathing; IMRT intensity modulated 
radiotherapy; Tomo TmoTherapy; V5, V10, V15, V20, V30, and V40 Gy volume receiving 5, 10, 15, 20, 
30, and 40 Gy, respectively; Dmax dose encompassing 2 % of the volume; V95 % and V107 % volume 
receiving 95 and 107 % of the prescribed dose, respectively.
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  Mean (SD) (n=20) p-value
BH FB
Dose distribution 
parameters Tomo IMRT Tomo IMRT
BH compared 
to FB, for both 
IMRT and Tomo
IMRT compared
to Tomo, for both 
BH and FB
Heart Mean (Gy) 1.1 (0.4) 1.5 (0.5) 2.1 (1.0) 2.7 (1.3) p < 0.01 p < 0.01
 Dmax (Gy) 6.5 (5.4) 8.6 (6.2) 17.0 (9.7) 24.7 (14.7) p < 0.01 p < 0.01
 
V5Gy (%) 2.1 (1.8) 2.5 (2.1) 6.9 (4.2) 7.4 (4.7) p < 0.01 BH: p = 0.06 / 
FB: p = 0.55
 V20Gy (%) 0.4 (0.6) 0.6 (0.8) 1.9 (1.9) 3.5 (3.0) p < 0.01 p < 0.03
 
V30Gy (%) 0.1 (0.2) 0.3 (0.4) 0.6 (1.0) 2.4 (2.3) p < 0.01 BH: p = 0.06 / 
FB: p < 0.01
LAD-
region
Mean (Gy) 4.9 (3.8) 6.7 (5.1) 11.3 (6.7) 14.9 (9.3) p < 0.01 p < 0.01
 Dmax (Gy) 15.0 (11.2) 18.8 (13.6) 27.1 (11.2) 31.4 (13.0) p < 0.01 p < 0.04
V5Gy (%) 26.3 (23.9) 30.3 (25.9) 55.2 (23.4) 54.9 (25.1) p < 0.01 BH: p = 0.05 / 
FB: p = 1.0
 V10Gy (%) 15.3 (18.2) 18.2 (21.5) 40.8 (24.9) 42.9 (26.6) p < 0.01 p > 0.10
V20Gy (%) 5.4 (9.7) 9.7 (15.1) 22.4 (22.2) 32.8 (27.1) p < 0.01 BH: p = 0.05 / 
FB: p < 0.01
Bilateral 
lung
Mean (Gy) 2.7 (0.8) 2.6 (0.9) 2.8 (0.9) 2.9 (1.1) IMRT: p = 0.02 / 
Tomo: p = 0.79
p > 0.10
Dmax (Gy) 37.5 (3.4) 33.4 (5.7) 29.7 (8.0) 35.5 (5.0) p < 0.01 p < 0.01
 
V5Gy (%) 10 (2.4) 10.1 (3.1) 11 (2.3) 10.1 (3.3) IMRT: p > 0.10 / 
Tomo: p < 0.02
BH:  p > 0.10 / 
FB: p < 0.02
 
V20Gy (%) 4.9 (1.9) 5.1 (2.2) 4.4 (2.5) 5.7 (2.6) IMRT: p < 0.03/ 
Tomo: p > 0.10
BH:  p > 0.10 / 
FB: p < 0.04
Lung 
Left 
Mean (Gy) 5.2 (1.5) 5.4 (1.8) 5.3 (1.8) 6.1 (2.3) IMRT: p < 0.01 / 
Tomo: p > 0.10
p > 0.10
 
Dmax (Gy) 37.5 (3.4) 37.1 (2.8) 34.1 (6.1) 38.7 (2.3) IMRT: p > 0.10 / 
Tomo: p < 0.02
p < 0.03
V5Gy (%) 20.5 (5) 21.4 (6.6) 23.0 (5) 21.9 (7.1) IMRT: p > 0.10 / 
Tomo: p < 0.01
p > 0.10
 
V20Gy (%) 9.8 (3.9) 10.9 (4.7) 8.8 (5.2) 12.4 (5.7) IMRT: p < 0.02 / 
Tomo: p > 0.10
BH:  p > 0.10 / 
FB: p < 0.02
PTVtrim V95% (%) 98.2 (1.0) 97.9 (0.15) 97.8 (1.4) 97.9 (0.18) p > 0.10 p > 0.10
 
V107% (%) 0 0.4 (1.0) 0 (0.1) 0.2 (0.4) p > 0.10     BH: p = 0.03 / 
FB: p = 0.06  
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Figure 1A:  Left: Mean dose administered to the heart in breath-hold and free-breathing for Intensity Modulated 
Radiotherapy (IMRT) and TomoTherapy (Tomo). Right: Mean dose administered to the LAD-region 
in breath-hold and free-breathing for Intensity Modulated Radiotherapy (IMRT) and TomoTherapy 
(Tomo). The cases were rearranged using the increasing (from left to right) IMRT FB technique values. 
For the convenience of comparison regression lines were added in the graphs.
Figure 1B:  Isodose lines in the caudal part of the patient on the breath-hold scan. Delineated Organs at Risk: 
white line = heart; thick black line = region of the Left Anterior Descending coronary artery; Planning 
Target Volume: black line = PTVtrim; 95% isodose = thick white line. Left: IMRT and TomoTherapy in 




The results show that, with TomoTherapy in breath-hold, when compared to tangential 
IMRT in breath-hold, the mean doses to the heart as well as to the LAD-region could be 
reduced significantly. This was achieved without compromising the doses to the target 
volumes. For the other dose values both techniques in breath-hold were comparable. 
The difference between the mean heart dose when using a tangential IMRT technique in 
breath-hold compared to TomoTherapy in breath-hold, was limited 1.5Gy (SD 0.5Gy) 
and 1.1Gy (SD 0.4Gy), respectively.  However, it should be emphasised that the com-
bination of a breath-hold technique with TomoTherapy cannot be performed in daily 
clinical practice, due to the longer beam-on time (a TomoTherapy treatment session in 
free-breathing fraction lasts about 20 minutes) and rotating technique [9]. Therefore, 
TomoTherapy can only be applied without breath-hold. We also showed, that less dose 
to the heart and LAD-region will be administered when using tangential  IMRT in 
breath-hold compared to TomoTherapy in free-breathing, see Figure 1. Theoretically, 
the tangential IMRT technique could be optimised. A higher dose reduction to the heart 
could be achieved by using a multiple field IMRT technique. However, Borges et al., 
reported that this could only be achieved at the expense of a higher dose in OARs and 
normal tissue [10]. Furthermore, we did not evaluate the dose in the contralateral breast 
as this item was analysed in other studies. Shiau et al. found no significant difference 
in mean doses in the contralateral breast between TomoTherapy and tangential IMRT. 
However, as the low dose (V5Gy) in the contralateral breast was higher for TomoTher-
apy compared to tangential IMRT, this should be taken into account when using a To-
moTherapy technique [5]. Recently, TomoDirect was introduced, allowing the admin-
istration of radiation using fixed gantry angles. As Qi et al. described in their study, the 
TomoDirect technique leads to less dose in the contralateral breast compared to helical 
TomoTherapy [11]. Finally, we underline the statement of Qi et al., that individualised 
radiation treatment is of importance and that the appropriate radiation technique needs 
to be selected according to the patients risk factor [11]. 
Conclusion 
In daily clinical practice tangential IMRT in breath-hold is the preferred technique to 
maximally reduce the dose to heart and LAD-region in left-sided whole breast irradiation. 
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Breast cancer radiotherapy has been associated with an increased risk of cardiac toxici-
ty. However, no data are available on the probability of developing coronary artery dis-
ease (CAD) in breast cancer patients when compared with healthy women. Therefore, 
baseline coronary artery calcium (CAC) scores, as an accepted tool to predict CAD, 
were determined and compared with the CAC scores of a healthy, asymptomatic cohort, 
the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. 
Materials and methods
Eighty consecutive patients with ductal carcinoma in situ or infiltrative breast cancer 
referred for radiotherapy after breast-conserving surgery were included in our study. 
Their cardiovascular risk profile was registered, and a 64 multislice CT scan was per-
formed. The CAC scores of an unselected (Caucasian only) Radiotherapy Centre West 
(RCWEST) cohort, as well as of those of a selected (comorbidity and race adjusted) 
RCWEST cohort, were determined. The scores of both cohorts were compared with 
those of the female (Caucasian only) MESA cohort. 
Results
For the unselected RCWEST cohort (n = 62) we found significant (p < .01) higher scores 
for women in the 55-64 age category compared with those of the MESA cohort. In the 
selected cohort (n = 55) the CAC scores of the women in the age category 55-64 were 
significantly (p = .02) higher compared with the MESA cohort. No significant differenc-
es were noted in the other age categories. 
Conclusion
Both cohorts revealed that CAC scores in the 55-64 age category were significantly 
higher than the CAC scores in the asymptomatic (female) MESA population. These 
data suggest that breast cancer patients bear a higher risk of developing coronary heart 
disease before the start of radiotherapy. Therefore, measures to decrease cardiac dose 




According to the data of the Early Breast Cancer Trialists Collaborative Group, breast 
cancer radiotherapy, as it was administered in 1970-1990, was associated with an in-
creased risk of fatal cardiovascular events (1). This finding was confirmed in a retro-
spective study in the Dutch Late Effects Breast Cancer cohort (2). Taylor et al. conclud-
ed that the heart dose from lefttangential radiotherapy had decreased considerably over 
the past 40 years. However, they also noted that for approximately half of left-sided 
patients, part of the heart still receives ≥20 Gy and found that the left anterior descend-
ing coronary artery, of all main coronary arteries, received the highest dose (3). Marks 
et al. found that the radiation induced heart perfusion defects are located in the anterior 
parts of the left ventricle (4). These data indicate that even today, left-sided breast can-
cer radiotherapy is potentially harmful to the heart, and specifically to the left anterior 
descending coronary artery. This is relevant because radiotherapy is frequently applied 
in the primary treatment of breast cancer. In a Dutch population-based study, it was 
shown that about 63% of women with breast cancer received radiotherapy as part of 
their primary treatment (5). 
However, no data are available on the frequency of risk factors predicting the probabili-
ty of coronary artery disease (CAD) for the group of women diagnosed with early-stage 
breast cancer before starting radiotherapy. Specifically, when compared with healthy 
women, no data are available on the number of CAC (i.e., coronary artery calcium, or 
CAC) deposits. Therefore, in our study, these baseline CAC scores were compared with 
the CAC scores of a healthy female population. In doing so, the CAC scores in 80 con-
secutive female breast cancer patients were compared with the CAC scores of a healthy, 
asymptomatic female cohort, the MESA cohort (6). 
The reasons for the use of CAC scores in our study design were as follows: a number of 
studies concluded that the amount of calcium deposits in the coronary arteries predicts 
the risk of subsequent cardiovascular events in cases without symptomatic CAD (7-11). 
Furthermore, Pletcher et al. stated in their systematic review and meta-analyses that 
CAC is an independent predictor of CAD (7). Finally, it was suggested that CAC depos-
its can be useful in deciding whether further diagnostic testing is necessary in asymp-
tomatic patients or patients with nonanginal chest pain and was shown that low-dose 
CT has proved to be a sensitive, noninvasive method for quantifying CAC deposits (8). 
With this study we attempted to identify differences in CAC scores for several cohorts 
to assess the risk on CAD before starting the radiation treatment.
Materials and methods
From September 2008 until October 2010, 80 women were included in this study. 
Consecutive patients with either ductal carcinoma in situ (<4 cm) or infiltrative breast 
cancer (<5 cm) and treated with breast-conserving surgery were considered eligible. If 
indicated, chemotherapy started after radiotherapy. The study was approved by the 
local ethical committee (Dutch southwestern region), and written informed consent 
was obtained for all participants. A low-dose, nongated 64 multislice CT scan, the 
Lightspeed VR 64-MSCT (GE, UK), was performed within 10-15 min. No intravenous 
contrast enhancement was used. The performed CT scan took place before the start of 
radiotherapy.
The overall CAC score consists of the sum of all the calcium lesions present in the left 
main artery, left anterior descending coronary artery, left circumflex artery, and right 
coronary artery and was estimated with a GE Advantage Workstation Volume (share 2, 
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version 4.4 (2007), rev. 1, DFOV 25 cm, pixel area 0.5 x 0.5 mm2). The method we used 
was described by Agatston et al. (12). All scans were evaluated by one radiologist (MH) 
specialized in determining CAC scores. To determine the inter-observer variability of 
the CAC values, a random selection (n = 58) of the available CAC scans was done. A 
second radiologist, blinded to the scores of the first observer, determined for each of the 
58 cases a second CAC score. 
The MESA study was designed to study the prevalence, risk factors, and progression 
of subclinical cardiovascular disease in a population-based sample of 6,814 men and 
women aged 45-84 years. All participants were free of clinically apparent cardiovas-
cular disease (6). To compare the results of the Radiotherapy Centre West (RCWEST) 
cohort to that of the MESA cohort, several risk factors of developing cardiac disease 
were registered. Age, height, body mass index (BMI, defined as weight in kilograms 
divided by height in square meters) and CAD risk factors: history of heart and vascular 
disease, including diabetes mellitus, hypertension, and hypercholesterolemia (the latter 
three only applicable when medication was used), were registered in specially designed 
questionnaires before starting the radiotherapy sessions. Smoking habits were regis-
tered and defined by the number of pack years. One pack year was defined by smoking 
a total of 20 cigarettes each day during 1 year. In the RCWEST cohort a woman was 
classified as a former smoker if she had stopped smoking more than one year before 
starting radiotherapy. 
As a first step, the CAC scores of the Caucasian RCWEST cohort were compared with 
those of the (female) Caucasian MESA cohort. We then excluded patients suffering 
from diabetes mellitus and those diagnosed beforehand with cardiovascular diseases. 
By doing so, we created a cohort that was better comparable (specifically with respect 
to cardiac risk factors) to that of the MESA cohort. Finally, the CAC scores of this latter 
selected RCWEST cohort were compared with the (female) Caucasian MESA data. The 
calcium scores were classified into percentiles, e.g., the 25th percentile implies that 25% 
of all cases have a CAC value lower than the given value. 
According to Bax et al. (13), the determined CAC values are categorized as follows: 
low-risk calcium scores—CAC values 0-100; medium-risk calcium scores—100 < CAC 
values <400; high-risk calcium scores—CAC values >400.
For optimal comparison with the MESA cohort, three age categories of patients were 
created: 45-54, 55-64, and 65-74.Two age categories of patients were excluded from 
our analysis because the youngest age group in our cohort (<45) is not included in the 
MESA cohort, and the oldest age group (75-84) consisted only of two patients.
Statistical analysis
Because the data were heavily skewed with 36% of the patients having a CAC score of 
zero, a log transformation was computed on all CAC values. On the log scale, the data 
were normally distributed. A paired t test was performed to determine the inter-observ-
er variability of the overall CAC values. The inter-observer variability of the CAC values 
was also evaluated for each single artery (left main artery, left anterior descending cor-
onary artery, left circumflex artery, and right coronary artery). A Wilcoxon signed rank 
test was performed for the latter analysis because the number of eligible data was <30.
For a comparison of the RCWEST cohort to the MESA cohort, the distribution of the 
CAC scores was analyzed with the Chi-square test. The MESA CAC distribution for 
each age group was computed into a ratio (expected) and was compared to the CAC 
distribution of the RCWEST cohort (observed). A Chi-square test was also performed 
for the comparison of age, race, smoking, and BMI between both cohorts. 
Chapter 3
111
For analysis, we used SPSS Statistics version 17.0. The level of statistical significance 
was considered p < 0.05 for all tests. (IBM SPSS Statistics for Windows. Armonk, NY: 
IBM Corp.)
Results
Eighty women diagnosed with either pure ductal carcinoma in situ (<4 cm; 5% of all 
cases) or infiltrative breast cancer (<5 cm; 95% of all cases) were included. Sixty-four 
percent of the women were postmenopausal. Thirteen percent of the patients in the 
RCWEST cohort had a history of cardiac disease; two patients had experienced a my-
ocardial infarction in the past, and two patients mentioned that they had experienced 
signs of myocardial ischemia (angina pectoris). Furthermore, 8 patients suffered from 
diabetes mellitus. In three of these eight patients, a combination of the excluding factors 
were present. Seven patients were not Caucasian.
The mean age of the patients included in the RCWEST cohort was 56 years (range, 29-
81), and for the MESA cohort, the mean age was 62 (range, 45-84). The mean BMI in 
the RCWEST cohort was 26 (range, 18-39); for the MESA cohort, no mean BMI was 
available. A significant difference between the RCWEST and the MESA cohort was 
found in the distribution of BMI categories; specifically, the BMI categories <25 and 30 
to <40 seem to be different. A significant difference was also found for the age catego-
ries: in the RCWEST cohort, a higher percentage of women in the 55- to 64-year age 
category was included; in the MESA cohort, more women were included in the 45- to 
54-year age category. Furthermore, the distribution of race was significantly different: 
in the RCWEST cohort, a larger number of Caucasian women was included. Finally, the 
smoking status of the RCWEST cohort differed significantly from those of the MESA 
cohort, specifically in the current smokers category (Table).
The mean overall CAC was 82 with a range of 0-779, with 53% of the CAC scores 
being zero.
Inter-observer variability CAC values
For 73% (n = 58) of the patients, the inter-observer variability between the two radiol-
ogists was evaluated. No significant differences (p = 0.3) in the overall CAC values were 
found. However, for each separate artery, it was difficult in some patients to determine 
to which artery the specific CAC value belonged. In these cases, the proportion of calci-
um deposits was situated near the bifurcation of two arteries. Both radiologists scored 
an overall CAC value of zero in the same patients.
Comparison with the MESA cohort
For the unselected Caucasian RCWEST cohort (n = 65; the 15 patients <45 and >74 
were excluded, see Materials and methods) we found significantly (p < 0.01) higher 
CAC scores when compared to those of the (female) Caucasian MESA cohort. This ap-
plied specifically for the CAC distribution for women in the age category of 55-64 years 
old. In the other age categories, no significant differences were found (age category 45-
54: p = 0.84; age category 65-74: p = 0.07).
Percentiles of CAC scores for three age categories of Caucasian patients only (45-54, 
55-64, and 65-74; n = 62) are shown in the Figure for both the RCWEST cohort and 
the MESA cohort. These scores showed that in the 45-54 age category (n = 11), the 
numbers of patients with the value 0 were approximately the same (25th-75th percen-
tile values), but the 95th percentile CAC value was higher in the MESA data. The CAC 
values of the RCWEST 55-64 age category (n = 33) increased more rapidly than the 
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MESA cohort, and the CAC values of the 65-74 age category (n = 18) seem to be of the 
same magnitude. 
The selected RCWEST cohort was created by excluding the cases with a history of 
cardiac disease, diabetes mellitus, and non-Caucasians and consisted of 55 patients. 
This selected cohort also showed a significantly (p = 0.02) higher CAC distribution for 
the women in the 55-64 age category compared with that of the MESA cohort. For the 
other age categories, no significant differences were found.
Table. Patient characteristics of the unselected RCWEST, The MESA and the selected RCWEST cohort. 
 
RCWEST 




< 45 13* 16.3 0
< 0.001
9*
45-54 13 16.3 30.1 11
55-64 33 41.3 27.7 27
65-74 19 23.8 28.6 17
75-84 2^ 2.5 13.6 2^
Race  
  Caucasian 73 91.3 40.2
< 0.001
66
  Chinese 0 0 11.4 n.a.
Black 2 2.5 27.8 n.a.
 Hispanic 1 1.3 20.6 n.a.
Hindustani 4 5 0 n.a.
Diabetes Mellitus (DM)  
Yes 6 7.5 n.a.
n.a.
n.a.
No 74 92.5 n.a. n.a.
Hypertension$  
Yes 11 13.8 43.8
n.a.¥
19
No 67 83.8 56.2 47
Combined with DM 2 2.5 n.a. n.a.
Smoking cigarettes    
Never 39 48.8 58.8
0.02
33
Former 23 28.8 29.2 25
Current 18 22.5 12.0 8
BMI (kg/m2)    
< 25 34 42.5 31.8
0.02
31
25-<30 31 38.8 34.6 25
30-40 15 18.8 28.5 10
≥ 40 0 0 5.0 0
*Excluded from analysis, no data available in MESA cohort 
^ Excluded from analysis, too few patients in RCWEST cohort 
$ RCWEST cohort: Only if a patient received medication for hypertension 
¥ N.a. since different definitions were used in both cohorts
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Figure.  Percentiles of coronary artery calcium (CAC) scores for three Caucasian age  
categories (45-54, 55-64, and 65-74 years) for both the Radiotherapy Centre  
West (RCWEST) cohort (blackline) and the Multi-Ethnic Study of Atherosclerosis  
(MESA) cohort (dashed line).
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Discussion
A comorbidity and race adjusted comparison revealed that the RCWEST cohort CAC 
scores in the 55-64 age category were significantly higher than the CAC scores in the 
(asymptomatic) MESA cohort. This applies both to the unselected Caucasian RCWEST 
cohort and to the selected RCWEST cohort, in which only Caucasian and “healthy” 
patients were included.
However, to compare our data reliably to the MESA data, we needed to divide the co-
hort into specific age categories. Because the RCWEST cohort consisted of 80 women, 
this resulted in a small number of patients for each category. Therefore, the results of 
the chi-square test are less reliable. Possibly because of the small number of patients in 
the age categories 45-54 and 65-74, no differences were found compared with those of 
the MESA cohort (6).
Although we did not find significant differences between the observers, the determina-
tion of the CAC values for each separate artery was difficult in some patients. Therefore, 
we restricted ourselves by using the values of one radiologist and, in doing so, eliminat-
ed a possible inter-observer bias.
The number of CAC values of zero in the Caucasian RCWEST cohort was 44%, which 
is lower than the 62% in the MESA cohort of McClelland (6). Also, in the Caucasian 
RCWEST cohort, fewer women older than 65 had a CAC value of zero (50th percentile 
46 for RCWEST and 13 for Caucasian MESA). This confirms the findings that signif-
icantly higher CAC values were found in one of the age categories of the RCWEST 
cohort.
According to Bax and colleagues (13), the relationship between CAC scores and CAD 
may be weakened because extensive calcification could possibly represent a more stable 
stage of CAD. Noncalcified and mixed lesions could be more vulnerable, but this is still 
a point of debate (14,15).
A drawback of our study is that we had to compare the Dutch RCWEST cohort with 
that of a healthy cohort, the American MESA cohort. However, no such data were 
available for the (healthy) Dutch female population. The MESA cohort consists of 
American women, and it is conceivable that those women experience different cardiac 
risk factors than Dutch women because of the different lifestyles in the United States 
(i.e., more dietary fat consumption, less physical activity, and higher BMI). Also, the 
number of current smokers in the RCWEST cohort is higher than in the MESA co-
hort; because we could not find the definition “formersmoker” in the MESA cohort, 
we applied the definition “smoker” if the patient had stopped less than 1 year before 
radiotherapy. Thereafter, we classified a patient as “former smoker” if the patient had 
stopped smoking without a time limitation. In that analysis, no significant differences 
were found between cohorts (p = 0.18). Furthermore, we compared our overall results 
for Caucasian women with those of the German Heinz Nixdorf Recall (HNR) study, 
a population-based study that recruited unselected participants in the German Ruhr 
area. This population would, theoretically, be better comparable to the Dutch RCWEST 
cohort, although the HNR study did not stratify for race (16). It was remarkable that 
in Caucasian women aged up to 60 years, the 50th percentile CAC values were all zero 
in both the HNR study and the RCWEST cohort. 
However, in the selected RCWEST cohort, we found CAC 50th percentile values that 
were around 8 times higher compared with the HNR study (22 vs. 2.6) for Caucasian 
women in the 65-69 age category (n = 15). For this comparison, we again had to divide 
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our group of patients into comparable age groups; in doing so, only a small number of 
patients remained in each age category. 
As for the BMI, a BMI of >25 kg/m2 is classified as overweight according to the World 
Health Organization guidelines. We found a smaller number of patients in the Dutch 
RCWEST cohort who could be classified as overweight (58%) than in the American 
MESA cohort (68%) (11), but we found higher BMI values in our study compared 
with the general Dutch female population according to Statistics Netherlands (CBS). 
In the Dutch female population aged ≥20 years old, the number of overweight patients 
in 2007 was 40% (17). However, the fact that the women in the RCWEST cohort ex-
perience a higher BMI compared with the Dutch female population corresponds to the 
finding that overweight is a risk factor for breast cancer. Remarkably, a BMI higher than 
30 kg/m2.seems to correlate with a worse disease-free survival in breast cancer patients 
(18, 19).
Because this cohort is not selected, our results might be representative of breast cancer 
patients treated with breastconserving therapy. Our study underlines the necessity to 
compare treatment associated CAD in patients with left-sided breast cancer with other 
cohorts of breast cancer patients, because those women may also eventually be more 
predisposed to develop CAD. In 2008, a heart-sparing breath-hold technique (20) was 
introduced in our department to decrease cardiac dose for leftsided breast cancer cases. 
We intend to quantify the efficacy of the heart-sparing technique by comparing the 
number of calcium deposits in the coronary arteries of breast cancer patients treated 
with and without use of the ABC technique before radiotherapy until 3 years after com-
pletion of the radiation treatment.
Conclusion
Despite the relatively small number of patients, the RCWEST cohorts revealed that the 
CAC scores in the 55-64 age category were significantly higher than the CAC scores in 
the asymptomatic (female) MESA cohort. These data suggest that breast cancer patients 
bear a higher risk of developing CAD. Therefore, measures to decrease cardiac dose 
further in breast cancer radiotherapyare even more important.
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Summary 
The aim of this prospective longitudinal study was to identify differences in Coronary 
Artery Calcium (CAC) scores between three groups of breast cancer patients (right-sid-
ed, left-sided treated with and without breath-hold) by comparing the CAC scores 
before the start of radiotherapy to those determined three years after radiotherapy. 
Breath-hold in breast-conserving radiotherapy leads to a less pronounced increase of 
CT based CAC scores. 
Abstract 
Purpose
The aim of this prospective longitudinal study was to identify differences in Coronary 
Artery Calcium (CAC) scores between three groups of breast cancer patients by com-
paring the CAC scores before the start of radiotherapy to those determined three years 
after radiotherapy.
Materials and methods
Multi-slice CT scans were carried out in 99 consecutive patients, referred for radiother-
apy after breast-conserving surgery. No regional radiotherapy was given. The patients 
were subdivided in three groups: left- and right-sided radiotherapy, and left-sided radio-
therapy using a breath-hold technique. The differences in increase of the overall and Left 
Anterior Descending (LAD) coronary artery CAC scores were determined. Within each 
patient the LAD minus RCA scores were also analyzed, representing the CAC scores of 
the LAD minus those of the Right Coronary Artery (RCA).
Results
After three years, a non-significant lower increase in overall CAC scores and a significant 
lower increase in mean CAC scores in the LAD was found for the group with left-sided 
breast cancer treated with breath-hold compared to the group without breath-hold. 
Furthermore, the LAD minus RCA scores in patients treated for left-sided breast cancer 
without breath-hold were higher when compared to those with right-sided breast can-
cers and those with left-sided breast cancer treated with breath-hold. 
Conclusion
Breath-hold in breast-conserving radiotherapy leads to a less pronounced increase of 
CT based CAC scores. Therefore, breath-hold is probably useful to prevent the devel-
opment of radiation-induced coronary artery disease. The drawbacks of our study were 




Radiotherapy for left-sided breast cancer has been associated with an increased risk 
of Coronary Artery Disease (CAD) [1,2]. This rate of major coronary events started to 
increase within a period of 5 years of exposure of radiotherapy. Also was determined 
that the incidence of major coronary events was proportional to the mean dose to the 
heart [3]. Furthermore, Nilson et al. found a higher amount of calcium deposits in 
the LAD coronary artery after radiation therapy for left-sided breast cancer compared 
to the same situation for right-sided breast cancer [4]. Whetal et al. confirmed that 
the presence of radiation-induced calcium deposits is seen as a surrogate marker for 
radiation-induced atherosclerotic lesions. They found more atherosclerotic lesions in 
the LAD of irradiated Hodgkin’s lymphoma survivors than in non-irradiated patients. 
These patients were treated with mediastinal or mantle field radiotherapy (including 
the pre-cranial arteries and/or coronary arteries) with a median dose of 40 Gy [5]. Ac-
cording to Greenland et al. and Oudkerk et al., the amount of calcium deposits in the 
coronary arteries (CAC scores) predicts the risk of subsequent cardiovascular events 
[6,7]. Another study showed that CAC scores, when compared with 11 other newer 
coronary heart disease risk markers, were the best predictors of the occurrence of cardi-
ovascular disease in persons who were initially without CAD [8]. Moreover, it appeared 
that adding CAC scores to the Framingham Risk score (FRS) improved the accuracy of 
risk predictions [8]. It should be emphasized that the FRS is the most commonly used 
CAD risk prediction score [9].
To the best of our knowledge, no studies have been carried out that compared the 
amount of CAC before and after radiotherapy in breast cancer patients treated with 
radiotherapy. Therefore, we prospectively determined CAC scores at baseline as well as 
three years after radiotherapy in 99 consecutive female breast cancer patients receiving 
breast-conserving radiotherapy.
The aim of this prospective longitudinal study was to identify possible differences in 
CAC scores between patients irradiated for right-sided breast cancer and patients irra-
diated for left-sided breast cancer. The latter group comprised both patients irradiated 
using a breath-hold technique and those irradiated without using a breath-hold tech-
nique. 
Materials and methods 
Patients
Patients with either DCIS (< 4 cm) or breast cancer (< 5 cm) and treated with breast-con-
serving surgery and whole breast radiotherapy were considered eligible. No regional 
radiotherapy was given. Every eligible patient referred to our department, Radiother-
apy Centre West (RCWEST), was asked to participate in this study. Seventy percent 
of all eligible patients agreed to participate. From September 2008 until July 2011, 
109 consecutive patients were included in this prospective study. The study was ap-
proved by the local ethical committee (METC Zuidwest Holland). Written informed 
consent was obtained from all participants. If indicated, adjuvant systemic therapy and/
or chemotherapy was given, starting after radiotherapy. Our patient population con-
sisted of three groups: i) 21 patients treated with left-sided radiotherapy (group L-BH); 
ii) 23 patients treated with right-sided radiotherapy (group R); and iii) 65 patients 
treated with left-sided radiotherapy using a breath-hold technique (group L+BH). From 
January 2010 onwards, in all left-sided breast cancer patients in RCWEST the Active 
Breathing Control (ABC) breath-hold method [10,11] was used. Therefore, the third 
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group (group L+BH), consisted of patients receiving radiotherapy using a breath-hold 
technique. Subsequently, from October 2010 hypofractionation schemes were routinely 
administered [12,13]. In 33 of these 65 left-sided breast cancer patients, treated with 
breath-hold, a hypofractionation scheme was used. 
CAC CT scan
CAC CT scans were carried out at baseline and after three years. CAC was measured 
using non-contrast, low-dose non-gated cardiac CT studies on a GE 64-slice MDCT 
scanner (LightSpeed VCT, General Electric Medical System®, Milwaukee, WI). The 
non-invasive CT scan was performed within 10-15 minutes. A 2.5 mm reconstructed 
slice thickness was used. 
The CAC score was calculated according to Agatston et al. [14]. The Agatston score 
requires three contiguous voxels of >130 Hounsfield units. The overall coronary cal-
cium score was determined on a GE Advantage Workstation Volume (share 2, version 
4.4 (2007), DFOV 25 cm, pixel size 0.5x0.5 mm2), by summing individual lesion scores 
from each of the main epicardial coronary arteries: Left Main Artery (LMA), Left An-
terior Descending (LAD) artery, Left Circumflex (LCX) artery, and Right Coronary 
Artery (RCA). 
To avoid interobserver variations, all scans were evaluated by one radiologist (MH), 
specialized in determining CAC scores, and one cardiologist (JS), in order to reach a 
consensus on all calculated calcium scores. Both were blinded for the side of the ra-
diotherapy (right of left breast). All scans were reviewed separately. When different 
scores were found, a joint review took place, and a final decision was reached based on 
consensus. CAC scores were categorized into three groups: i) a low-risk group: 0 – 100; 
ii) a medium risk group: 100-400; iii) a high-risk group: > 400 [15]. We compared the 
distribution of these three risk groups in time within each of the three patients groups: 
R, L-BH and L+BH. 
Radiotherapy
Details on the patient position, the CT scan before the radiation treatment, the breath-
hold technique and the delineation of the target and critical organs were described ear-
lier [11]. A 3D-Conformal Radiation Therapy (3D-CRT) technique was used. Details 
about this technique and dose specification were also described earlier [11]. Total doses 
were: 50 Gy in 25 fractions for the conventionally fractionated cases, and 42.56 Gy 
in 16 fractions for the cases irradiated with a hypofractionation scheme. If indicated 
according to the national guidelines, a boost dose, using a photon based technique, 
was added to the tumor bed. This boost dose was given after completion of the whole 
breast irradiation. The boost doses ranged from 13.30 Gy-26 Gy, in 5 to 13 fractions 
respectively, see Table 1. 
Risk factors
The following cardiac risk factors were obtained before starting radiotherapy: age, 
height, BMI (Body Mass Index, defined as weight in kilograms divided by height in 
square meters), postmenopausal status, smoking habits. Also, specific CAD risk factors 
were obtained: history of heart and vascular disease, including diabetes mellitus, hy-
pertension and hypercholesterolemia (the latter three were only found applicable when 




Since we were interested in the difference between the baseline score and the score three 
years after radiation therapy, the patients who were not able to undergo a CAC CT scan 
after three years were excluded from the CAC analyses. 
Concerning the CAC scores we determined:
1.  the (mean) overall CAC scores and the (mean) LAD CAC scores at baseline and at 
three years after radiation for group L-BH, group R and group L+BH. 
2.  the (mean) differences between CAC scores within each patient in the LAD and the 
RCA (LAD minus RCA CAC scores), at baseline and at three years after radiation, for 
the three groups. Representing the differences in the individual patient. The RCA is the 
coronary artery that receives the lowest dose when administering whole breast radio-
therapy, since the RCA is lying furthest away from the radiation treatment fields, both 
in left-sided as well as right-sided breast cancer radiotherapy. Therefore, this artery was 
used as a reference. 
Statistical analysis
A descriptive analysis of the change of the CAC scores in time was carried out, reporting the 
mean, median, standard deviation and Standard Error (SE). The presence or absence of sta-
tistical significance of categorical values was determined using the Chi-square test. We fitted 
mixed models for the various outcome variables assuming no differences at baseline, and 
carried out a one-way analysis of variance (ANOVA) for the continuous values. For anal-
ysis, we used SPSS Statistics version 20.0 (IBM SPSS Statistics for Windows. Armonk, NY: 
IBM Corp.). P-values ≤ 0.05 (two-sided) were considered statistically significant for all tests.
Results
General characteristics of the patients and risk factors
For all 109 women a baseline CAC score was calculated. After three years of follow-up, 
ten women were lost to follow-up since they had either died, suffered from metastases 
or had received cardiac vessel metal implants which seriously distorted the quality of 
the CAC CT images. Hence, after three years of follow-up, in 99 women both a baseline 
and a follow-up CAC score were available (see Table 3 for the range when the follow-up 
calcium CT scan had taken place). 
Of the 99 women 12% were diagnosed with pure DCIS (<4 cm) and 88 % with breast 
cancer (< 5cm). Forty percent of the patients received adjuvant chemotherapy, the latter 
was anthracyline based in all patients, Table 1.
The mean age of the patients was 56 years (range 28-74). Patient and treatment char-
acteristics are summarized in Table 1. Sixty-eight percent of all 99 women had a post-
menopausal status at baseline; 83% of the left-sided breast cancer patients irradiated 
without breath-hold; 70% of the right-sided breast cancer patients; and 62% of the 
left-sided breast cancer patients irradiated with breath-hold. Of all the women 91% 
was Caucasian, 3% was Spanish, 2% was Black and 4% was Hindustani.
The mean BMI in the RCWEST cohort was 26 (range 18-39), corresponding with over-
weight on the BMI scale [16]. Seventeen percent in the total RCWEST cohort had a BMI 
higher or equal to 30, corresponding with obesity on the BMI scale [16]. 
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Table 1: Patient and treatment characteristics of the three RCWEST groups.
Seventeen percent of the women were smoking before they started with the radiation 
treatment. Around 52% of the women had a smoking history with a mean number of 
history pack years of 11 (range 0 – 56). Also, before the start of the radiation therapy 
20% of the women were used to drinking more than 2 units of alcohol each day, 27% 
of them less than 1 unit per day. 
One patient had experienced a cardiac arrest in the past and two patients reported 
that they had experienced signs of angina pectoris in the past. During the follow-up 
period no coronary vascular events or other (new) heart diseases had been reported. 
Furthermore, 23 patients suffered from hypertension and eleven patients suffered from 
diabetes mellitus. No differences were seen between the three groups, see Table 2. 
Table 2:  Distribution of the risk factors in the three RCWEST groups. Calcium scores:  
mean scores LAD and overall score.
At baseline, a comparable distribution of the risk factors between the three groups: 
L-BH, R and L+BH, was noted, see Table 2. After three years, only a small non-signifi-
cant shift was noted in the CAC risk distribution (p>0.1), Table 3.
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(yes/no) RT dose (Gy)




R  (n=20) 55.6 [39-71] Right no 50.00  
16 (n=5) / 20 
(n=3) / 26 (n=3) 6  
L-BH  (n=18) 61.2 [44-74] Left no 50.00  
16 (n=8) / 20 
(n=1) 8  
L+BH
 (n=28)
54.3 [28 - 72]
Left yes 50.00  
16 (n= 13) / 20 
(n=3)   
 (n=1) Left Yes 42.00 *  26  
 (n=32) Left yes 42.56  
13.30 (n=17) / 
18.62 (n=3)   
 * Radiotherapy stopped prematurely, hence the planned dose of 50 Gy was not given   
          
      
Table 2      
Group R L-BH L+BH p-value  
(n = 99) (n=20) (n=18) (n=61)   
Postmenopausal at baseline 14 15 38 p = 0.2  
Smoking 3 2 12 p = 0.7  
History pack years >= 10 10 8 24 p = 0.7  
Alcohol; > 2 units per day 5 7 8 p = 0.05  
BMI < 25 6 8 29 p = 0.4  
BMI >= 25 14 10 32   
History of cardiac diseases * 3** 4 5 p = 0.3  
Hypertension *** 5 5 13 p = 0.8  
DM  *** 4 1 6 p = 0.3  
* mostly arrhythmias
** one patient with a cardiac arrest
** some patients suffer from both hypertension and DM 
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low 
risk*
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medium 
risk*












CAC                      
low 
risk*
CAC      
medium 
risk*






R (n=20) 14.5 / 0.0 0 - 105 80.1 / 0.0 0 - 825 n=17 n=1 n=2 60% 29.9 / 0.0 0 - 255 138.0 / 0.0 0 - 1334 n=16 n=2 n=2 55%
L-BH (n=18) 49.3 / 6.5 0 - 334 75.2 / 11.0 0 - 477 n=14 n=3 n=1 28% 77.3 / 9.5 0 - 634 138.3 / 25.5 0 - 1055 n=13 n=3 n=2 28%
L+BH (n=61) 19.3 / 0.0 0 - 401 35.7 / 0.0 0 - 645 n=54 n=6 n=1 66% 28.8 / 0.0 0 - 509 64.9 / 0.0 0 - 1039 n=51 n=7 n=3 51%
* low-risk group: 0 – 100; medium risk group: 100-400; high-risk group: > 400 ** R = mean 1165 (974-1399); L-BH = mean 1161 (960-1398); L+BH = mean 1094 (889-1337)
Table 3
Baseline 3 years (1095 days) after RT **
p-value = 0.4 p-value = 0.8
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Table 3:  Calcium scores (mean and median; range; CAC risk group; percentage of calcium score ‘zero’) in all 
patients at baseline and three years after radiation therapy.
The mean overall CAC score at baseline was 52 with a range of 0 - 825. For the LAD at 
baseline we found a mean CAC score of 24 (range 0 – 401). After three years, the mean 
overall CAC score was 93 (range 0 – 1334) and for the LAD the mean CAC score was 
38 (range 0 - 634). For the three groups the mean and median calcium scores of the 
overall and the LAD score were summarized in Table 3. 
After analyzing the three cohorts it became apparent that the increase in the LAD cal-
cium scores after three years was higher in group L-BH, see Figure 1: red line in the left 
part of the Figure. The mean increase in CAC scores for the overall and the LAD score 
in all three cohorts is visualized in Figure 1.
In comparing the observed differences in calcium scores over time, less increased mean 
calcium scores were found for the left-sided breast cancer patients treated with breath-
hold (group L+BH) and right-sided (R) breast cancer patients compared to left-sided 
patients treated without breath-hold (L-BH). For the overall CAC scores these changes 
were non-significant (p>0.10). For the LAD, comparing left-sided without breath-hold 
(L-BH) and right-sided breast cancer (R), no significant difference was found (p=0.2); 
for left-sided breast cancer patients treated with the breath-hold technique (L+BH) ver-
sus left-sided patients without the breath-hold technique (L-BH) a significant lower 
calcium score was found (p=0.04; 95%CI: -42.7 to -1.15). 
Calcium scores: LAD minus RCA 
Concerning the calcium scores in the LAD minus the RCA, we found significant differ-
ences in the three groups (p=0.03). Lower scores were observed in the group of patients 
treated for left-sided breast cancer with breath-hold (L+BH) compared to left-sided 
breast cancer patients treated without a breath-hold technique (L-BH). See Figure 2 
for mean differences in LAD minus RCA scores between baseline and three years after 
radiotherapy. 
Baseline 3 years (1095 days) after RT **
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n=51 n=7 n=3 51%
p-value = 0.4 p-value = 0.8
*  low-risk group: 0 – 100; medium risk group: 100-400;  
high-risk group: > 400 
**  R = mean 1165 (974-1399); L-BH = mean 1161 (960-1398);  
L+BH = mean 1094 (889-1337)
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Figure 1:  Mean calcium score increase in time with 1 Standard Error (SE) at baseline and at three years after 
radiotherapy. LAD score (left) and overall score (right); note: the scales in both Figures differ. Red solid 
line: Left-sided breast cancer patients, group L-BH. Black dashed line: Right-sided breast cancer patients, 
group R. Blue dotted line: Left-sided breast cancer patients treated in breath-hold, group L+BH. 
Discussion
In this prospective longitudinal study we found a less pronounced increase in coronary 
artery calcium scores in patients with left-sided radiotherapy when using a breath-hold 
technique (L+BH) compared to those with left-sided radiotherapy without breath-hold 
(L-BH). Specifically with respect to the CAC scores of the Left Anterior Descending 
(LAD) coronary artery, this difference was statistically significant. Furthermore, three 
years after radiotherapy, significant differences were found for the CAC scores of the 
LAD minus the CAC scores of the RCA for left-sided breast cancer without breath-
hold (L-BH), right-sided radiotherapy (R) and left-sided radiotherapy with breath-hold 
(L+BH). The increased CAC scores three years after radiotherapy, administered without 
a breath-hold technique, are indicative for a more pronounced development of (radi-
ation-induced) atherosclerosis. These findings are consistent with the preclinical data 
of Stewart et al. [17]. They found that irradiation accelerates the development of mac-
rophage-rich, inflammatory atherosclerotic lesions in carotid arteries of mice. Similar 
findings were reported by Schultz-Hector & Trott [18] and Basavaraju & Easterly [19].
Some drawbacks and strong points of our study should be mentioned.
In our cohort, the radiotherapy regimens were identical. As only breast-conserving radi-
otherapy was administered, regional radiotherapy was given in none of the patients. All 
patients were treated with 3D-conformal radiotherapy techniques in the same institute. 
The biological effective breast doses were identical [20, 21]. 
Drawbacks were the limited sample size of our cohort and the relatively short follow-up 
period of three years. Probably, larger differences will be found after a longer follow-up 
period. Whetal et al. did find an increased number of calcified and non-calcified arther-
osclerotic lesions of the pre-cranial artery in irradiated Hodgkin’s lymphoma survivors 
(HLSs) [5]. The relative number of calcified lesions in the pre-cranial arteries of irradi-
ated compared to non-irradiated patients they found was, however, comparable. The 
HLSs were examined 5-13 years after radiotherapy [5]. In this study no baseline CAC 
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scores were determined; and the control group were non-irradiated patients referred for 
CT angiography of the pre-cranial arteries due to the suspicion of a recent stroke or TIA 
[5]. Conversely, Chang et al. performed coronary calcium CT scans in twenty asympto-
matic breast cancer patients five to fourteen years after their radiation treatment. Chang 
et al. did not find increased calcium scores in left-sided breast cancer patients. The latter 
was probably due to the fact that most of them had a calcium score ‘zero’; also, no 
baseline CAC values were available [22].
Figure 2:  Mean CAC score: LAD minus RCA with 1 Standard Error (SE) at baseline and at three years after 
radiotherapy. Mean difference between baseline and 3 years after radiotherapy. Red solid line: Left-
sided breast cancer patients (group L-BH). Black dashed line: Right-sided breast cancer patients  
(group R). Blue dotted line: Left-sided breast cancer patients treated in breath-hold (group L+BH).
Another drawback of our study was, that we did not investigate, for each individual pa-
tient, the relation between the amount of CAC and the delivered dose levels to the heart 
and the LAD. However, for a 3D conformal radiotherapy technique as well as for an 
IMRT technique without breath-hold, we have reported that the mean heart dose and 
the mean LAD dose could be decreased significantly by using a breath-hold technique 
[11]. These findings are in line with earlier reported decrease in LAD dose when using 
a breath-hold technique [23-26]. 
A strong point of our study was that the relevance of the use of the CT based CAC score 
is well supported by the literature. The CT based CAC score is known for its highly 
predictive value of developing cardiac vascular events. Kavousi et al. stated in 2012 that 
CAC scores even improved the Framingham Risk Score (FRS) predictions. However, 
they indicated that these scores may not be generalizable to younger or non-Caucasian 
populations. We want to stress that only very few non-Caucasian patients were includ-
ed in our study. Besides this, although the mean age in the RCWEST groups was lower 
than that in the study performed by Kavousi et al., 56 years (SD 10.5) compared to 69.1 
years (SD 8.5) respectively; the patients in our RCWEST cohort could not be classified 
as “young” [8]. 
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Raggi et al. reported the relevance of low CAC scores. They found that a low CAC 
value was associated with higher survival rates (concerning all cause death) in all ages 
[27]. Also, a systematic review stated that the absence of an increased CAC score was 
associated with a low risk of future cardiovascular events [28]. 
In the RCWEST patients, it was not possible to calculate the FRS, since we did not 
measure the serum cholesterol levels and blood pressure. 
A potential drawback seemed to be the differences of the CAC scores ‘zero’ between 
the three groups. Three years after radiotherapy 55% of the right-sided breast can-
cer patients of RCWEST still had a CAC score ‘zero’. In the left-sided breast cancer 
patients it was 28% and in the left-sided breast cancer patients treated with a breath-
hold technique it was 51%, see Table 2. The cohort of left-sided breast cancer patients 
treated with breath-hold consisted of relatively many patients with a CAC score ‘zero’ 
at baseline, i.e. 66%. With respect to these findings we want to emphasize that every 
consecutive patient was asked to participate in this study and that about 70% agreed to 
participate. Findings mentioned above can, therefore, be interpreted as a coincidence. 
The risk factors for cardiovascular disease in the three RCWEST patient groups (L-BH, 
R and L+BH) were comparable, including the CAC risk distribution, Tables 2 and 3. 
We found small differences in age and postmenopausal status at baseline, we therefore 
added the LAD minus RCA value in the analysis. This value represents the differences 
in CAC scores in the individual patient. 
According to these findings summarized above we suggest that decreasing the heart 
dose in radiotherapy would be of great importance in breast cancer patients. 
Conclusion
Breath-hold in breast-conserving radiotherapy leads to less increase in time of CT based 
CAC scores. A breath-hold technique therefore is probably useful to protect left-sided 
breast cancer patients against the development of radiation induced coronary artery 
disease. Drawbacks of our study are the small numbers and the relatively short fol-
low-up period. 
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Radiotherapy is an integral part of breast conserving therapy. It substantially improves 
treatment efficacy by decreasing local recurrence rates and results in an increased breast 
cancer specific survival [1-6]. With the introduction of the planning CT scan over the 
last decades, it was possible to gather more precise information on both dose homoge-
neity in the target volume and mean and maximum dose in the organs at risk. In recent 
years the knowledge concerning the side effects of this radiation treatment has increased 
further and, amongst others, the effect on the heart was documented [7,8]. Based on 
this knowledge, important aspects of the treatment delivery have been changed in order 
to minimise the dose in the heart. Still, a number of unanswered questions remain and 
further improvements in the treatment delivery seem possible. In this thesis, several 
strategies to optimise the radiation treatment for patients with breast cancer were an-
alysed. First, we focussed on optimising the target volume delineation. Subsequently, 
several treatment planning techniques were compared in order to decrease the dose 
to the heart. Also, with decreasing the dose in the heart, changes of calcium scores in 
the coronary arteries of the various patient categories were followed in the years after 
treatment.
Delineation of volumes in breast cancer radiotherapy 
Optimal definition of the target is the first step in the radiation treatment process. 
Improperly defined target volumes may lead to a systematic geographic miss in the in-
dividual patient during the whole course of radiation treatment [9-11]. Ultimately, this 
may negatively affect the treatment efficacy and could also lead to an increased dose to 
organs at risk. 
Several uncertainties, (e.g. positioning inaccuracies; technical inaccuracies), were defined 
influencing the efficacy of the radiation treatment. As was stated by several authors the 
inter-observer differences in delineating the target volume is a large uncertainty in the 
radiotherapy process [12,13]. These uncertainties can be defined by, for example the 
Conformity Index (CI), a tool for quantification of the variability of delineation. For 
the special circumstance where the number of observers equals two, it is defined as the 
volume of agreement divided by the total encompassing volume. This has been general-
ised to any number of observers by Kouwenhoven et al. [14]. This tool, the generalised 
CI (CIgen), was used in our delineation studies [15-17]. 
In breast conserving radiotherapy, the target volume delineation aims at delineating 
the glandular breast tissue (CTV Breast) and the Lumpectomy Cavity (LC). In order to 
improve the uniformity of the delineation of these structures the following measures 
seem relevant: 
1.     Use of guidelines; 
2.     Allocating breast cancer dedicated staff members.
3.     Addition of MR images.
Ad 1: The use of guidelines improved the consistency of the target delineation [12,18,19], 
however, this was questioned by Van Mourik et al. They still reported considerable 
variation between observers despite the use of delineation guidelines for the LC [13]. 
Also, Boersma et al. stated that the interpretation of guidelines is the weakest link in the 
chain of delineating the LC, even when using a pre-operative CT scan [20]. Therefore, 
a dedicated team of radiation oncologists is necessary.
Ad 2: Radiation oncologists with expertise in breast cancer radiotherapy should consult 
each other when delineating the LC, since  the interpretation of the LC is difficult and 
large differences exist. Several studies revealed that some observers delineate the target 
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volume systematically larger or smaller than others [12,21]. As peer review of the de-
lineated volumes might improve the consistency of delineating the target volume, and 
as the review by radiologists seems to be of importance, radiologists should be readily 
available for consultation [13]. Furthermore, consultation of radiologists improves the 
image interpretation and could also contribute to a better use of the optimal window/
level settings in delineating the target volume. 
Ad 3: Adding MR imaging may improve the visibility of the target volume [10]. There-
fore, in our delineation studies we compared the delineation of the CTV Breast and the 
LC of 10 patients (delineated by two radiologists and two radiation oncologists) on both 
the CT and MR images separately and on the co-registered CT-MR images. In these 
studies the conformity indices were compared. However, in our study we found that 
adding MR images did not improve the consistency of the delineated volumes [15-17]. 
For the CTV Breast the largest variations were found in the medial and lateral borders 
of the target volume. Apart from the effect of these variations on the dose in the glandu-
lar breast tissue, Li et al. pointed out that these variations have the largest impact on the 
dose in the surrounding structures [22] and could thus increase the dose in the organs 
at risk (OAR). Another study analysing the additional value of using an MR imaging 
in target delineation of breast tissue also showed that the use of these images did not 
improve the consistency between observers [23], this is in line with our results.
Concerning the delineation of the LC, we found that the delineated volumes differ 
widely between observers. Also, the addition of MR images in these cases did not im-
prove the consistency. A joint review of the delineated LC might provide a more con-
sistent volume, and could avoid a geographic miss of the LC. 
Figure 1.  Coronal view of ten delineated lumpectomy cavity (LC) volumes in anterior and posterior view.  
Colour map: blue, high agreement between observers; red, low agreement between observers,  
according to the scale given.
In both CT and CT-MR delineated LC volumes we found a CI of roughly 0.50. To note is 
that delineation differences in small volumes (when compared to larger volumes) appear 
to have a large impact on the calculated CIs. Furthermore, registration of CT and MRI re-
mains difficult due to respiratory motion artefacts, together with distortion of breast tissue 
by overlying MR receiver coils. We found that multimodality breast markers are obligato-
ry in performing an optimal CT-MR registration [24]. Avoiding the adjustment of CT-MR 
registration manually is important since this influences the definite LC volumes [20].
Adding surgical clips is a prerequisite to determine the lumpectomy volume according 
to the systematic review of Yang et al. [10]. The surgical clips are visible on the CT scan 
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and can be used as a helping tool in delineating the LC. However, defining the LC with 
the use of clips appear to be difficult as well, since the clips represent only a few points 
of the LC’s border and an interpolation is usually required, resulting in delineation 
inaccuracies [10]. 
Apart from the variations reported in delineating the target volumes, Lorenzen et al. 
also described that variations can be found when delineating the heart and the coronary 
arteries. The use of guidelines for delineation of the heart improved the consistency 
considerably. However the use of guidelines did not improve the consistency of the left 
anterior descending (LAD) coronary artery delineation, since the LAD was not visible 
on all CT slices [25]. Therefore, aiming at delineating the LAD region instead of the 
LAD itself seems more appropriate. 
Future perspectives: delineation of volumes
Based on our study results we do not advise to use MR images in addition to the CT 
scan when delineating either the glandular breast tissue or the lumpectomy cavity. It was 
demonstrated that differences in the delineated volume had great impact on the dose in the 
OAR. Therefore, we strongly suggest the following procedure in the delineating process. 
Firstly, we recommend that each observer should take advantage of the full potential of 
the planning system. By using the CT information in all three projections the observer 
keeps a better overview of the delineated structures. As a second recommendation, we 
expect that implementation of auto-contouring in the clinic may further improve the 
consistency in the generated structures. But, still, the expected conformity in delineation 
of the lumpectomy cavity needs to be proven. Thirdly, the ability of the radiation ther-
apists to delineate the glandular breast tissue could further increase the efficiency in a 
radiation therapy department [26]. However, we are aware that a shift in activities and 
responsibilities of the radiotherapy team needs to be implemented gradually. 
Treatment planning techniques in breast cancer radiotherapy
Performing treatment planning studies 
Treatment planning studies have proven their value. The results give insight into the 
pros and cons of the several available treatment techniques. The results can be used to 
decide whether a new technique should be used in daily practice [27]. However, in order 
to make a true comparison of the various techniques, it is essential to define the same in-
itial conditions for each separate technique. Depending on the defined hypothesis either 
the level of target coverage can be set equally, and in doing so enable the evaluation of 
the dose in the OAR, or the doses in the OAR are set equally, allowing evaluation of the 
differences in target coverage for the various compared treatment techniques. Also, the 
level of details of the calculated treatment technique needs to be described extensively, 
e.g. in a supplementary Table, in order to maximise the usefulness of the described 
planning techniques [27]. This is certainly helpful to the radiotherapy staff enabling 
them to reproduce the described radiation technique. Consequently, both reviewer and 
the journal, to which the manuscript was submitted, need to take their responsibility in 
maintaining uniformity in the described treatment planning studies. 
Apart from these treatment-planning studies in daily practice the radiation oncologist 
will approve the final treatment plan. But he or she may decide to compromise the plan-
ning target volume coverage to spare an OAR.
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Sparing organs at risk in breast cancer radiotherapy
Contralateral breast cancer (CBC)
Some patients with breast cancer have an elevated risk of developing a second breast 
cancer in the contralateral breast after radiotherapy [28,29]. Especially women who 
are diagnosed with breast cancer at young age (younger than 35 years old) and with a 
family history of breast cancer or an oestrogen receptor negative primary tumour, have 
a higher incidence of contralateral breast cancer [30]. Furthermore, Stovall et al. stated 
that for young patients (younger than 40 years old) an increased risk was found for 
doses in the contralateral breast higher than 1 Gy [31]. Also, Hooning et al. calculated 
the CBC risk and found a hazard ratio of 1.23 on the risk of medial contralateral breast 
cancer when receiving a radiation dose to the medial part of the contralateral breast 
up to 3.6 Gy in women < 45 years old [32]. For each individual patient the radiation 
oncologist should always decide if a higher dose in the contralateral breast outweighs 
a higher dose in the heart and the LAD-region. Recently, Abo-Madyan et al. stated that 
the use of multiple beam IMRT or VMAT increases the risk of CBC, although the abso-
lute risk was low. Tangential IMRT results in a lower CBC risk [33]. 
Heart and coronary arteries
It is important to always reduce the dose in the heart and coronary arteries as much as 
possible, since several studies state that a higher dose in these arteries is associated with 
an increased risk of cardiovascular disease [7,8,34,35]. Paszat et al. found a higher risk 
of anterior myocardial infarction when larger volumes of the heart were incorporated 
in the treatment fields [36]. Interestingly, radiation techniques have changed over time 
and have led to a reduced heart dose. Graham et al. investigated the dose differences 
before and after routine 3D planning or cardiac contouring (before and after contour-
ing era). They reported a significant lower mean heart dose in low risk patients (without 
treatment of internal mammary nodes or a boost dose), but no difference in the mean 
LAD dose. However, a correlation was reported between the Maximum Myocardial 
Depth (MMD) and the LAD dose; the mean doses in the inferior part of the LAD in-
creased from 49% to 84% of the prescribed breast dose when the MMD was >15 mm. 
They also identified a 15-mm MMD as a useful transition point from low to high mean 
inferior-LAD doses [37]. On the opposite Aznar et al. stated that the dose delivered to 
the coronary arteries and the dose delivered to the heart are not necessarily correlated 
and that both organs at risk need to be delineated in order to get proper information 
of the applied doses [38]. Delineating the LAD is, however, difficult, and as Vennarini 
et al. stated, only one-third of the artery could be objectively visualised [39]. Therefore, 
delineating an LAD-region, instead of just the LAD, would be more appropriate in or-
der to avoid a misinterpretation of the received dose [40,41]. 
Lung 
The Quantec tolerance guidelines provide organ-specific dose/volume/outcome data. 
For the lungs, a dose tolerance has been described to avoid radiation pneumonitis, i.e. 
the volume that receives 20 Gy needs to remain below 30% for both lungs [42]. Also, 
the risk of radiation induced secondary lung cancers was increased, especially after a 
long term follow up period of 20 years [43,44]. A recently published review clearly 
showed that the risk of second lung cancers after breast cancer radiotherapy increases 
gradually in time. A dose-response relation for lung cancer has also been described, in-
dicating a risk that seems to increase linearly with 8.5% (95% CI 3.1% to 23.3%) per 
delivered Gy to the lung [44]. A nested case-control study by Grantzau et al. confirmed 
that this risk was enhanced in ever smokers, with an excess rate of 17.3% per Gy [45]. 
General Discussion
139
Treatment planning techniques in breast cancer radiotherapy
With IMRT the dose homogeneity is increased and a 3-7% decrease of hotspots can be 
achieved. Two phase-III trials demonstrated that women in the IMRT treatment arms 
had less acute toxicity, long-term telangiectasia and fibrosis compared to women irra-
diated with 3D-CRT techniques [46]. The phase-III trial of Donovan et al. points out 
that doses higher than 105% can result in more induration of the breast [47]. However, 
the used IMRT techniques were more complex than the tangential IMRT technique we 
currently use [47-50]. The authors of both trials concluded that an IMRT technique 
should specifically be used for patients with large breasts. Munshi et al. report the same 
findings, they advise to perform a 2D technique in patients with small breasts [51]. In 
our treatment planning studies we see a higher homogeneity when using tangential 
IMRT compared to a 3D-CRT technique; this tangential IMRT technique is less com-
plex and succeeds to significantly lower the dose in the heart and LAD, regardless of the 
volume of the breast. 
It is remarkable that Graham et al. did not find a significant reduction of the cardiac 
dose in a comparison study from 2D to 3D CT-treatment planning [37]. They reported 
that the inferior part of the LAD received a high mean dose which could be lowered 
by using a breath-hold technique. Aznar et al. confirmed this finding. They performed a 
study on the dose levels in the specific parts of the heart [38]. In our treatment planning 
comparison study we found that, when using an IMRT technique, the dose decreased, 
in the heart as well as in the LAD-region. Specifically the caudal part of the treatment 
fields, including the LAD, received a lower dose. We, therefore, concluded that an IMRT 
technique adds a substantial gain in lowering the dose, especially in the caudal part of 
the heart, and, hence, in the caudal part of the LAD.
Finally, in defining the most optimal radiotherapy treatment technique with the lowest 
heart dose, one must not forget that the heart moves in and out (to some degree) of 
the radiotherapy treatment fields. Several studies quantified the movement of the heart 
[52,53]. Wang et al. advised more than 5 mm of distance between the LAD and the field 
edge because of the motion of the heart itself [54]. These variations should be kept in 
mind when evaluating the radiotherapy treatment plans. Adding a margin around the 
critical structures could be helpful.
Future perspectives: treatment planning
As several studies have shown, it is important to avoid as much radiation dose as possi-
ble in the heart and coronary arteries. Epidemiological studies show that even low doses 
need to be avoided as well. Based on literature [45,55] and our study results we advise 
the following arbitrary constraints when performing radiotherapy in left-sided breast 
conserving radiotherapy, since no absolute thresholds could be defined. The constraints, 
we advice, appear to be feasible from our treatment planning studies (using a fraction-
ation scheme of 42.56 Gy in 16 fractions):
1.     Mean heart dose < 2 Gy; 
2.     Mean lung dose < 5 Gy; 
3.     Mean dose outside the PTV as low as reasonably achievable. 
4.      In patients younger than 45 years the dose in the contralateral breast should 
be as low as possible. In BRCA 1/2 carriers this is of even more importance.
We propose to perform a tangential IMRT technique in all patients, regardless of age 
and size of the breast, since in all studied patients an increase in dose homogeneity was 
found, as well as a reduction in dose in the heart, specifically in the caudal part of the 
treatment fields. By using a tangential IMRT technique the dose will better encompass 
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the target volume and the dose in the heart and LAD will be decreased as well. Moreo-
ver, when using a tangential IMRT technique no increase in the low dose regions in the 
normal tissue was found, even when applying a multiple beam IMRT technique.
Another important aspect of the radiation treatment is to achieve the lowest dose in 
the normal tissue outside the treatment fields. In our treatment planning studies the 
proton therapy technique results in the lowest dose in the heart and coronary arteries 
and would, therefore, be the treatment of choice. However, an increased risk of skin 
toxicity could be expected when using protons [56]. The used proton technique (i.e. us-
ing multiple proton beams instead of a single beam) or the use of scanning techniques, 
advances in patient positioning and fractionation schedules seem to be important in 
reducing the skin dose [56,57]. Furthermore, as yet, proton therapy is not available in 
the Netherlands. However, if a limited use of proton therapy would be available, we 
would recommend a comparative assessment between costs, toxicity and the urgency 
of a dose reduction. 
Another option to reduce the dose in the surrounding structures is the Accelerated Par-
tial Breast Irradiation (APBI) technique. To determine if a patient is eligible for an APBI 
technique guidelines are available (ASTRO and ESTRO guidelines) [58,59]. According 
to these guidelines a patient could be classified in the so called “low risk” group. APBI 
techniques are widely available and appear to be feasible. The lower number of frac-
tions is convenient for the patient. Furthermore, aiming only at the lumpectomy cavity 
the dose in the heart is lower. This is specifically valid for Intra Operative Radiother-
apy (IORT) since the dose in the surrounding structures remains low by using proper 
shielding. 
Breath-hold techniques in left-sided breast cancer radiotherapy
When using the most optimal 3D conformal radiotherapy treatment technique in 
left-sided breast cancer to reduce the dose in the organs at risk, it became clear that the 
LAD coronary artery still could receive a relatively high maximum dose (2.7 Gy - 41.7 Gy; 
to note: some patients received nodal irradiation as well) [39]. We found that the mean 
LAD dose could be reduced with 50% when using a breath-hold technique, and for the 
high dose region this reduction was even larger. This was confirmed in other studies as 
well [60,61]. However, the randomised trial from Zellars et al. showed that ABC was 
not significantly associated with prevention of perfusion deficits compared before and 
six months after the radiation treatment. The reason that in four years time only 50 pa-
tients could be enrolled to this study remains unclear. Furthermore, a longer follow-up 
is needed to confirm their findings [62].
Several methods for performing a breath-hold technique are available, e.g. Active 
Breathing Control (ABC), voluntary breath-hold in combination with on-line registra-
tion of the patient position, Real-time Position Management system. [60,63-65]. The 
reproducibility of the various breath-hold methods was studied, all methods proved 
to be safe, including the ABC technique [66]. Recently Mittauer et al. investigated the 
dosimetric impact of breath-hold variations when using ABC. The estimated effect for 
the target coverage was negligible, however a large impact was estimated for the OARs 
[67]. One needs to consider this when applying breath-hold techniques. Most impor-
tant is that the patient performs a moderate deep inspiration breath-hold (mDIBH) to 
achieve the largest distance between the heart and the radiation fields [68]. Remou-
champs et al. defined a breath-hold threshold level of 75% of the maximum aspiratory 
capacity of the patient. The mDIBH level was chosen as a balance between achieving 
substantial heart displacement and maintaining patient comfort [68]. However, in a 
randomised cross-over study, the Royal Marsden found that a voluntary breath-hold 
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and the ABC technique were comparable as regards the reproducibility and the dose in 
the OARs, but that patients and staff preferred the voluntary breath-hold technique. It 
remains unclear why 136 of the in total 159 patients were excluded from the study [69]. 
In the diversity of treatment planning techniques for some patients the heart dose ap-
pears to be low as well without breath-hold, see Figure 2. In these patients treatment 
without a breath-hold technique could be an option, especially since no threshold for 
the heart and LAD dose could be defined in the literature. Also, the introduction of 
an age restriction could be considered, although Darby et al. recently found that car-
diac events were observed within just 5 years after the radiation treatment and were 
independent of age [8]. In our institution 98% of the patients were able to complete 
the active breathing control method [64]. Moreover, this method potentially enables a 
more individualised approach. Summarising, the ABC technique is a reproducible and 
reliable technique. Therefore, we decided to use this type of breath-hold technique in 
all patients. Recently, Register et al. confirmed that no specific anatomic surrogate for 
the dosimetric benefits of DIBH technique could be identified; only the heart volume 
in the treatment field predicted the reduction in mean heart dose. They stated that a 
breath-hold technique should be used for all patients receiving left-sided breast cancer 
irradiation [70].
 
The results of our planning studies (Figure 2) clearly show that the breath-hold tech-
nique significantly reduces both the dose in the heart and the LAD-region. From our 
treatment planning studies TomoTherapy in breath-hold, when compared to tangential 
IMRT in breath-hold, appears to add an extra dose reduction. Unfortunately, it is not 
possible yet to combine TomoTherapy with breath-hold in a clinical setting. Further-
more, the mean heart dose reduction when using the TomoTherapy technique is limit-
ed, 1.5Gy (SD 0.5Gy) for IMRT in breath-hold and 1.1Gy (SD 0.4Gy) for the Tomo-
Therapy technique in breath-hold. Therefore, the most optimal treatment technique 
for left-sided breast cancer radiotherapy appears to be the tangential IMRT technique 
combined with a breath-hold technique. 
Whether the use of a breath-hold technique reduces the risk of coronary heart disease 
cannot be confirmed, although our calcium score study revealed a positive effect. Three 
years after whole breast irradiation we found a significantly smaller increase of LAD 
calcium scores in the group irradiated using a breath-hold technique when compared to 
patients irradiated without the use of breath-hold. Specifically, the individual findings of 
the coronary artery calcium (CAC) score in each patient are important. When the RCA 
CAC score was subtracted from the LAD CAC score it became clear that in the group 
of left-sided breast cancer patients, treated with a breath-hold technique, a significantly 
smaller increase in CAC score was noted 3 years after whole breast irradiation. There-
fore, the risk of cardiac heart disease may have decreased as well, since the amount of 
CAC scores predicts the risk of subsequent cardiovascular events [71,72]. Drawbacks of 
our study are the small numbers and the relatively short follow-up period.
Finally, in performing treatment-planning studies, guidelines need to be formulated 
in order to be able to compare the results of studies. The scientific journals could be 
helpful in designing these guidelines. In combination with the ICRU recommendations, 
guidelines for planning studies can be helpful to optimise the radiation treatment tech-
niques in daily practice.
Future perspectives: breath-hold techniques 
With the increased knowledge concerning the several applied breath-hold techniques, it 
seems that aiming at an optimal enlargement of the thoracic volume is of importance. 
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Figure 2.  The various treatment planning techniques, with and without breath-hold. The 20 cases were  
rearranged using the increasing (from left to right) IMRT FB technique values. 
A mean deep inspiration breath-hold of 75% of the maximum aspiratory capacity of 
the patient needs to be achieved to attain the largest thoracic amplitude. With a shallow 
breath-hold without increasing this amplitude the heart still may receive a relatively 
high radiation dose. The ABC method informs the staff with vital information about the 
maximal amplitude of each individual patient. 
A breath-hold technique can also be used to reduce the dose in the ipsilateral lung. This 
is valid for patients with right-sided breast cancer radiotherapy as well. In all patients 
decreasing the risk of developing a secondary lung cancer is of importance and, there-
fore, the dose in the lungs should be kept as low as possible, which specifically applies 
to smokers [45]. 
Finally, when combining a breath-hold technique with a tangential IMRT technique a 
further dose reduction was found, especially in the caudal part of the treatment fields. 
Therefore, nowadays we advise to use a tangential IMRT technique in combination with 
a breath-hold technique. To note: the Active Breathing Control technique has the advan-
tage of taking into account the thoracic amplitude. Whether the CTV-PTV margins can be 
decreased, with the use of a breath-hold technique, needs to be examined in future studies.
Coronary artery disease and breast cancer radiotherapy 
Several pre-clinical studies reported that arteries are particularly sensitive to radiation 
[73-75]. It appeared that the carotid intima-media thickness increased linearly with 
increasing length of time after radiotherapy [76]. Stewart recently suggested that micro-
vascular changes and atherosclerosis in experimental studies are the likely underlying 
causes of radiation-induced cardiovascular damage, at ≥ 2Gy and ≥ 8Gy, respectively, 
to the whole heart or a part of the heart [77,78]. 
Whetal et al. confirmed that the presence of radiation-induced calcium deposits is consid-
ered as a surrogate marker for radiation-induced atherosclerotic lesions in patients treat-
ed for Hodgkin’s lymphoma [79]. Also Daniels et al. found a high prevalence of asympto-
matic coronary artery disease. They stated that this might justify the screening of Hodgkin 
disease survivors who had received mediastinal radiotherapy. However, they performed a 
computed tomographic coronary angiography, which is an invasive method [80]. 
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Gondrie et al. tried to incorporate unexpected image findings, such as arterial calcium 
scores, and outcome data relevant to patients. They state that truly meaningful conclusions 
about the prognostic value of unexpected and emerging image findings can be reached and 
used to improve patient-care [81]. Jairam et al. presented in 2014 a calculation tool, which 
can be used in daily practice by radiologists to determine whether a subject has high calci-
fications scores relative to other patients with the same age and gender [82]. 
Groarke et al. claimed that a low threshold for screening with non-invasive imaging 
might help to identify injury at a stage where timely intervention may reduce cardiovas-
cular morbidity and mortality in cancer survivors. But much cheaper and easier would 
be to use the low dose planning CT scan used for radiation treatment planning [83] 
together with the calculation tool of Jairam et al. [82].  
Future perspective: coronary artery disease
The calculation tool of Jairam et al. [82] could be applied to identify patients with a 
high rate of calcifications on the CT scan and, therefore, having a high risk of develop-
ing a coronary vascular event. These patients could be proposed for a radiation tech-
nique with a low dose in the heart and the coronary arteries: e.g. the proton technique 
or if applicable an APBI technique. 
Position verification in breast cancer radiotherapy
Another crucial step in the radiation treatment process is the position verification pro-
cedure on the linear accelerator. Several studies aimed at improving this process in order 
to achieve daily optimal patient positioning. It appeared that an on-line clip match pro-
cedure improves the localisation of the treatment volume [84-88]. In our institution we 
studied the optimal position verification procedure since 2008 [89]. In 2014 we started 
with an on-line surgical tantalum clips match as a position verification procedure for 
the boost fields [90]. 
Future perspective: position verification
To reduce the risk of geographical miss an on-line position procedure is of fundamental 
importance in administering a boost or external APBI. Instead of aiming at the bony 
structures we aim directly at the lumpectomy cavity by matching on the tantalum clips 
that represent the lumpectomy cavity. Tantalum clips are widely available and less ex-
pensive compared to gold markers. These clips can be placed in the lumpectomy cavity 
on a routinely basis. It is, therefore, easy to incorporate this procedure into daily practice.
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Concluding remarks
As was stated before, lessons can be learned from the various published studies. Im-
provements in radiation techniques have been achieved. However, the surrounding 
healthy tissue will still receive a radiation dose, when the glandular breast tissue is ir-
radiated after breast conserving surgery. Only omitting radiation treatment completely 
will prevent this. Up until now no subgroup of patients can be defined in whom radi-
otherapy can be safely omitted, since the risk on ipsilateral recurrence is significantly 
reduced when applying radiotherapy. However, in selected subgroups, for example in 
patients older than 70 years, with low-grade, small ductal carcinoma in situ [91], omit-
ting radiation therapy after complete excision of the tumour and perform a wait and 
see policy could be an option. 
In future, we need to focus on individualisation of the radiation treatment, taking into 
account tumour and patient-related risk factors, to try to cure the patient with the 
optimal and most convenient type of treatment, and reduce the treatment-related con-
sequences as much as possible. In order to achieve the most optimal treatment we need 
to aim at an optimal definition of target volumes. Furthermore, several radiation treat-
ment techniques could be used to reduce the dose in the heart and the LAD: i.e. tangen-
tial IMRT in combination with breath-hold, external APBI, IORT or, in specific cases 
by using protons. And, as a last step in the radiation treatment process, performing an 
optimal procedure to correct for positioning inaccuracies is a prerequisite. Thereby, 
preserving the patient’s quality of life is of utmost importance. Finally, this needs to be 
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Preclinical and clinical studies reveal that breast cancer radiotherapy is associated with 
an increased rate of major coronary events. This is especially true for women with 
left-sided breast cancer. Consequently, when irradiating women with left-sided breast 
cancer, specific measures should be taken to decrease the heart dose as much as possible 
and avoid radiation-induced coronary artery disease. 
This thesis contains three chapters. In each chapter we focussed on relevant aspects 
of decreasing the heart dose in whole breast irradiation. In chapter 1 we focussed on 
optimising the target volume delineation. Optimal definition of the target is the first 
step in radiation treatment. Improperly defined target volumes may lead to a systematic 
geographical miss during the full course of radiation treatment. An increased visibility 
of the glandular breast tissue (Clinical Target Volume; CTV breast) and the lumpecto-
my cavity (LC) may be obtained by using Magnetic Resonance Imaging (MRI) based 
delineation instead of Computed Tomography (CT) based delineation. Therefore, we 
examined if adding MR images, scanned in supine position, might be beneficial. The lat-
ter may enable a decrease in the interobserver variability of delineating the CTV breast 
as well as that of the LC. In our studies we compared, amongst others, the interobserver 
variability of the delineation of the CTV Breast and that of the LC in 10 breast cancer 
patients after breast-conserving surgery. Two radiologists and two radiation oncologists 
delineated the relevant target volumes based on the co-registered CT-MR images. We 
found that the addition of MR images did not improve consistency of the delineation of 
the CTV breast nor for the LC. For the LC the mean conformity index, when using the 
Cavity Visualisation Score (CVS), increased when this target volume was clearly visible 
on the CT and MR images. In cases with low CVS the use of clips may be helpful to 
define the LC with more precision. Furthermore, after comparing five different regis-
tration methods, surgical clips evidently were not always clearly visible on MR images. 
We found that multimodality breast markers are obligatory in performing an optimal 
CT-MR registration. A breast-marker-based co-registration of CT and MR data sets 
gave the best results in terms of the rest volume. 
In chapter 2 the results of 3 treatment-planning studies of whole breast irradiation are 
presented. In using the most optimal 3D-conformal radiotherapy treatment technique 
in left-sided breast cancer to reduce the dose in the organs at risk, it became clear that 
the Left Anterior Descending (LAD) coronary artery still could receive a relatively high 
maximum dose. We found that the mean LAD dose could be reduced by 50% when 
using a breath-hold technique. Several methods for performing a breath-hold technique 
are available. Most important is that the patient performs a moderate Deep Inspiration 
Breath-Hold (mDIBH) to achieve the largest distance between the heart and the border 
of the tangential radiation fields. In our institution, we noted that 98% of the patients 
was able to complete the Active Breathing Control method. 
Furthermore, the treatment-planning studies give insight into the pros and cons of the 
several treatment techniques when using a breath-hold technique. All this can be used 
to decide whether a new technique should be performed in daily practice. Our treat-
ment-planning studies revealed higher dose homogeneity when using tangential Inten-
sity Modulated Radiotherapy (IMRT) in breath-hold compared to a 3D-conformal Ra-
diotherapy (3D-CRT) technique in breath-hold; this tangential IMRT technique is less 
complex and succeeds in significantly lowering the dose in the heart and in the LAD 
coronary artery. Specifically the caudal part of the treatment fields, including the LAD, 
received a lower dose. Therefore, we concluded that a tangential IMRT technique in 
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breath-hold adds a substantial gain to lowering the dose, especially in the caudal part 
of the heart, and, hence, in the caudal part of the LAD. 
Furthermore, we studied the added value of TomoTherapy and a proton technique 
when using a breath-hold technique. The TomoTherapy treatment study revealed that 
the mean dose of the heart and LAD-region was reduced when using TomoTherapy in 
breath-hold in comparison to tangential IMRT in breath-hold. However, we found that 
the combination of a breath-hold technique with TomoTherapy cannot be performed 
in daily clinical practice, due to the long beam-on time. The lowest dose in the heart 
and coronary arteries was found in the proton therapy study, with and without using a 
breath-hold technique. Protons would, theoretically, be the treatment of choice. Howev-
er, as yet, proton therapy is not available in The Netherlands. If a limited use of proton 
therapy would be at our disposal, we would recommend a comparative assessment be-
tween the expected treatment efficacy, the degree of expected treatment-related toxicity, 
the possibility to apply “Accelerated Partial Breast Irradiation” (APBI) and costs. 
Summarising, performing a tangential IMRT technique in breath-hold is currently the 
most optimal combination. Whether the use of a breath-hold technique reduces the risk 
of coronary heart disease could not be confirmed in these planning studies. 
The results of our study on coronary artery calcium (CAC) scores were presented in 
chapter 3. The CAC scores, as obtained by CT scanning without using contrast en-
hancement, accurately predicts the risk of subsequent cardiovascular events. The CAC 
score is seen as a surrogate marker of coronary artery damage. Firstly, we found that 
the coronary artery calcium (CAC) scores (determined before the start of the radiother-
apy treatment) in the age category 55-64 years were significantly higher than the CAC 
scores in an asymptomatic female American cohort. These data suggest that breast can-
cer patients are at a higher risk of developing coronary artery disease. 
Secondly, three years after whole breast irradiation we found significantly less increase 
of CAC scores of the LAD in the group irradiated using a breath-hold technique when 
compared to patients irradiated without the use of breath-hold. When in each patient 
the Right Coronary Artery (RCA) CAC score was subtracted from the LAD CAC score, 
the group of left-sided breast cancer patients, treated with a breath-hold technique, 
showed less increase in CAC score 3 years after whole breast irradiation. Therefore, the 
risk of cardiac heart disease may have decreased. However, drawbacks of our study are 
the small numbers and the relatively short follow-up period.
In the general discussion several future perspectives were pointed out. As for the de-
lineation of target volumes we do not advise to use MR images in addition to the CT 
scan when delineating either the glandular breast tissue or the lumpectomy cavity. We 
concluded that currently a tangential IMRT technique combined with a breath-hold 
technique is the most optimal treatment technique for left-sided breast cancer whole 
breast radiotherapy. This recommendation is based on the observations that in all stud-
ied patients an increase in dose homogeneity was found, as well as a reduction in dose 
in the heart, specifically in the caudal part of the LAD. Based on literature data and 
our study results we advise the following constraints when performing radiotherapy in 
left-sided breast-conserving radiotherapy (using a fractionation scheme of 42.56 Gy in 
16 fractions), since no absolute thresholds could be defined. 
Summary
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1.     Mean heart dose < 2 Gy; 
2.     Mean lung dose < 5 Gy; 
3.      Mean dose outside the Planning Target Volume (PTV) as low as reasonably 
achievable. 
4.      In patients younger than 45 years the dose in the contralateral breast should 
be as low as possible. In BRCA 1/2 carriers this is of even more importance. 
Our treatment planning studies revealed that these constraints are feasible. 
We also advise to perform a breath-hold technique in all left-sided breast cancer
patients, regardless of age and breast size. 
Finally, some concluding remarks were given. We have described that improvements 
in breast cancer radiotherapy have been achieved. However, the surrounding healthy 
tissue will still receive a radiation dose, when the glandular breast tissue is irradiated. 
Focussing on individualisation of the radiation treatment is of the utmost importance. 
In future research we have to aim at decreasing the (late) side-effects of the radiotherapy 
and increasing the quality of life further. Introducing APBI into daily practice should 
be the objective of future clinical research. Research should also focus on the question 
whether breast radiotherapy can be omitted after breast-conserving surgery. Finally, 







In preklinische en klinische studies is aangetoond dat vrouwen die bestraald worden 
voor borstkanker, ten gevolge van die bestraling een grotere kans hebben op het ont-
staan van hart- en vaatziekten. Dit geldt vooral voor vrouwen met linkszijdige borst-
kanker. Daarom is het van belang dat met name voor deze laatste categorie vrouwen 
specifieke maatregelen genomen worden om de hartdosis zo veel mogelijk te beperken 
opdat coronair lijden veroorzaakt door bestraling wordt voorkomen.
Dit proefschrift bevat drie hoofdstukken. De bespreking van een aantal relevante aspec-
ten om de hartdosis tijdens electieve borstbestraling waar mogelijk te verlagen, staat in 
elk hoofdstuk centraal.
In hoofdstuk 1 wordt  het optimaliseren van de wijze van intekenen van het te be-
stralen doelgebied besproken. Dit is de eerste stap op weg naar het opstellen van een 
bestralingsplan. Niet optimaal ingetekende doelgebieden kunnen tijdens de gehele 
bestralingsperiode leiden tot het onjuist bestralen van deze doelgebieden. Zowel het 
borstklierweefsel (Clinical Target Volume; CTV breast) als het operatiegebied (lumpec-
tomieholte; Lumpectomy Cavity; LC) is met Magnetic Resonance Imaging (MRI) in 
plaats van Computed Tomography (CT), waarschijnlijk met meer nauwkeurigheid te 
bepalen. Daarom onderzochten wij in dit proefschrift of het toevoegen van MR beel-
den, gescand in rugligging, van meerwaarde zou kunnen zijn. Dit laatste zou tot gevolg 
kunnen hebben dat de interobserver variatie bij het intekenen van het CTV breast en de 
LC kleiner wordt. In onze studies vergeleken we dit in tien patiënten die een CT scan 
hadden ondergaan na een borstsparende operatie. Twee radiologen en twee radiothe-
rapeuten hebben de relevante doelgebieden ingetekend gebaseerd op geregistreerde CT-
MR beelden en gebaseerd op de reguliere CT beelden. Uit het onderzoek bleek dat door 
toevoegen van MR beelden de interobservervariatie van de intekeningen voor zowel 
het CTV breast als voor de LC niet kleiner was geworden. Bij het gebruik van de “Ca-
vity Visualisation Score” (CVS) bleek dat de gemiddelde conformityindex groter werd, 
hetgeen duidt op een betere overeenkomst tussen de intekenaars, als het doelvolume 
duidelijk zichtbaar was op CT en MR beelden. Wanneer er sprake is van een lage CVS 
zouden clips een goed hulpmiddel kunnen zijn om de LC beter te kunnen definiëren. 
Ook werd onderzocht wat de beste methode is om de MR beelden met die van de CT 
te fuseren. Nadat we vijf verschillende registratiemethoden hebben vergeleken, blijkt 
dat chirurgische clips niet altijd zichtbaar zijn op MR beelden, en dat “multimodality” 
markers gebruikt dienen te worden om een optimale CT-MR registratie te laten plaats-
vinden. Wij concludeerden dat het beste resultaat wordt bereikt wanneer de markers, 
geplaatst op de te bestralen borst, worden gebruikt.
In hoofdstuk 2 worden de resultaten van drie planningstudies, betreffende de elec-
tieve linkszijdige bestraling van het borstklierweefsel, beschreven. Uit onze studies 
werd duidelijk dat de gemiddelde dosis in de LAD met 50% kan worden verlaagd 
wanneer een ademhalingsgecontroleerde techniek wordt toegepast tijdens de bestra-
ling. Er zijn verschillende ademhalingsgecontroleerde technieken beschikbaar. In 
RCWEST wordt de “Active Breathing Control” (ABC) methode toegepast. We heb-
ben aangetoond dat 98% van de patiënten in staat is om deze methode uit te voeren. 
Ook is de waarde van een aantal bestralingstechnieken onderzocht. Deze planningstu-
dies laten zien dat een betere homogeniteit kan worden bereikt als een tangentiële In-
tensity Modulated Radiotherapy (IMRT) techniek wordt toegepast; dit vergeleken met 
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3D-conformatie radiotherapie (3D-CRT) techniek beide in combinatie met een adem-
halingsgecontroleerde techniek. Deze tangentiële IMRT techniek is goed uitvoerbaar en 
leidt tot een significante verlaging van de dosis in het hart en de Left Anterior Descen-
ding (LAD) coronair arterie. Vooral het caudale gedeelte van het hart, inclusief de LAD, 
krijgt een lagere dosis. We concluderen dan ook dat een tangentiële IMRT techniek in 
combinatie met een ademhalingsgecontroleerde techniek een substantiële bijdrage levert 
aan het verlagen van de dosis in het hart, vooral in het caudale gedeelte van het hart. 
Tevens werd de meerwaarde van een TomoTherapie en een protonen techniek onder-
zocht. In beide gevallen werd eveneens de waarde van een ademhalingsgecontroleerde 
techniek onderzocht. Als we gebruik maken van de ademhalinggecontroleerde techniek 
blijkt uit deze planningsstudie dat, vergeleken met een IMRT-techniek, de gemiddel-
de dosis die het hart en de LAD ontvangen lager uitkomt. Echter, vanwege de lange 
bestralingstijden is het uitvoeren van een ademhalingsgecontroleerde TomoTherapie-
techniek (nog) niet uitvoerbaar. De laagste hart- en LAD-dosis werd bereikt met het 
toepassen van een protonentechniek. Dit laatste gold zowel mét, als zonder het toe-
passen van de ademhalingsgecontroleerde techniek. Om deze reden zou de protonen-
techniek theoretisch gezien de voorkeur hebben. Momenteel is een protonentechniek 
nog niet toepasbaar in Nederland. Indien de protonen techniek beschikbaar zou zijn, 
raden we aan om alvorens te besluiten deze techniek bij patiënten met borstkanker 
toe te passen eerst een afweging te maken waarin worden meegenomen: de verwachte 
efficiency van de behandeling, de te verwachten toxiciteit van de behandeling, mogelijk-
heden voor het uitvoeren van “Accelerated Partial Breast Irradiation” (APBI) en kosten. 
Wij concluderen dat het uitvoeren van een tangentiële IMRT-techniek in combinatie 
met een ademhalingsgecontroleerde techniek de beste combinatie is. Of door het toe-
passen van deze ademhalingsgecontroleerde bestralingstechnieken daadwerkelijk de 
kans op het ontstaan van hart-en vaatziekten na bestraling verkleind wordt, kan niet 
uit deze planningsstudies worden geconcludeerd.
De resultaten van de coronair–arterie-calcium (CAC) studie worden uiteengezet in 
hoofdstuk 3. De CAC scores werden bepaald op een CT scan die zonder toevoegen 
van contrast werd uitgevoerd. Volgens de literatuurgegevens blijken deze scores een 
uitstekende voorspeller te zijn voor het ontstaan van hart- en vaatziekten. Daarom 
wordt de CAC-score gezien als een surrogaat voor schade in de coronair-arteriën. In 
de eerste studie hebben we aangetoond dat de CAC-scores (bepaald voor de start van 
de bestraling) van vrouwen met borstkanker in de leeftijdscategorie van 55-64 jaar sig-
nificant hoger waren dan de CAC-scores in een cohort asymptomatische Amerikaanse 
vrouwen zonder borstkanker. Deze bevinding wekt de suggestie dat vrouwen met borst-
kanker meer risico met zich mee dragen op het ontwikkelen van hart- en vaatziekten. 
In de tweede studie hebben we drie jaar na afloop van de radiotherapie een signifi-
cant lagere stijging gevonden van de CAC scores in de LAD in de groep van vrouwen 
met linkszijdige borstkanker en bestraald met de ademhalingsgecontroleerde techniek 
vergeleken met vrouwen bestraald voor linkszijdige borstkanker zonder de ademha-
lingsgecontroleerde techniek. Tevens bleek, in de groep vrouwen die linkszijdig werden 
bestraald met de ademhalingsgecontroleerde techniek, dat het verschil tussen de CAC 
score van de LAD en de CAC score van de rechter coronair arterie (RCA), bepaald voor 
elke individuele patiënt, drie jaar na de bestraling minder stijgt in vergelijking met vrou-
wen die linkszijdig werden bestraald zonder de ademhalingsgecontroleerde techniek. 
Beperkingen van deze studie zijn de kleine aantallen en de relatief korte follow-up.
In het discussie-hoofdstuk worden diverse toekomstperspectieven uiteengezet. Ten aan-
Samenvatting
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zien van het intekenen van het doelvolume ontraden we om MR beelden routinematig 
te gebruiken naast de CT beelden. Dit geldt voor zowel het intekenen van het borstklier-
weefsel als voor het intekenen van de lumpectomieholte. Verder concluderen we dat de 
tangentiële IMRT-techniek in combinatie met een ademhalingsgecontroleerde, de beste 
techniek is voor het electief bestralen van linkszijdige borstkanker. Dit is gebaseerd op 
het feit dat uit onze planningsstudies naar voren is gekomen dat in alle onderzochte 
patiënten een betere dosishomogeniteit was gevonden, en tevens een verlaging van de 
dosis in het hart, met name in het caudale gedeelte van de LAD. Omdat geen absolute 
drempelwaarden kunnen worden gedefinieerd, adviseren wij, gebaseerd op onze bevin-
dingen en daaromtrent gepubliceerd onderzoek, om de volgende drempelwaarden voor 
linkszijdige borstbestralingen toe te passen. 
We gaan uit van een fractioneringsschema van 42.65Gy in 16 fracties. 
1.    Gemiddelde hart dosis < 2 Gy;
2.    Gemiddelde long dosis < 5 Gy;
3.     Gemiddelde dosis buiten het te bestralen gebied, Planning Target Volume (PTV), 
zo laag mogelijk.
4.     Bij patiënten jonger dan 45 jaar moet de dosis in de contralaterale borst zo laag 
mogelijk gehouden worden. In patiënten met een BRCA 1/2 genafwijking is dit zo 
mogelijk van nog groter belang.
Onze planningstudies tonen aan dat deze drempelwaarden haalbaar zijn. Verder ad-
viseren we de ademhalingsgecontroleerde techniek toe te passen bij alle patiënten met 
linkszijdige borstkanker, zonder een leeftijdsgrens aan te houden of criteria te stellen 
aan de grootte van de te bestralen borst.
Conclusie: we hebben beschreven dat verbeteringen in radiotherapie-technieken bij 
borstkanker kunnen worden behaald. Echter, ondanks deze inspanningen zal het ge-
zonde weefsel nog steeds een zekere dosis ontvangen als de gehele borst wordt be-
straald. Mede hierom is het individualiseren van de bestralingsbehandeling van groot 
belang. Vervolgonderzoek zal tot doel moeten hebben negatieve (late) effecten van de 
radiotherapie te beperken en de kwaliteit van leven van de patiënt te verhogen. De 
introductie van partiële borstbestraling (APBI) zal verder onderzocht moeten worden. 
Dit geldt eveneens voor de vraag of de electieve borstbestraling wellicht volledig ach-
terwege gelaten kan worden na borstsparende operatie. Besluitvorming hieromtrent 
kan niet worden geforceerd zonder de patiënt hierin te kennen en kennis te nemen van 







3D-CRT  3D-Conformal Radiotherapy
ABC  Active Breathing Control
APBI  Accelerated Partial Breast Irradiation
BCT   Breast Conserving Therapy
BH   Breath-Hold
BMI   Body Mass Index
CAC   Coronary Artery Calcium
CAD  Coronary Artery Disease
CI  Conformity Index
CICT;CTV  Conformity Index on CT for the CTV Breast
CICTMR;CTV  Conformity Index on CT compared to CTMR for the CTV Breast
CICT;LC    Conformity Index on CT for the Lumpectomy Cavity 
CICTMR;LC  Conformity Index on CT compared to CTMR for the  
Lumpectomy Cavity
CT  Computer Tomography
CVS  Cavity Visualisation Score
CTV   Clinical Target Volume
DCS   Dice Similarity Coefficient   
mDIBH   moderate Deep Inspiration Breath Hold
DVH  Dose Volume Histogram
FB   Free-Breathing
FRS   Framingham Risk Score
GBT  Glandular Breast Tissue
HLSs   Hodgkin’s Lymphoma Survivors 
IMPT  Intensity Modulated Proton Therapy
IMRT  Intensity Modulated RadioTherapy
IORT   Intra Operative RadioTherapy
LAD  Left Anterior Descending (coronary artery)
LC   Lumpectomy Cavity
LMA   Left Main Artery
LMx   Left Circumflex artery
MESA   Multi-Ethnic Study of Atherosclerosis
MRI   Magnetic Resonance Imaging
MST   Mamma Sparende Techniek
NMI   Normalized Mutual Information 
PTV   Planning Target Volume
RBE   Relative Biological Effectiveness
RCA   Right Coronary Artery
RCWEST Radiotherapy Centre West
RT  Radiation Therapy
SD   Standard Deviation
SE   Standard Error
TSE   Turbo Spin Echo
VMAT  Volumetric Arc Therapy
WFS   Water-Fat Shift 
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Preclinical and clinical studies reveal that 
left-sided breast cancer radiotherapy 
is associated with an increased rate of 
major coronary events. Consequently, 
when irradiating women with left- 
sided breast cancer, specific measures 
should be taken to decrease the heart 
dose as much as possible and to avoid 
radiation-induced coronary artery 
disease. This thesis focuses on several 
strategies to optimise the radiation 
treatment for patients with left-sided 
breast cancer. 
With respect to whole breast  
irradiation we concluded that:
-  the routine use of MR images in  
addition to the CT scan, when  
delineating either the glandular  
breast tissue or the lumpectomy  
cavity, does not have added value. 
-  tangential IMRT technique combined 
with a breath-hold technique should 
be the treatment technique of choice 
for left-sided breast cancer. 
-  a breath-hold technique should and 
can be used in all left-sided breast 
cancer patients, regardless of age  
and breast size.
-  breath-hold in left-sided whole  
breast radiotherapy results in a less 
pronoun ced increase of coronary  
calcium score and, hence, could  
result in less radiation-induced  
cardio vascular damage.
